<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Mol Biosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Mol Biosci</journal-id><journal-id journal-id-type="pmc-domain-id">2732</journal-id><journal-id journal-id-type="pmc-domain">fmolb</journal-id><journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id><journal-title-group><journal-title>Frontiers in Molecular Biosciences</journal-title></journal-title-group><issn pub-type="epub">2296-889X</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC8385298</article-id><article-id pub-id-type="pmcid-ver">PMC8385298.1</article-id><article-id pub-id-type="pmcaid">8385298</article-id><article-id pub-id-type="pmcaiid">8385298</article-id><article-id pub-id-type="pmid">34458323</article-id><article-id pub-id-type="doi">10.3389/fmolb.2021.719678</article-id><article-id pub-id-type="publisher-id">719678</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Molecular Biosciences</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Multifunctional Fructose 1,6-Bisphosphate Aldolase as a Therapeutic Target</article-title><alt-title alt-title-type="left-running-head">Pirovich et al.</alt-title><alt-title alt-title-type="right-running-head">Targeting Multifunctional Aldolase</alt-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Pirovich</surname><given-names initials="DB">David B.</given-names></name><xref ref-type="corresp" rid="c001">*</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1354431/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Da&#8217;dara</surname><given-names initials="AA">Akram A.</given-names></name><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/571071/overview"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Skelly</surname><given-names initials="PJ">Patrick J.</given-names></name><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/143092/overview"/></contrib></contrib-group><aff>Molecular Helminthology Laboratory, Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine, Tufts University, <addr-line>North Grafton</addr-line>, <addr-line>MA</addr-line>, <country>United States</country>
</aff><author-notes><fn fn-type="edited-by"><p><bold>Edited by:</bold><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/46325/overview">Nikolaos E. Labrou</ext-link>, Agricultural University of Athens, Greece</p></fn><fn fn-type="edited-by"><p><bold>Reviewed by:</bold><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/529515/overview">Benjamin Bernard Armando Raymond</ext-link>, UMR5089 Institut de Pharmacologie et de Biologie Structurale (IPBS), France</p><p><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/438815/overview">Haizhen Wu</ext-link>, East China University of Science and Technology, China</p></fn><corresp id="c001">*Correspondence: David B. Pirovich, <email>david.pirovich@tufts.edu</email></corresp><fn fn-type="other"><p>This article was submitted to Protein Chemistry and Enzymology, a section of the journal Frontiers in Molecular Biosciences</p></fn></author-notes><pub-date pub-type="epub"><day>11</day><month>8</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>8</volume><issue-id pub-id-type="pmc-issue-id">375432</issue-id><elocation-id>719678</elocation-id><history><date date-type="received"><day>02</day><month>6</month><year>2021</year></date><date date-type="accepted"><day>31</day><month>7</month><year>2021</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2021</year></date></event><event event-type="pmc-live"><date><day>26</day><month>08</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-10 13:25:50.700"><day>10</day><month>11</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2021 Pirovich, Da&#8217;dara and Skelly.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Pirovich, Da&#8217;dara and Skelly</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fmolb-08-719678.pdf"/><abstract><p>Fructose 1,6-bisphosphate aldolase is a ubiquitous cytosolic enzyme that catalyzes the fourth step of glycolysis. Aldolases are classified into three groups: Class-I, Class-IA, and Class-II; all classes share similar structural features but low amino acid identity. Apart from their conserved role in carbohydrate metabolism, aldolases have been reported to perform numerous non-enzymatic functions. Here we review the myriad &#8220;moonlighting&#8221; functions of this classical enzyme, many of which are centered on its ability to bind to an array of partner proteins that impact cellular scaffolding, signaling, transcription, and motility. In addition to the cytosolic location, aldolase has been found the extracellular surface of several pathogenic bacteria, fungi, protozoans, and metazoans. In the extracellular space, the enzyme has been reported to perform virulence-enhancing moonlighting functions e.g., plasminogen binding, host cell adhesion, and immunomodulation. Aldolase&#8217;s importance has made it both a drug target and vaccine candidate. In this review, we note the several inhibitors that have been synthesized with high specificity for the aldolases of pathogens and cancer cells and have been shown to inhibit classical enzyme activity and moonlighting functions. We also review the many trials in which recombinant aldolases have been used as vaccine targets against a wide variety of pathogenic organisms including bacteria, fungi, and metazoan parasites. Most of such trials generated significant protection from challenge infection, correlated with antigen-specific cellular and humoral immune responses. We argue that refinement of aldolase antigen preparations and expansion of immunization trials should be encouraged to promote the advancement of promising, protective aldolase vaccines.</p></abstract><kwd-group><kwd>aldolase</kwd><kwd>vaccine</kwd><kwd>inhibitor</kwd><kwd>moonlighting function</kwd><kwd>glycolysis</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Institute of Allergy and Infectious Diseases<named-content content-type="fundref-id">10.13039/100000060</named-content></funding-source><award-id rid="cn001">AI056273</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Glycolysis is the highly conserved ten-step metabolic pathway in which glucose is catabolized to pyruvate, leading to the formation of the high-energy molecules adenosine triphosphate (ATP) and reduced nicotinamide adenine dinucleotide (NADH). The fourth step in the glycolytic pathway is the aldol cleavage of the six-carbon fructose 1,6-bisphosphate (F1,6BP) into two triosephosphates: glyceraldehyde 3-phosphate (GAP) and dihydroxyacetone phosphate (DHAP) (<xref rid="B105" ref-type="bibr">Michels and Fothergill-Gilmore, 2017</xref>). The reaction, illustrated in <xref ref-type="fig" rid="F1">Figure 1</xref>, is catalyzed by the enzyme fructose 1,6-bisphosphate aldolase (FBA, EC 4.1.2.13), sometimes referred to as simply &#8220;aldolase&#8221;. The C3-C4 carbon bond in F1,6BP is cleaved to form GAP and DHAP following the formation of an intermediate within the active site of the aldolase enzyme (<xref rid="B31" ref-type="bibr">Cooper et al., 1996</xref>; <xref rid="B82" ref-type="bibr">Labb&#233; et al., 2012</xref>). Aldolase has been characterized in many bacteria, archaea, and eukaryotes (<xref rid="B149" ref-type="bibr">Stribling and Perham 1973</xref>; <xref rid="B175" ref-type="bibr">Yeltman and Harris 1977</xref>; <xref rid="B130" ref-type="bibr">Ramsaywak et al., 2004</xref>; <xref rid="B54" ref-type="bibr">Galkin et al., 2007</xref>) and plays central roles not just in glycolysis but also in gluconeogenesis (the metabolic pathway forming glucose from pyruvate) and fructose metabolism (<xref rid="B42" ref-type="bibr">Droppelmann et al., 2015</xref>; <xref rid="B15" ref-type="bibr">Bu et al., 2018</xref>; <xref rid="B102" ref-type="bibr">Melkonian et al., 2020</xref>).</p><fig id="F1" position="float" orientation="portrait"><label>FIGURE 1</label><caption><p>The fourth step in glycolysis: fructose 1,6-bisphosphate aldolase (FBA) catalyzes the reversible conversion of the six-carbon glycolytic enzyme fructose 1,6-bisphosphate (F1,6BP, left) into two three-carbon intermediates glyceraldehyde 3-phosphate (GAP) and dihydroxyacetone phosphate (DHAP, right).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmolb-08-719678-g001.jpg"/></fig><p>There are three different classes of aldolases: Class-I, Class-IA, and Class-II. Class-I aldolases utilize a lysine residue within the active site to create a stabilizing Schiff base intermediate with the substrate. Class-I aldolases typically form homotetramers with a total molecular weight of &#8764;160&#160;kDa (<xref rid="B57" ref-type="bibr">Gamblin et al., 1990</xref>; <xref rid="B31" ref-type="bibr">Cooper et al., 1996</xref>). In contrast, Class-II aldolases are metal-dependent and rely on divalent ions (typically Zn<sup>2+</sup>) to stabilize the carbanion intermediate formed by the substrate within the active site (<xref rid="B127" ref-type="bibr">Prasad et al., 2013</xref>; <xref rid="B105" ref-type="bibr">Michels and Fothergill-Gilmore, 2017</xref>). Class-II aldolases typically form homodimers with a total molecular weight of &#8764;78&#160;kDa but can also form tetramers and octamers (<xref rid="B31" ref-type="bibr">Cooper et al., 1996</xref>; <xref rid="B122" ref-type="bibr">Pegan et al., 2009</xref>). Class-I aldolases are typically found in higher eukaryotic organisms (e.g. plants and animals), while Class-II aldolases are more common in morphologically less complex eukaryotic organisms (e.g., protozoans, fungi, yeasts, and algae), in prokaryotes and in some archaea (<xref rid="B158" ref-type="bibr">Tunio et al., 2010</xref>; <xref rid="B127" ref-type="bibr">Prasad et al., 2013</xref>; <xref rid="B47" ref-type="bibr">Falcicchio et al., 2014</xref>; <xref rid="B105" ref-type="bibr">Michels and Fothergill-Gilmore, 2017</xref>). Some parasitic protozoans, for instance <italic toggle="yes">Trypanosoma brucei</italic> (<xref rid="B36" ref-type="bibr">Dax et al., 2006</xref>), <italic toggle="yes">Leishmania donovani</italic> (<xref rid="B67" ref-type="bibr">Gupta et al., 2014</xref>), and <italic toggle="yes">Plasmodium falciparum</italic> (<xref rid="B12" ref-type="bibr">Bosch et al., 2007</xref>), have been reported to possess Class-I aldolases and not Class-II aldolases. A third class of aldolases, designated Class-IA, is found in archaea (e.g., <italic toggle="yes">Thermoproteus tenax, Pyrococcus furiosus</italic>) (<xref rid="B143" ref-type="bibr">Siebers et al., 2001</xref>). These have a similar mechanism of action as Class-I aldolases and have been reported to exist as homo-octamers, decamers or even higher oligomers (<xref rid="B92" ref-type="bibr">Lorentzen et al., 2003</xref>; <xref rid="B93" ref-type="bibr">Lorentzen et al., 2004</xref>).</p><p>Most organisms have an aldolase belonging to one class exclusively, but some bacteria (e.g., <italic toggle="yes">Escherichia coli</italic>, <italic toggle="yes">Mycobacterium tuberculosis</italic>, <italic toggle="yes">Streptococcus pneumoniae</italic>) and algae (e.g., red algae, glaucocystophytes, some diatoms) have been reported to possess both a Class-I and a Class-II aldolase (<xref rid="B158" ref-type="bibr">Tunio et al., 2010</xref>; <xref rid="B3" ref-type="bibr">Allen et al., 2012</xref>; <xref rid="B141" ref-type="bibr">Shams et al., 2014</xref>). The core characteristics of the three classes of aldolase are summarized in <xref rid="T1" ref-type="table">Table 1</xref>.</p><table-wrap id="T1" position="float" orientation="portrait"><label>TABLE 1</label><caption><p>A summary of characteristics the three classes of aldolase and the organisms in which they are found.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Aldolase class</th><th align="center" rowspan="1" colspan="1">Organisms</th><th align="center" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="left" colspan="1">I</td><td rowspan="2" align="left" colspan="1">Higher eukaryotes (plants, animals), some protozoans (e.g., <italic toggle="yes">Trypanosoma brucei, Leishmania donovani</italic>, <italic toggle="yes">Plasmodium falciparum</italic>), some bacteria, some algae</td><td align="left" rowspan="1" colspan="1">&#8226; Mechanism of action: Schiff base forms substrate intermediate</td><td rowspan="2" align="left" colspan="1"><xref rid="B57" ref-type="bibr">Gamblin et al. (1990)</xref>, <xref rid="B31" ref-type="bibr">Cooper et al. (1996)</xref>, <xref rid="B105" ref-type="bibr">Michels and Fothergill-Gilmore (2017)</xref>, <xref rid="B127" ref-type="bibr">Prasad et al. (2013)</xref>, <xref rid="B158" ref-type="bibr">Tunio et al. (2010)</xref>, <xref rid="B36" ref-type="bibr">Dax et al. (2006)</xref>, <xref rid="B12" ref-type="bibr">Bosch et al. (2007)</xref>, <xref rid="B56" ref-type="bibr">Galperin et al. (1998)</xref>, <xref rid="B3" ref-type="bibr">Allen et al. (2012)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Structure: Typically forms homo-tetramers, contains TPI &#946;/&#945;-barrel fold</td></tr><tr><td rowspan="2" align="left" colspan="1">IA</td><td rowspan="2" align="left" colspan="1">Archaea</td><td align="left" rowspan="1" colspan="1">&#8226; Mechanism of action: Schiff base forms substrate intermediate</td><td rowspan="2" align="left" colspan="1"><xref rid="B93" ref-type="bibr">Lorentzen et al. (2004)</xref>, <xref rid="B92" ref-type="bibr">Lorentzen et al. (2003)</xref>, <xref rid="B143" ref-type="bibr">Siebers et al. (2001)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Structure: Typically forms homo-octamers/decamers/higher oligomers, contains TPI &#946;/&#945;-barrel fold</td></tr><tr><td rowspan="2" align="left" colspan="1">II</td><td rowspan="2" align="left" colspan="1">&#8220;Lower&#8221; eukaryotes (some protozoans (e.g., <italic toggle="yes">Giardia lamblia</italic>), fungi, yeasts, algae), most bacteria, some archaea</td><td align="left" rowspan="1" colspan="1">&#8226; Mechanism of action: Divalent ion forms substrate intermediate, metal-dependent</td><td rowspan="2" align="left" colspan="1"><xref rid="B105" ref-type="bibr">Michels and Fothergill-Gilmore (2017)</xref>, <xref rid="B127" ref-type="bibr">Prasad et al. (2013)</xref>, <xref rid="B31" ref-type="bibr">Cooper et al. (1996)</xref>, <xref rid="B122" ref-type="bibr">Pegan et al. (2009)</xref>, <xref rid="B158" ref-type="bibr">Tunio et al. (2010)</xref>, <xref rid="B141" ref-type="bibr">Shams et al. (2014)</xref>, <xref rid="B56" ref-type="bibr">Galperin et al. (1998)</xref>, <xref rid="B54" ref-type="bibr">Galkin et al. (2007)</xref>, <xref rid="B47" ref-type="bibr">Falcicchio et al. (2014)</xref>, <xref rid="B3" ref-type="bibr">Allen et al. (2012)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#8226; Structure: Typically forms homo-dimers, contains TPI &#946;/&#945;-barrel fold</td></tr></tbody></table><table-wrap-foot><fn><p>TPI, triosephosphate isomerase</p></fn></table-wrap-foot></table-wrap><p>Classical bacterial Class-I aldolases share modest sequence homology with Class-I aldolases of eukaryotes (<xref rid="B155" ref-type="bibr">Thomson et al., 1998</xref>). For example, the Class-I aldolase of the bacterium <italic toggle="yes">Staphylococcus carnosus</italic> shares &#8764;34% amino acid identity with human aldolases, &#8764;25% with <italic toggle="yes">Drosophila melanogaster</italic> aldolase, and &#8764;37% with <italic toggle="yes">P. falciparum</italic> aldolase (<xref rid="B166" ref-type="bibr">Witke and G&#246;tz 1993</xref>). In general, Class-I and Class-II aldolases exhibit no sequence homology (<xref rid="B115" ref-type="bibr">Nakahara et al., 2003</xref>) but share similar structural features [a triosephosphate isomerase (TPI) &#946;/&#945;-barrel fold and similar active sites (<xref rid="B56" ref-type="bibr">Galperin et al., 1998</xref>) as noted in <xref rid="T1" ref-type="table">Table 1</xref>], have generally similar sizes (&#8764;40&#160;kDa), and catalyze the same enzymatic reactions. The active sites of Class-I and Class-II aldolases are found in different parts of the TPI barrel, and thus the two classes are considered functionally analogous enzymes that likely evolved independently from one another to perform the same catalytic function using distinct mechanisms of action (<xref rid="B2" ref-type="bibr">Alefounder et al., 1989</xref>; <xref rid="B98" ref-type="bibr">Marsh and Lebherz 1992</xref>; <xref rid="B115" ref-type="bibr">Nakahara et al., 2003</xref>; <xref rid="B141" ref-type="bibr">Shams et al., 2014</xref>). Class-IA aldolases show little similarity&#8211;as low as 20% at the amino acid level&#8211;to classical Class-I or Class-II aldolases (<xref rid="B143" ref-type="bibr">Siebers et al., 2001</xref>). However, some important catalytic and substrate-binding residues are conserved between archaean and Class-I aldolases, suggesting that the two protein families share a common evolutionary origin (<xref rid="B92" ref-type="bibr">Lorentzen et al., 2003</xref>; <xref rid="B93" ref-type="bibr">Lorentzen et al., 2004</xref>). Indeed, some bacterial Class-I aldolases, such as the <italic toggle="yes">E. coli</italic> Class-I aldolase&#8211;unusual among the Class-I aldolases&#8211;are similar to Class-IA aldolases in sequence, quaternary structure, and biochemical activity (<xref rid="B143" ref-type="bibr">Siebers et al., 2001</xref>).</p><p>Vertebrates possess three isoforms of Class-I aldolase&#8211;aldolase A (ALDOA), aldolase B (ALDOB), and aldolase C (ALDOC), which are encoded by three different genes (<xref rid="B157" ref-type="bibr">Tolan et al., 1987</xref>). These isoenzymes are expressed in specific tissues and are similar to one another in molecular mass (&#8764;40&#160;kDa) and catalytic mechanism. ALDOA is expressed mainly in red blood cells and muscle tissue, ALDOB is expressed in the liver, kidney, and small intestine, and ALDOC is expressed in the brain, smooth muscle, and neuronal tissue (<xref rid="B4" ref-type="bibr">Arakaki et al., 2004</xref>; <xref rid="B23" ref-type="bibr">Chang et al., 2018</xref>). Each isoenzyme has high sequence identity with its counterparts; human ALDOA and ALDOB share 66% identity, ALDOB and ALDOC share 68% identity, and ALDOA and ALDOC share 78% identity (<xref rid="B4" ref-type="bibr">Arakaki et al., 2004</xref>). While all three aldolases contribute to the glycolytic pathway, ALDOB and ALDOC have been reported (<xref rid="B23" ref-type="bibr">Chang et al., 2018</xref>) to also perform fructolytic functions: i.e., these isoenzymes are additionally able to convert fructose 1-phosphate, derived from the phosphorylation of fructose by fructokinase, into DHAP and glyceraldehyde (<xref rid="B150" ref-type="bibr">Sun and Empie 2012</xref>). Class-II aldolase sequence similarities vary wildly: the Class-II aldolase of <italic toggle="yes">E. coli</italic> shares 10% amino acid identity with that of the bacterium <italic toggle="yes">Rhodobacter sphaeroides</italic>, but 49% identity with the Class-II aldolase of the fungus <italic toggle="yes">Schizosaccharomyces pombe</italic> (<xref rid="B114" ref-type="bibr">Mutoh and Hayashi 1994</xref>).</p><p>The amino acid sequences of aldolase enzymes from a variety of organisms from diverse phyla were aligned using the neighbor-joining method to construct the phylogenetic tree shown in <xref ref-type="fig" rid="F2">Figure 2</xref>. It is clear that Class-I aldolases and Class-II aldolases are phylogenetically distinct entities that cluster into separate branches. Class-IA aldolases are also distinct, but these cluster near the unusual Class-I aldolase of <italic toggle="yes">E. coli</italic> (<xref rid="B143" ref-type="bibr">Siebers et al., 2001</xref>).</p><fig id="F2" position="float" orientation="portrait"><label>FIGURE 2</label><caption><p>Phylogenetic tree of fructose 1,6-bisphosphate aldolases constructed by Molecular Evolutionary Genetics Analysis (MEGA) Version 7.0.21 software using amino acid sequences obtained from the UniProt database. The sequences were aligned by BioEdit Sequence Alignment Editor software using ClustalW Multiple sequence alignment. The evolutionary history was inferred using the Neighbor-Joining method. The optimal tree with the sum of branch length = 10.38 is shown. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1,000 replicates) are shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. Evolutionary distances were computed using the Poisson correction method and are in the units of the number of amino acid substitutions per site. The analysis involved 24&#160;amino acid sequences. The UniProt accession numbers for the sequences are as follows: <italic toggle="yes">Candida albicans</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="Q9URB4">Q9URB4</ext-link>); <italic toggle="yes">Caenorhabditis elegans</italic> FBA 1 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P54216">P54216</ext-link>); <italic toggle="yes">Caenorhabditis elegans</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P46563">P46563</ext-link>); <italic toggle="yes">Drosophila melanogaster</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P07764">P07764</ext-link>); <italic toggle="yes">Escherichia coli</italic> Class-I (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P0A991">P0A991</ext-link>); <italic toggle="yes">Escherichia coli</italic> Class-II (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P0AB71">P0AB71</ext-link>); <italic toggle="yes">Francisella novicida</italic> (A0A2L1CHL1); <italic toggle="yes">G. lamblia</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="O97447">O97447</ext-link>); <italic toggle="yes">Haloferax volcanii</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="D4GYE0">D4GYE0</ext-link>); <italic toggle="yes">Homo sapiens</italic> ALDOA (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P04075">P04075</ext-link>); <italic toggle="yes">Homo sapiens</italic> ALDOB (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P05062">P05062</ext-link>); <italic toggle="yes">Homo sapiens</italic> ALDOC (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P09972">P09972</ext-link>); <italic toggle="yes">Mus musculus</italic> ALDOA (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P05064">P05064</ext-link>); <italic toggle="yes">Mus musculus</italic>n ALDOB (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="Q91Y97">Q91Y97</ext-link>); <italic toggle="yes">Mus musculus</italic> ALDOC (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P05063">P05063</ext-link>); <italic toggle="yes">Nicotiana tabacum</italic> (F2VJ75); <italic toggle="yes">Phaeodactylum tricornutum</italic> Class-I (B7GE67); <italic toggle="yes">Phaeodactylum tricornutum</italic> Class-II (B7G4R3); <italic toggle="yes">Plasmodium falciparum</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P14223">P14223</ext-link>); <italic toggle="yes">Pyrococcus furiosus</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P58314">P58314</ext-link>); <italic toggle="yes">Saccharomyces cerevisiae</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P14540">P14540</ext-link>); <italic toggle="yes">Schistosoma mansoni</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P53442">P53442</ext-link>); <italic toggle="yes">Thermoproteus tenax</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P58315">P58315</ext-link>); <italic toggle="yes">Trypanosoma brucei</italic> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-protein" xlink:href="P07752">P07752</ext-link>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmolb-08-719678-g002.jpg"/></fig><p>In this review, we discuss non-traditional functions of aldolases in prokaryotic and eukaryotic organisms. In addition, we review the literature showing that these conserved, classically intracellular proteins can also be commonly found in the extracellular environment and we describe the moonlighting functions of aldolases found extracellularly. Finally, we examine efforts to curtail diseases by inhibiting aldolase using drugs or by targeting the enzymes as vaccines candidates.</p></sec><sec id="s2"><title>Non-canonical Functions of Intracellular Aldolases</title><p>In addition to catalyzing the fourth step in glycolysis, some aldolases can also exhibit other enzymatic properties. For instance, in some archaean species, aldolase acts as a fructose 1,6-bisphosphate phosphatase (<xref rid="B136" ref-type="bibr">Say and Fuchs 2010</xref>). Apart from their well-established involvement in carbohydrate metabolism, aldolases have been reported to perform several additional, or &#8220;moonlighting&#8221;, functions as indeed have other glycolytic enzymes (<xref rid="B73" ref-type="bibr">Jeffery 1999</xref>; <xref rid="B141" ref-type="bibr">Shams et al., 2014</xref>). Enolase, for example, which catalyzes the eight step in glycolysis, has been reported to possess several non-glycolytic moonlighting functions which could benefit mammalian cells [e.g., stabilizing the mitochondrial membrane (<xref rid="B40" ref-type="bibr">Didiasova et al., 2019</xref>)] and pathogens alike [e.g. by binding plasminogen - <italic toggle="yes">Streptococcus pneumoniae</italic> (<xref rid="B8" ref-type="bibr">Bergmann et al., 2001</xref>) and <italic toggle="yes">Schistosoma mansoni</italic> (<xref rid="B48" ref-type="bibr">Figueiredo et al., 2015</xref>)].</p><sec id="s2-1"><title>Intracellular Moonlighting Functions of Aldolase</title><p>A key feature of the moonlighting action of aldolase arises from its ability to bind to a wide variety of other proteins. For instance, within some mammalian cells, aldolase can contribute to intracellular scaffolding by e.g., interacting with actin (<xref rid="B163" ref-type="bibr">Wang et al., 1997</xref>) and vacuolar-type H<sup>+</sup>-ATPase (V-ATPase) (<xref rid="B104" ref-type="bibr">Merkulova et al., 2011</xref>) or by inhibiting Wiskott-Aldrich Syndrome Protein (WASP)-dependent actin polymerization (<xref rid="B86" ref-type="bibr">Lew and Tolan 2013</xref>). In the yeast <italic toggle="yes">Saccharomyces cerevisiae</italic>, aldolase helps control RNA polymerase III-directed transcription through a physical interaction (<xref rid="B27" ref-type="bibr">Cie&#347;la et al., 2014</xref>). Aldolase has additionally been reported (<xref rid="B131" ref-type="bibr">Rangarajan et al., 2010</xref>) to regulate endocytosis by binding to the intracellular trafficking protein sorting nexin 9 (SNX9). Aldolase has also been reported to bind with phospholipase D2 (<xref rid="B77" ref-type="bibr">Kim et al., 2002</xref>), heparin (<xref rid="B152" ref-type="bibr">Ta et al., 1999</xref>), band three of erythrocytes (<xref rid="B148" ref-type="bibr">Strapazon and Steck 1976</xref>), and &#947;-tubulin (<xref rid="B162" ref-type="bibr">Volker and Knull 1997</xref>), but the functional roles of these interactions are unknown.</p><p>One remarkable function of aldolase is its ability to serve as a sensor of glucose availability. When the intracellular concentration of the aldolase substrate F1,6BP is low, aldolase has been found to interact with V-ATPase. This promotes the activation of AMP-activated protein kinase (AMPK) and it is this protein that then stimulates ATP production by increasing the activity or expression of proteins involved in catabolism while switching off biosynthetic pathways (<xref rid="B177" ref-type="bibr">Zhang et al., 2017</xref>; <xref rid="B89" ref-type="bibr">Li et al., 2019b</xref>).</p><p>Cancer cells favor aerobic glycolysis as their primary means of energy production in a phenomenon known as the Warburg effect (<xref rid="B160" ref-type="bibr">Vander Heiden et al., 2009</xref>). This leads to high expression of many glycolytic enzymes to fulfill the energy demand of synthesizing the cellular metabolites needed for increased replication (<xref rid="B33" ref-type="bibr">Curcio et al., 2021</xref>). Overexpression of human ALDOA in pancreatic cancer cells results both in increased rates of glycolysis and increased metastasis, leading to poor prognosis and reduced survival rates (<xref rid="B33" ref-type="bibr">Curcio et al., 2021</xref>). In some cancer cells, aldolase can promote DNA-dependent protein kinase (DNA-PK) activation by binding to its catalytic subunit; DNA-PK phosphorylates the tumor suppressor protein p53 to enhance its activity (<xref rid="B95" ref-type="bibr">Ma et al., 2018</xref>). Aldolase can also activate the oncogenic Wingless/Int-1 (Wnt) signaling pathway in mammalian cells by blocking the elimination of the signaling molecule &#946;-catenin implicated in promoting colorectal cancer (<xref rid="B19" ref-type="bibr">Caspi et al., 2014</xref>). In bladder cancer, ALDOA was reported (<xref rid="B88" ref-type="bibr">Li et al., 2019a</xref>) to act as an oncogene by interacting with E-cadherin-epidermal growth factor receptor (EGFR) signaling, leading to cancer cell metastasis. In sum, these studies reveal both pro-oncogenic (<italic toggle="yes">via</italic> Wnt/E-cadherin-EGFR signaling) as well as anti-oncogenic (<italic toggle="yes">via</italic> p53 upregulation) functions for aldolase under different circumstances.</p><p>Human ALDOA can bind to the untranslated regions (UTRs) of the Japanese encephalitis virus (JEV) RNA antigenome and can influence viral replication. Expression of the viral nonstructural protein 5 (NS5) reduces to &#8764;41% in ALDOA-knockout human embryonic kidney (HEK238T) cells (<xref rid="B156" ref-type="bibr">Tien et al., 2014</xref>). In addition, JEV infection increased expression of ALDOA by 33% in these cells. ALDOA was similarly found to bind to a stemloop of the 3&#8242;-UTR in simian hemorrhagic fever virus, but the function of this binding, if any, is unknown (<xref rid="B96" ref-type="bibr">Maines et al., 2005</xref>).</p></sec><sec id="s2-2"><title>Moonlighting Functions of Aldolase Inside Pathogens</title><p>In the intracellular pathogenic bacterium <italic toggle="yes">Francisella novicida</italic>, aldolase is necessary for bacterial replication within macrophages; the enzyme acts as a transcriptional repressor of the <italic toggle="yes">katG</italic> gene encoding catalase (KatG). When <italic toggle="yes">F. novicida</italic> bacteria escape from the host cell phagosome into the cytosol, bacterial aldolase is upregulated and downregulates <italic toggle="yes">katG</italic> expression. This results in an accumulation of the katG substrate hydrogen peroxide which, in turn, activates the calcium (Ca<sup><italic toggle="yes">2+</italic></sup>) transporter TRPM2. A subsequent increase in intracellular calcium activates the macrophage inflammatory response (primarily, production of IL-6) (<xref rid="B139" ref-type="bibr">Shakerley et al., 2016</xref>). This outcome is considered beneficial for the bacteria since it creates optimal conditions for bacterial survival by increased dissemination to recruited phagocytes (<xref rid="B179" ref-type="bibr">Ziveri et al., 2017</xref>).</p><p>In the apicomplexan parasites <italic toggle="yes">P. falciparum</italic>, <italic toggle="yes">T. gondii,</italic> and <italic toggle="yes">Babesia gibsoni</italic>, intracellular aldolase tetramers bind to both intracellular F-actin/myosin filaments (which anchor to the parasite&#8217;s inner membrane complex) and to transmembrane adhesins thrombospondin-related anonymous protein (TRAP)/micronemal protein 2 (MIC2) (which bind to host cell surfaces). In this manner, aldolase contributes to parasite motility and host cell invasion (<xref rid="B29" ref-type="bibr">Collingridge et al., 2010</xref>; <xref rid="B64" ref-type="bibr">Goo et al., 2013</xref>). The TRAP-binding site of aldolase is hypothesized to overlap with its glycolytic active site, and binding leads to inhibition of the enzyme&#8217;s classical catalytic function (<xref rid="B16" ref-type="bibr">Buscaglia et al., 2003</xref>; <xref rid="B12" ref-type="bibr">Bosch et al., 2007</xref>; <xref rid="B14" ref-type="bibr">Boucher et al., 2018</xref>). However, the requirement for aldolase in the TRAP/MIC2-binding model for apicomplexan motility and invasion is not seen in <italic toggle="yes">T. gondii</italic>; knockdown and mutation of aldolase did not affect <italic toggle="yes">T. gondii</italic> invasion of human foreskin fibroblast (HFF) cells (<xref rid="B142" ref-type="bibr">Shen and Sibley 2014</xref>).</p></sec></sec><sec id="s3"><title>Evidence for Surface Localization of Aldolase on Many Pathogens</title><p>In addition to being widely distributed inside cells, in several instances aldolase has been reported (<xref rid="B61" ref-type="bibr">G&#243;mez-Arreaza et al., 2014</xref>; <xref rid="B141" ref-type="bibr">Shams et al., 2014</xref>; <xref rid="B125" ref-type="bibr">Pirovich et al., 2019</xref>) to be found on a cell&#8217;s exterior membranes, including on the host-exposed surface of many pathogenic organisms (both bacteria and eukaryotic parasites). One of the notable mysteries in the study of moonlighting proteins is that many surface-localized proteins, including aldolase, lack transmembrane domains and signal peptides involved in canonical secretion pathways: bioinformatics analysis of 22 published studies on bacterial surface proteomes revealed that &gt;1,000 of 3,619 proteins found on the cell surface lack such domains (<xref rid="B164" ref-type="bibr">Wang and Jeffery 2016</xref>). Further study of secretory/surface adhesion mechanisms are needed but there are reported non-classical secretion pathways that may be exploited to export moonlighting glycolytic enzymes; for example, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been shown to be secreted by the type III secretion system in <italic toggle="yes">E. coli</italic>, while <italic toggle="yes">S. pneumoniae</italic> enolase associates with the bacterial cell surface using an as-yet-unknown &#8220;anchorless&#8221; binding mechanism (<xref rid="B164" ref-type="bibr">Wang and Jeffrey 2016</xref>).</p><p>Extracellular aldolase can interact with host factors and can promote pathogen virulence and survival (<xref rid="B49" ref-type="bibr">Figuera et al., 2013</xref>; <xref rid="B118" ref-type="bibr">Oldfield et al., 2017</xref>). This surface localization has led many researchers to consider aldolase as a possible drug target or vaccine candidate, given its accessibility. Next, we review the various moonlighting functions of extracellular aldolases that have been reported to aid in the survival of a wide variety of pathogens. We also examine attempts to block aldolase function by targeting these multifunctional enzymes using drugs or vaccines.</p><p>Given the pivotal role aldolase plays in glycolysis&#8211;a process that takes place in the cell cytoplasm, it is somewhat surprising to find reports that this highly-conserved enzyme can additionally be found in the extracellular environment. Here, we review the evidence that aldolase can be found in sites other than its traditional location inside the cell. <xref ref-type="fig" rid="F3">Figure 3</xref> lists those pathogens (which include bacteria, protozoans, fungi, and metazoans) in which aldolase is reported to be surface-localized.</p><fig id="F3" position="float" orientation="portrait"><label>FIGURE 3</label><caption><p>A list of bacterial, fungal, protozoan, and metazoan pathogens reported to possess surface-localized fructose 1,6-bisphosphate aldolase (FBA) (left box) and a list of pathogens whose FBA has been reported to perform a specific moonlighting function: that is of binding plasminogen (top right box) and subsequently promoting its conversion into plasmin (top right box, insert). The conversion of plasminogen into plasmin (illustrated in the bottom right box) is catalyzed by protease activators including tissue plasminogen activator (tPA) or urokinase-type plasminogen activator (uPA). The outcome is fibrinolysis (since plasmin cleaves fibrin blood clots) and/or extracellular matrix (ECM) damage (since plasmin cleaves ECM proteins such as fibronectin and laminin). These mechanisms can be exploited by pathogens to favor their invasion and survival within their hosts <italic toggle="yes">in vivo</italic>, as FBA has been reported to enhance (green arrow) plasmin activation in the presence of activators. Abbreviations: FBA, fructose 1,6-bisphosphate aldolase; ECM, extracellular matrix; tPA, tissue plasminogen activator; uPA, urokinase-type plasminogen activator.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fmolb-08-719678-g003.jpg"/></fig><p>Evidence that aldolase can indeed be extracellular arises from proteomic analysis of isolated membrane preparations of several streptococcal bacteria including <italic toggle="yes">Streptococcus pneumoniae</italic> (<xref rid="B91" ref-type="bibr">Ling et al., 2004</xref>), <italic toggle="yes">S. pyogenes</italic> (<xref rid="B138" ref-type="bibr">Severin et al., 2007</xref>), <italic toggle="yes">S. oralis</italic> (<xref rid="B118" ref-type="bibr">Oldfield et al., 2017</xref>), <italic toggle="yes">S. agalactiae</italic> (<xref rid="B118" ref-type="bibr">Oldfield et al., 2017</xref>)<italic toggle="yes">,</italic> and <italic toggle="yes">S. suis</italic> (<xref rid="B168" ref-type="bibr">Wu et al., 2008</xref>). Additionally, aldolase has been detected in the secretions of <italic toggle="yes">S. pyogenes</italic> (<xref rid="B85" ref-type="bibr">Lei et al., 2000</xref>) and <italic toggle="yes">S. agalactiae</italic> (<xref rid="B118" ref-type="bibr">Oldfield et al., 2017</xref>).</p><p>Aldolase has been found (<xref rid="B103" ref-type="bibr">Mendon&#231;a et al., 2016</xref>) at the cell surface of several other bacteria: e.g., <italic toggle="yes">Coxiella burnetii</italic>, the causative agent of Q fever (<xref rid="B51" ref-type="bibr">Flores-Ramirez et al., 2014</xref>), and <italic toggle="yes">Listeria</italic> species (including the important foodborne pathogen <italic toggle="yes">Listeria monocytogenes</italic>). Indeed, western blot analysis confirmed (<xref rid="B103" ref-type="bibr">Mendon&#231;a et al., 2016</xref>) that the hybridoma-derived antibody mAB-3F8, used to detect <italic toggle="yes">Listeria</italic> spp. as well as to distinguish <italic toggle="yes">Listeria</italic> from other bacterial species, binds aldolase in <italic toggle="yes">Listeria</italic> cell wall preparations. In <italic toggle="yes">Neisseria meningitidis</italic> (a causative agent of bacterial meningitis), sub-cellular fractionation and immunoblotting localized (<xref rid="B158" ref-type="bibr">Tunio et al., 2010</xref>) aldolase to the outer membrane of the bacterial cell, and this surface accessibility was further confirmed by immunofluorescent localization. Immunofluorescence was also used to confirm (<xref rid="B37" ref-type="bibr">de la Paz Santangelo et al., 2011</xref>) a surface-localized aldolase in the medically important bacteria <italic toggle="yes">Mycobacterium tuberculosis</italic>, the causative agent of <italic toggle="yes">tuberculosis</italic>; live bacterial cells could be tagged with an anti-FBA antibody. In addition, these bacteria demonstrated surface aldolase enzymatic activity. <italic toggle="yes">(Mtb. bovis)</italic> was also found to have surface-associated aldolase as revealed by mass spectrometry analysis of a bacterial surface membrane fraction (<xref rid="B119" ref-type="bibr">Pagani et al., 2019</xref>). Both <italic toggle="yes">Mycoplasma bovis</italic> and <italic toggle="yes">Mycoplasma hyopneumoniae</italic>, devastating pathogenic agents of bovine bronchopneumonia (<italic toggle="yes">M. bovis</italic>) and porcine enzootic pneumonia (<italic toggle="yes">M. hyopneumoniae</italic>) possess surface-exposed aldolase as revealed by immunofluorescence (<xref rid="B58" ref-type="bibr">Gao et al., 2018</xref>), and flow cytometry of live bacterial cells stained with an anti-FBA antibody (<xref rid="B176" ref-type="bibr">Yu et al., 2018</xref>), respectively. Immunofluorescence assays confirmed the presence of aldolase on the surface of <italic toggle="yes">Clostridium perfringens</italic>, a causative agent of necrotic enteritis in poultry (<xref rid="B165" ref-type="bibr">Wilde et al., 2019</xref>). Cell fractionation and western blot analysis also revealed the presence of aldolase on the surface of the bacterial pathogen <italic toggle="yes">Klebsiella pneumoniae,</italic> a causative agent of disseminated <italic toggle="yes">K. pneumoniae</italic> invasive syndrome&#8211;a complication for some diabetics (<xref rid="B84" ref-type="bibr">Lee et al., 2020</xref>).</p><p>Surface localization of aldolase is not unique to bacterial pathogens: pathogenic fungi in the <italic toggle="yes">Candida</italic> genus (<italic toggle="yes">C. albicans, C. glabrata</italic> and <italic toggle="yes">C. parapsilosis</italic>) express aldolase at the cell surface as determined by mass spectrometry analysis of cell wall surface shavings (<xref rid="B32" ref-type="bibr">Crowe et al., 2003</xref>; <xref rid="B22" ref-type="bibr">Chaffin 2008</xref>; <xref rid="B75" ref-type="bibr">Karkowska-Kuleta et al., 2019</xref>). Other fungal pathogens possessing surface-associated aldolase include <italic toggle="yes">Cryptococcus neoformans</italic> (<xref rid="B147" ref-type="bibr">Stie et al., 2009</xref>) and <italic toggle="yes">Paracoccidioides</italic> strain <italic toggle="yes">Pb01</italic> (now classified as <italic toggle="yes">P. lutzii</italic>) (<xref rid="B153" ref-type="bibr">Teixeira et al., 2014</xref>; <xref rid="B25" ref-type="bibr">Chaves et al., 2015</xref>).</p><p>Proteomic analysis of biotinylated surface proteins of parasitic protozoan <italic toggle="yes">Entamoeba histolytica</italic> trophozoites revealed aldolase (along with other glycolytic enzymes&#8211;hexokinase, phosphofructokinase, triosephosphate isomerase, glyceraldehyde 3-phosphate dehydrogenase, and enolase) (<xref rid="B10" ref-type="bibr">Biller et al., 2014</xref>).</p><p>Certain metazoan parasites too have surface-associated aldolase. The aldolase of the parasitic trematode <italic toggle="yes">Schistosoma mansoni</italic> (one of the causative agents of schistosomiasis), for example, was localized <italic toggle="yes">via</italic> immunocytochemistry to both sub-tegumental regions and the tubercles of the schistosome tegument (skin) (<xref rid="B43" ref-type="bibr">El-Dabaa et al., 1998</xref>). Tegumental extracts from another parasitic trematode, <italic toggle="yes">Fasciola hepatica,</italic> revealed (<xref rid="B110" ref-type="bibr">Morales and Espino 2012</xref>; <xref rid="B132" ref-type="bibr">Ravid&#224; et al., 2016</xref>) the presence of aldolase. Immunolocalization assays localized the enzyme to the tegument of adult <italic toggle="yes">Clonorchis sinensis</italic> trematode parasites (<xref rid="B90" ref-type="bibr">Li et al., 2014</xref>). Aldolase was identified by western blotting in detergent-dissociated tegumental surface membranes of the protoscolex of the tapeworm <italic toggle="yes">Echinococcus granulosus</italic>, and immunolocalization of fixed <italic toggle="yes">E. granulosus</italic> cysts confirmed the presence of the enzyme in the protoscolex and cyst wall of the parasite (<xref rid="B94" ref-type="bibr">Lorenzatto et al., 2012</xref>).</p><p>Immune staining using antibodies against recombinant aldolase (rFBA) of the parasitic nematode <italic toggle="yes">Onchocerca volvulus</italic> localized the enzyme to the region of cuticle separation during an L3 to L4 larval molt (<xref rid="B99" ref-type="bibr">McCarthy et al., 2002</xref>). Surface-associated antigens collected using a 0.25% cetrimonium bromide-saline solution wash of the filarial parasitic nematode <italic toggle="yes">Dirofilaria immitis</italic> revealed the presence of aldolase among other glycolytic enzymes (glyceraldehyde 3-phosphate dehydrogenase and enolase) (<xref rid="B63" ref-type="bibr">Gonz&#225;lez-Miguel et al., 2013</xref>). Finally, immunofluorescent staining of multiple developmental stages of the parasitic nematode <italic toggle="yes">Trichinella spiralis</italic> localized aldolase to the surface of these worms (<xref rid="B174" ref-type="bibr">Yang et al., 2019</xref>).</p></sec><sec id="s4"><title>Moonlighting Functions of Aldolase to Aid Pathogen Survival</title><p>Extracellular or surface-associated aldolase has been reported to exhibit a variety of moonlighting functions in pathogenic organisms which have been hypothesized to aid in their invasion, colonization, and/or in immune evasion within their hosts (<xref rid="B61" ref-type="bibr">G&#243;mez-Arreaza et al., 2014</xref>). Often, surface-associated or secreted aldolase has been shown to interact with a number of host factors in a manner which could skew host biological pathways (such as the immune response or hemostasis) in a direction that favors the pathogen&#8217;s survival.</p><p>A commonly reported moonlighting function of the surface-localized aldolase found in pathogens is its ability to interact with plasminogen, a key component of the host coagulation response (<xref rid="B141" ref-type="bibr">Shams et al., 2014</xref>; <xref rid="B5" ref-type="bibr">Ay&#243;n-N&#250;&#241;ez et al., 2018</xref>). Plasminogen is the zymogen precursor to the fibrinolytic serine protease plasmin, which degrades fibrin clots. Plasminogen is proteolytically converted to its active form by the proteases tissue plasminogen activator (tPA) or urokinase plasminogen activator (uPA) (<xref rid="B21" ref-type="bibr">Cesarman-Maus and Hajjar 2005</xref>). In addition to fibrin clots, plasmin can also degrade components of the host basal membrane and extracellular matrix (ECM), such as fibronectin and laminin (<xref rid="B111" ref-type="bibr">Moser et al., 1993</xref>; <xref rid="B9" ref-type="bibr">Bhattacharya et al., 2012</xref>). A number of the bacterial species mentioned above have been reported to utilize their surface-localized aldolase to bind plasminogen including <italic toggle="yes">N. meningitidis</italic> (<xref rid="B140" ref-type="bibr">Shams et al., 2016</xref>), <italic toggle="yes">M. tuberculosis</italic> (<xref rid="B37" ref-type="bibr">de la Paz Santangelo et al., 2011</xref>), and <italic toggle="yes">Mycoplasma bovis</italic> (<xref rid="B58" ref-type="bibr">Gao et al., 2018</xref>)&#8212;a trait shared by pathogenic fungi (<italic toggle="yes">C. albicans</italic> (<xref rid="B32" ref-type="bibr">Crowe et al., 2003</xref>)<italic toggle="yes">, C. neoformans</italic> (<xref rid="B147" ref-type="bibr">Stie et al., 2009</xref>), <italic toggle="yes">P. lutzii</italic> (<xref rid="B25" ref-type="bibr">Chaves et al., 2015</xref>) and by parasites [<italic toggle="yes">Schistosoma bovis</italic> (<xref rid="B129" ref-type="bibr">Ramajo-Hern&#225;ndez et al., 2007</xref>), <italic toggle="yes">D. immitis</italic> (<xref rid="B63" ref-type="bibr">Gonz&#225;lez-Miguel et al., 2013</xref>)] alike. Recombinant forms of several of these aldolases were shown to bind to plasminogen by western blotting and/or ELISA (<xref rid="B147" ref-type="bibr">Stie et al., 2009</xref>; <xref rid="B25" ref-type="bibr">Chaves et al., 2015</xref>; <xref rid="B62" ref-type="bibr">Gonz&#225;lez-Miguel et al., 2015</xref>; <xref rid="B140" ref-type="bibr">Shams et al., 2016</xref>; <xref rid="B58" ref-type="bibr">Gao et al., 2018</xref>), and in several cases, the recombinant aldolases were also shown to enhance the activation of plasminogen into plasmin in the presence of tPA <italic toggle="yes">in vitro</italic> (<xref rid="B147" ref-type="bibr">Stie et al., 2009</xref>; <xref rid="B37" ref-type="bibr">de la Paz Santangelo et al., 2011</xref>; <xref rid="B25" ref-type="bibr">Chaves et al., 2015</xref>; <xref rid="B62" ref-type="bibr">Gonz&#225;lez-Miguel et al., 2015</xref>; <xref rid="B38" ref-type="bibr">de la Torre-Escudero et al., 2017</xref>). Such binding and activation of plasminogen on pathogen surfaces has been postulated to enhance host tissue damage and facilitate invasion by degradation of the ECM (<xref rid="B9" ref-type="bibr">Bhattacharya et al., 2012</xref>), disruption of blood clotting reactions, and to be important for immune evasion [as activated plasmin has additionally been reported to cleave complement components (<xref rid="B5" ref-type="bibr">Ay&#243;n-N&#250;&#241;ez et al., 2018</xref>)] in a process known as &#8220;bacterial metastasis&#8221; (<xref rid="B83" ref-type="bibr">L&#228;hteenm&#228;ki et al., 2005</xref>; <xref rid="B39" ref-type="bibr">Degen et al., 2007</xref>; <xref rid="B172" ref-type="bibr">Xolalpa et al., 2007</xref>; <xref rid="B5" ref-type="bibr">Ay&#243;n-N&#250;&#241;ez et al., 2018</xref>). <xref ref-type="fig" rid="F2">Figure 2</xref> lists the wide variety of organisms that have been demonstrated to possess an extracellular aldolase (left) and instances in which the enzyme has been shown to bind to plasminogen, promoting its activation (right). Pathogens have been reported to use a number of other glycolytic enzymes, including triosephosphate isomerase (TPI), GAPDH, phosphoglycerate mutase (PGM) and enolase, to bind and activate plasminogen (<xref rid="B125" ref-type="bibr">Pirovich et al., 2019</xref>; <xref rid="B124" ref-type="bibr">Pirovich et al., 2020</xref>).</p><p>Aldolase has also been reported to act as an adhesin in a number of bacterial pathogens, interacting with host receptors to help facilitate invasion. <italic toggle="yes">S. pneumoniae</italic> aldolase binds to the human cell membrane protein flamingo cadherin receptor (FCR); adding recombinant aldolase or anti-FBA antibodies reduced streptococcal adhesion to the human lung cell carcinoma line A549 (<xref rid="B11" ref-type="bibr">Blau et al., 2007</xref>). Similarly, recombinant <italic toggle="yes">Clostridium perfringens</italic> aldolase can inhibit adhesion of these bacteria to Caco-2 cells, indicating aldolase&#8217;s role as an adhesin in these bacteria too (<xref rid="B165" ref-type="bibr">Wilde et al., 2019</xref>). <italic toggle="yes">Mycoplasma bovis</italic> aldolase binds to host cell fibronectin, and this facilitates cell binding to embryonic bovine lung (EBL) cells (<xref rid="B72" ref-type="bibr">Huang et al., 2019</xref>). Aldolase-deficient mutants of <italic toggle="yes">N. meningitidis</italic> had a reduced capability to bind to monolayers of human brain microvascular endothelial (HBME) and human larynx carcinoma (HEp-2) cells <italic toggle="yes">in vitro</italic> (<xref rid="B158" ref-type="bibr">Tunio et al., 2010</xref>). Blocking surface-localized aldolase of <italic toggle="yes">Klebsiella pneumoniae</italic> with FBA-specific antibodies enhanced bactericidal activity of human neutrophils against the KP-M1 strain of <italic toggle="yes">K. pneumoniae</italic> in an as yet unknown manner (<xref rid="B84" ref-type="bibr">Lee et al., 2020</xref>).</p><p>Aldolases from pathogens have also been shown to have immunomodulatory effects on their hosts. <italic toggle="yes">Leishmania donovani</italic> aldolase was reported to block IFN&#947;-induced nitric oxide synthase (iNOS) production by macrophages by specifically binding and activating the macrophage protein Src homology two domain containing protein tyrosine phosphatase-1 (SHP-1) (<xref rid="B116" ref-type="bibr">Nandan et al., 2007</xref>). Aldolase found in extract fractions of the parasitic nematode <italic toggle="yes">Trichuris trichiura</italic> was reported to have immunomodulatory effects on peripheral blood mononuclear cells (PBMCs) isolated from na&#239;ve individuals <italic toggle="yes">via</italic> stimulation and/or inhibition of the production of Th1 and Th2 cytokines (<xref rid="B135" ref-type="bibr">Santos et al., 2013</xref>). These results may present opportunities for novel therapeutics to treat or prevent these infections by blocking the immunomodulatory effects aldolase has on the host.</p><p><xref rid="T2" ref-type="table">Table 2</xref> provides a summary of the various functions the aldolase enzyme has been reported to perform (left column) and lists the diverse life forms in which those functions have been reported (middle column).</p><table-wrap id="T2" position="float" orientation="portrait"><label>TABLE 2</label><caption><p>A summary of enzymatic and non-enzymatic functions that different aldolases have been reported to perform (left column), either in the intracellular (upper section) or extracellular (lower section) environment. The life forms in which those functions have been reported are listed in the middle column.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Location</th><th align="center" rowspan="1" colspan="1">Functions</th><th align="center" rowspan="1" colspan="1">Organisms</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td rowspan="16" align="left" colspan="1">Intracellular</td><td align="left" rowspan="1" colspan="1">Glycolysis (catalyzes step 4)</td><td align="left" rowspan="1" colspan="1">Ubiquitous</td><td align="left" rowspan="1" colspan="1">
<xref rid="B105" ref-type="bibr">Michels and Fothergill-Gilmore (2017)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Gluconeogenesis, fructose metabolism</td><td align="left" rowspan="1" colspan="1">Ubiquitous</td><td align="left" rowspan="1" colspan="1"><xref rid="B42" ref-type="bibr">Droppelmann et al. (2015)</xref>, <xref rid="B180" ref-type="bibr">Lebherz and Rutter (1969)</xref>, <xref rid="B15" ref-type="bibr">Bu et al. (2018)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Fructose 1,6 phosphatase activity</td><td align="left" rowspan="1" colspan="1">Archaea</td><td align="left" rowspan="1" colspan="1">
<xref rid="B136" ref-type="bibr">Say and Fuchs (2010)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Cellular scaffolding (binds to actin, V-ATPase, WASP)</td><td align="left" rowspan="1" colspan="1">Mammalian cells</td><td align="left" rowspan="1" colspan="1"><xref rid="B163" ref-type="bibr">Wang et al. (1997)</xref>, <xref rid="B86" ref-type="bibr">Lew and Tolan (2013)</xref>, <xref rid="B24" ref-type="bibr">Chang et al. (2019)</xref>, <xref rid="B59" ref-type="bibr">Gizak et al. (2019)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Binds to phospholipase D2</td><td align="left" rowspan="1" colspan="1">Mammalian cells</td><td align="left" rowspan="1" colspan="1">
<xref rid="B77" ref-type="bibr">Kim et al. (2002)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Binds to heparin</td><td align="left" rowspan="1" colspan="1">Mammalian cells</td><td align="left" rowspan="1" colspan="1">
<xref rid="B152" ref-type="bibr">Ta et al. (1999)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Binds to erythrocyte band 3 protein</td><td align="left" rowspan="1" colspan="1">Erythrocytes</td><td align="left" rowspan="1" colspan="1">
<xref rid="B148" ref-type="bibr">Strapazon and Steck (1976)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Binds to g-tubulin</td><td align="left" rowspan="1" colspan="1">Mammalian cells</td><td align="left" rowspan="1" colspan="1">
<xref rid="B162" ref-type="bibr">Volker and Knull (1997)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucose sensor (binds to v-ATPase)</td><td align="left" rowspan="1" colspan="1">Mammalian cells</td><td align="left" rowspan="1" colspan="1"><xref rid="B177" ref-type="bibr">Zhang et al. (2017)</xref>, <xref rid="B88" ref-type="bibr">Li et al. (2019a)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Signaling (Wnt, AMPK, E-cadherin-EGFR pathways impacted)</td><td align="left" rowspan="1" colspan="1">Mammalian cells</td><td align="left" rowspan="1" colspan="1"><xref rid="B19" ref-type="bibr">Caspi et al. (2014)</xref>, <xref rid="B89" ref-type="bibr">Li et al. (2019b)</xref>, <xref rid="B88" ref-type="bibr">Li et al. (2019a)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Endocytosis control (binds to SXN9)</td><td align="left" rowspan="1" colspan="1">Mammalian cells</td><td align="left" rowspan="1" colspan="1">
<xref rid="B131" ref-type="bibr">Rangarajan et al. (2010)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Translational regulation (P53 upregulation, RNA polymerase III-directed transcription, catalase upregulation)</td><td align="left" rowspan="1" colspan="1">Mammalian cells, yeast, <italic toggle="yes">Francisella</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B95" ref-type="bibr">Ma et al. (2018),</xref>
<xref rid="B27" ref-type="bibr">Cie&#347;la et al. (2014),</xref>
<xref rid="B179" ref-type="bibr">Ziveri et al. (2017)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Viral replication (binds to UTRs)</td><td align="left" rowspan="1" colspan="1">Japanese encephalitis virus (JEV), simian hemorrhagic fever virus</td><td align="left" rowspan="1" colspan="1"><xref rid="B156" ref-type="bibr">Tien et al. (2014)</xref>, <xref rid="B96" ref-type="bibr">Maines et al. (2005)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Motility complex formation (binds to TRAP in <italic toggle="yes">Plasmodium</italic> spp. + <italic toggle="yes">Babesia gibsoni</italic>/MIC2 in <italic toggle="yes">Toxoplasma</italic> spp.)</td><td align="left" rowspan="1" colspan="1">Apicomplexans</td><td align="left" rowspan="1" colspan="1"><xref rid="B29" ref-type="bibr">Collingridge et al. (2010)</xref>, <xref rid="B117" ref-type="bibr">Nemetski et al. (2015)</xref>, <xref rid="B64" ref-type="bibr">Goo et al. (2013)</xref>, <xref rid="B142" ref-type="bibr">Shen and Sibley (2014)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Blocking iNOS production in macrophages <italic toggle="yes">via</italic> binding to SHP-1</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Leishmania donovani</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B116" ref-type="bibr">Nandan et al. (2007)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Immunomodulation of PBMCs</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Trichuris trichiura</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B135" ref-type="bibr">Santos et al. (2013)</xref>
</td></tr><tr><td rowspan="4" align="left" colspan="1">Extracellular</td><td align="left" rowspan="1" colspan="1">Plasminogen binding and activation</td><td align="left" rowspan="1" colspan="1">Bacteria, fungi, metazoan parasites</td><td align="left" rowspan="1" colspan="1">
<xref rid="B5" ref-type="bibr">Ay&#243;n-N&#250;&#241;ez et al. (2018)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Host cell adhesion and invasion (binds to FCR, fibronectin)</td><td align="left" rowspan="1" colspan="1">Bacteria</td><td align="left" rowspan="1" colspan="1"><xref rid="B158" ref-type="bibr">Tunio et al. (2010)</xref>, <xref rid="B11" ref-type="bibr">Blau et al. (2007)</xref>, <xref rid="B165" ref-type="bibr">Wilde et al. (2019)</xref>, <xref rid="B72" ref-type="bibr">Huang et al. (2019)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-phagocytic (mechanism unknown)</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Klebsiella pneumoniae</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B84" ref-type="bibr">Lee et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Downregulates Th1 immunity</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Schistosoma japonicum</italic>
</td><td align="left" rowspan="1" colspan="1">
<xref rid="B173" ref-type="bibr">Yan et al. (2020)</xref>
</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: SNX9, sorting nexin 9; V-ATPAse, Vacuolar-type ATPase; WASP, Wiskott-Aldrich Syndrome Protein; AMPK, AMP-activated protein kinase; Wingless/Int-1, Wnt; EGFR, epidermal growth factor receptor; UTRs, untranslated regions; TRAP, thrombospondin-related anonymous protein; MIC2, micronemal protein 2; iNOS, inducible nitric oxide synthase; SHP-1, Src homology 2 domain containing protein tyrosine phosphatase-1; PBMC, peripheral blood mononuclear cells; FCR, flamingo cadherin receptor.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s5"><title>Aldolase as a Drug Target</title><p>The essential nature of aldolase has made it an attractive drug target; abolishing the enzyme&#8217;s abilities to 1) drive glycolysis and/or 2) contribute virulence-enhancing moonlighting functions offer an effective solution to staving off disease caused not only by a large and diverse array of pathogens but also by cancers.</p><sec id="s5-1"><title>Class-I Aldolase Inhibition</title><p>Inhibitors of Class-I aldolases have been used to target cancer cells; the muscle isoform of aldolase (ALDOA) is the most abundant isoform in multiple human cancer types (<xref rid="B23" ref-type="bibr">Chang et al., 2018</xref>), and its overexpression predicts poor survival probabilities in patients with lung and pancreatic cancer (<xref rid="B24" ref-type="bibr">Chang et al., 2019</xref>; <xref rid="B33" ref-type="bibr">Curcio et al., 2021</xref>). A number of ALDOA inhibitors, reviewed by <xref rid="B33" ref-type="bibr">Curcio et al. (2021)</xref>, had promising anti-oncogenic impact. For example, the inhibitor TDZD-8 1,2,4-thiadiazole was shown to reduce glycolytic activity <italic toggle="yes">in vitro</italic> and <italic toggle="yes">in vivo</italic> in breast cancer cells. While not acting directly on aldolase, the drug inhibited the activity of hypoxia-inducible factor 1-alpha (HIF1&#945;), which mediates the hypoxic response in tumors, and this led to an upregulation in transcription of glycolytic enzymes including ALDOA (<xref rid="B66" ref-type="bibr">Grandjean et al., 2016</xref>). The HIF1&#945; inhibitor TX-2098 similarly reduced expression of ALDOA and vascular endothelial growth factor (VEGF) in a xenograft model of pancreatic cancer (<xref rid="B107" ref-type="bibr">Miyake et al., 2012</xref>).</p><p>Raltegravir, an antiviral compound known to target HIV integrase, can also inhibit the formation of a protein-protein interaction between ALDOA and &#947;-actin by binding directly to aldolase; the drug has been shown to reduce tumor size and invasive metastasis of lung cancer in mice (<xref rid="B24" ref-type="bibr">Chang et al., 2019</xref>). Another compound, &#8220;UM0112176&#8221;, emulates raltegravir&#8217;s mechanism of disrupting ALDOA interaction with actin, disrupting the cytoskeleton and initiating a cascade of intracellular events leading to cancer cell apoptosis (<xref rid="B59" ref-type="bibr">Gizak et al., 2019</xref>). A bisphosphonate-based aldolase inhibitor (2-phosphate-naphthalene 6-bisphosphonate) designed to mimic F1,6BP was found to inhibit the proliferation of HeLa cancer cells with an inhibition constant (<italic toggle="yes">K</italic>
<sub>i</sub>) of &#8764;38&#160;nM, while HEK293 cells exhibiting a normal phenotype were not affected (<xref rid="B70" ref-type="bibr">Heron et al., 2018</xref>).</p><p>The Class-I aldolases of several protozoan parasites have also been considered drug targets (<xref rid="B41" ref-type="bibr">D&#246;beli et al., 1990</xref>; <xref rid="B6" ref-type="bibr">Bakker et al., 2000</xref>; <xref rid="B161" ref-type="bibr">Verlinde et al., 2001</xref>; <xref rid="B36" ref-type="bibr">Dax et al., 2006</xref>). In the case of <italic toggle="yes">Plasmodium berghei</italic>, screening of a library of compounds revealed a candidate (Compound 24) that targeted the aldolase-TRAP complex within the glideosome (a macromolecular complex that helps the parasite move) and inhibited both movement of <italic toggle="yes">P. berghei</italic> sporozoites as well as hepatocyte invasion. Compound 24 inhibited <italic toggle="yes">Plasmodium</italic> aldolase catalytic activity but only when TRAP was present. It is unknown whether Compound 24 binds to aldolase or TRAP, or whether it only binds when the two form a complex (<xref rid="B117" ref-type="bibr">Nemetski et al., 2015</xref>). Another candidate (Compound 9, designed to mimic the formation of a Schiff base within the enzyme&#8217;s active site) was inhibitory against a range of protozoan parasites with Class-I aldolases; 100&#160;&#956;M Compound 9 blocked recombinant <italic toggle="yes">T. brucei</italic> aldolase enzymatic action (by &gt;99%), recombinant <italic toggle="yes">Leishmania mexicana</italic> aldolase (by 85%), and recombinant <italic toggle="yes">P. falciparum</italic> aldolase (by 70%) but had no appreciable impact on human liver aldolase catalytic function (<xref rid="B36" ref-type="bibr">Dax et al., 2006</xref>). The detrimental effects of targeting <italic toggle="yes">T. brucei</italic> aldolase was validated in RNAi knockdown experiments; partial depletion of aldolase was sufficient to rapidly kill trypanosomes <italic toggle="yes">in vitro</italic> by disrupting aldolase activity as well as those of downstream glycolytic enzymes (<xref rid="B17" ref-type="bibr">C&#225;ceres et al., 2009</xref>).</p></sec><sec id="s5-2"><title>Class-II Aldolase Inhibition</title><p>Class-II aldolases belonging to pathogenic microbes have also been considered as pharmacological therapeutic targets due to the structural and mechanical differences they possess compared with the Class-I aldolases of their vertebrate hosts (as reviewed in <xref rid="T1" ref-type="table">Table 1</xref>) (<xref rid="B18" ref-type="bibr">Capodagli et al., 2014</xref>; <xref rid="B137" ref-type="bibr">Semenyuta et al., 2019</xref>). The essential nature of aldolase to the viability of these pathogenic organisms has been confirmed by an inability to generate viable mutants with disrupted aldolase gene function <italic toggle="yes">via</italic> mutagenesis. For example, <italic toggle="yes">M. tuberculosis</italic> aldolase knockout bacteria could only be generated in the presence of a rescue copy of the gene (<xref rid="B37" ref-type="bibr">de la Paz Santangelo et al., 2011</xref>; <xref rid="B82" ref-type="bibr">Labb&#233; et al., 2012</xref>). The Class-II aldolase inhibitory compound phosphoglycolohydroxamate (PGH) (<xref rid="B30" ref-type="bibr">Collins 1974</xref>) has been commonly utilized to study both the inhibition and the x-ray crystal structures of Class-II aldolases of a variety of microbial pathogens (e.g., <italic toggle="yes">E. coli</italic> (<xref rid="B68" ref-type="bibr">Hall et al., 1999</xref>), <italic toggle="yes">M. tuberculosis</italic> (<xref rid="B121" ref-type="bibr">Pegan et al., 2013</xref>)<italic toggle="yes">, Giardia lamblia</italic> (<xref rid="B54" ref-type="bibr">Galkin et al., 2007</xref>, <xref rid="B55" ref-type="bibr">Galkin et al., 2009</xref>)). However, despite its selectivity for Class-II aldolases, PGH hydrolyzes spontaneously into a toxic byproduct (hydroxylamine) that inhibits other mammalian enzymes (such as triosephosphate isomerase (<xref rid="B30" ref-type="bibr">Collins 1974</xref>)), making it, on balance, a poor candidate inhibitor of microbial aldolases for use <italic toggle="yes">in vivo</italic> (<xref rid="B35" ref-type="bibr">Daher et al., 2010</xref>).</p><p>As Class-II aldolases rely on divalent ions (often zinc or cobalt) as cofactors to stabilize the intermediate formed within the enzyme&#8217;s active site, compounds containing metal-chelating groups have been synthesized and tested for their inhibitory nature against aldolases belonging to a variety of pathogenic microorganisms (<xref rid="B35" ref-type="bibr">Daher et al., 2010</xref>; <xref rid="B82" ref-type="bibr">Labb&#233; et al., 2012</xref>). In one study (<xref rid="B35" ref-type="bibr">Daher et al., 2010</xref>), a compound (Compound 1) was designed to both 1) mimic sedoheptulose 1,7-bisphosphate, a substrate of aldolase with a stronger binding affinity to Class-II aldolases than fructose 1,6-bisphosphate, and 2) possess a hydroxamic acid to act as a chelating agent for the zinc ion present in the active site with an electronic density similar to that of the transition state of fructose 1,6-bisphosphate. Compound 1 showed half maximal inhibitory constant (IC<sub>50</sub>) values against aldolases from <italic toggle="yes">M. tuberculosis</italic> and <italic toggle="yes">C. albicans</italic> in the nanomolar range and had high selectivity for Class-II aldolases.</p><p>A series of compounds derived from the metal-chelating dipicolinic acid (DPA) were synthesized and tested (<xref rid="B82" ref-type="bibr">Labb&#233; et al., 2012</xref>) for inhibition of aldolases belonging to <italic toggle="yes">M. tuberculosis</italic>, <italic toggle="yes">Magnaporthe grisea</italic> (the fungal causative agent of Rice Blast), <italic toggle="yes">Pseudomonas aeruginosa</italic> [an opportunistic bacterial pathogen of immunocompromised patients (<xref rid="B7" ref-type="bibr">Bassetti et al., 2018</xref>)], and <italic toggle="yes">Bacillus cereus</italic> [a food-borne bacterial pathogen (<xref rid="B13" ref-type="bibr">Bottone 2010</xref>)]. These compounds&#8217; actions were also compared to those of 2,3-dimercaptopropanesulfonate (DMPS)&#8212;a chelating agent previously used therapeutically in both animals and humans (<xref rid="B144" ref-type="bibr">Siemann et al., 2003</xref>; <xref rid="B50" ref-type="bibr">Flora and Pachauri 2010</xref>). The IC<sub>50</sub> against each aldolase was determined for all inhibitors, with 6-(phosphonomethyl)picolinic acid showing the lowest IC<sub>50</sub> values: strongest inhibition was against <italic toggle="yes">M. tuberculosis</italic> aldolase, with an IC<sub>50</sub> of &#8764;57&#160;&#956;M, while IC<sub>50</sub> values against <italic toggle="yes">M. grisea</italic>, <italic toggle="yes">B. cereus</italic>, and <italic toggle="yes">P. aeruginosa</italic> aldolases were 78, 78, and 130&#160;&#956;M, respectively. The compound showed no inhibition of rabbit muscle aldolase, confirming its specificity towards Class-II aldolase.</p></sec></sec><sec id="s6"><title>Aldolase as a Vaccine Target</title><p>Sera from individuals infected by pathogens including (but not limited to) <italic toggle="yes">Streptococcus agalatiae</italic> (<xref rid="B52" ref-type="bibr">Fluegge et al., 2004</xref>), <italic toggle="yes">Francisella tularensis</italic> (<xref rid="B53" ref-type="bibr">Fulton et al., 2011</xref>)<italic toggle="yes">, Campylobacter concisus</italic> (<xref rid="B79" ref-type="bibr">Kovach et al., 2011</xref>), <italic toggle="yes">Giardia lamblia</italic> (<xref rid="B120" ref-type="bibr">Palm et al., 2003</xref>), <italic toggle="yes">Onchocerca volvulus</italic> (<xref rid="B99" ref-type="bibr">McCarthy et al., 2002</xref>), <italic toggle="yes">Schistosoma mansoni</italic> (<xref rid="B69" ref-type="bibr">Harrop et al., 1999</xref>), <italic toggle="yes">Schistosoma haematobium</italic> (<xref rid="B113" ref-type="bibr">Mutapi et al., 2011</xref>)<italic toggle="yes">,</italic> and <italic toggle="yes">Schistosoma mekongi</italic> (<xref rid="B154" ref-type="bibr">Thiangtrongjit et al., 2018</xref>) have been shown to harbor aldolase-specific antibodies. In addition, as detailed below, aldolase has been tested as a vaccine candidate against several of these, and other, pathogens.</p><sec id="s6-1"><title>Bacteria</title><p>Aldolase has been tested as a vaccine against <italic toggle="yes">Streptococcus pneumoniae</italic>, one of the leading causes of bacterial pneumonia and meningitis worldwide (<xref rid="B126" ref-type="bibr">Portnoi et al., 2006</xref>). A cohort of mice immunized (<xref rid="B91" ref-type="bibr">Ling et al., 2004</xref>) with recombinant <italic toggle="yes">S. pneumoniae</italic> aldolase and alum adjuvant were subsequently protected against a respiratory challenge with two genetically unrelated strains of <italic toggle="yes">S. pneumoniae</italic> (WU2 and 9VR); 36% of immunized mice survived while 100% of unimmunized control mice died. In other work (<xref rid="B60" ref-type="bibr">Elhaik Goldman et al., 2016</xref>), immunization of mice with rFBA in Freund&#8217;s adjuvant had a greater protective effect (36% survival rate) than either rFBA + alum (26% survival rate) or a plasmid DNA vaccine containing the aldolase coding DNA (19% survival rate). CD4<sup>+</sup> T-cells from mice immunized with rFBA + Freund&#8217;s that were co-cultured with rFBA-pulsed antigen-presenting cells (APCs) showed significantly increased proliferation compared to similarly treated CD4<sup>+</sup> T cells from adjuvant-immunized mice. Analysis of cytokines secreted from memory CD4<sup>+</sup> T-cells from these mice revealed an increase in Th1-type cytokines [e.g., interferon-gamma (IFN&#947;), interleukin (IL)-12, IL-2, tumor necrosis factor alpha (TNF&#945;)], Th2-type cytokines (e.g., IL-4, IL-5, IL-10) and Th17-type cytokine IL-17A, revealing a robust, mixed immune response to this immunogen. The observed protection may have resulted from the inhibition of moonlighting aldolase function: capsular shedding exposes the bacterial cell wall proteins to host antibodies, which may bind to surface-localized aldolase and neutralize host adhesion (<xref rid="B11" ref-type="bibr">Blau et al., 2007</xref>; <xref rid="B60" ref-type="bibr">Elhaik Goldman et al., 2016</xref>).</p><p>Aldolase has also been tested as a potential vaccine candidate in two fish species important for biomedical research and aquaculture: the zebrafish (<italic toggle="yes">Danio rerio</italic>) and the turbot (<italic toggle="yes">Scopthalamus maximus</italic>), respectively (<xref rid="B151" ref-type="bibr">Sun et al., 2015</xref>). In the zebrafish work, recombinant aldolases (emulsified in Montanide&#8482; ISA 763A adjuvant) from a panel of five aquatic, pathogenic bacteria (<italic toggle="yes">Edwardsiella tarda, Aeromonas hydrophila, Vibrio anguillarum, V. harveyi, V. alginolyticus</italic>) isolated from fish were used to vaccinate cohorts of zebrafish. One cohort each was subsequently challenged with one of the fish pathogens. In general, there was a high level of protection in the immunized fish, with relative percent survival (RPS) rates of 50&#8211;80% compared to 27% for controls (<xref rid="B151" ref-type="bibr">Sun et al., 2015</xref>). Turbot were administered <italic toggle="yes">E. tarda</italic>-rFBA (or PBS as a control) and subsequently challenged with <italic toggle="yes">E. tarda</italic> 4 weeks post-vaccination; vaccinated turbot reached a RPS of 68%, and consistent with zebrafish vaccination data, turbot vaccinated with <italic toggle="yes">E.</italic> tarda-rFBA showed a high antibody level against the aldolases of four other aquatic bacteria, presumably reflecting the high sequence conservation between the bacterial aldolases (75&#8211;98%) (<xref rid="B151" ref-type="bibr">Sun et al., 2015</xref>). Furthermore, serum from <italic toggle="yes">E. tarda</italic>-rFBA-vaccinated turbot was shown to kill all five bacterial species <italic toggle="yes">in vitro</italic> with ranges of 18.6&#8211;52.4% bactericidal capacity. This result, along with the localization of aldolase in the outer membrane led to the conclusion that antibodies raised against rFBA by vaccination bound to aldolase on the surface of these bacteria and enhanced complement-mediated bactericidal activity of the sera (<xref rid="B151" ref-type="bibr">Sun et al., 2015</xref>). Increased expression of TLR2, TLR4, TLR5, and MyD88 was seen in whole lysates of the spleen and kidney of vaccinated fish. This is notable as TLRs have been suggested to enhance the adaptive immune response, and the usage of TLR ligands as adjuvants is promising in optimizing the immunogenicity of vaccines (<xref rid="B159" ref-type="bibr">van Duin et al., 2006</xref>). Additionally, expression of MHC II and CD4 genes were significantly upregulated compared to MHC I and CD8 genes. Finally, vaccinated fish exhibited increased mRNA expression of IgM in the spleen and kidney, and expression of IL-1&#946;, IL-8, and IL-10 were all upregulated during the early stages post-vaccination. When compared to a previous vaccination trial with the glycolytic enzyme GAPDH, aldolase showed lower antibody titers but a slightly higher RPS, suggesting that the two enzymes may elicit different immune responses and might be combined to increase vaccine efficacy (<xref rid="B151" ref-type="bibr">Sun et al., 2015</xref>).</p><p>Aldolase vaccines have also been tested against <italic toggle="yes">Clostridium perfringens</italic> in broiler chickens; these immunization experiments used a variety of mechanisms to deliver the antigens to the chickens and examined both the immunoprotective capability of aldolase vaccination and the immune responses of vaccinated birds. Following identification of aldolase as an immunogenic secreted protein unique to virulent isolates of <italic toggle="yes">C. perfringens</italic>, <xref rid="B80" ref-type="bibr">Kulkarni et al. (2007)</xref> vaccinated chickens intramuscularly with recombinant <italic toggle="yes">C. perfringens</italic> aldolase before introducing a mild, moderate, or severe oral challenge infection of <italic toggle="yes">C. perfringens</italic>. Vaccination provided significant protection against a mild challenge but not against a moderate or severe challenge (as measured by a reduction in gross intestinal lesion score). However, in a second &#8220;mild-moderate&#8221; challenge vaccination experiment, it was shown that recombinant aldolase was able to offer significant protection (lower lesion scores). Immunized birds showed high antigen-specific antibody titers, and intestinal antibody responses revealed higher titers of IgY than IgA&#8211;likely due to the systemic route of inoculation of the vaccine (<xref rid="B80" ref-type="bibr">Kulkarni et al., 2007</xref>).</p><p>In other vaccine work (<xref rid="B81" ref-type="bibr">Kulkarni et al., 2008</xref>), chickens were immunized orally with an attenuated <italic toggle="yes">Salmonella</italic> vaccine vector expressing either <italic toggle="yes">C. perfringens</italic> aldolase or pyruvate:ferredoxin-oxidoreductase (PFOR) or hypothetical protein (HP) (<xref rid="B80" ref-type="bibr">Kulkarni et al., 2007</xref>). After two immunizations over 2&#160;weeks, the birds were challenged with <italic toggle="yes">C. perfringens</italic> through their feed. Protection was once again assessed by gross intestinal lesion scoring, and by analysis of antibodies in sera and intestinal washings of the chickens. Vaccinated birds were significantly protected compared to controls, showing a lower mean lesion score (1.11 on a 0&#8211;5 scale), a significant increase in their body weight (mean weight gain of 1.73&#160;kg), and showed a significant increase in antigen-specific antibody titers in their serum compared to pre-immunization levels.</p><p>The attenuated <italic toggle="yes">Salmonella</italic> vaccine vector model was employed again (<xref rid="B165" ref-type="bibr">Wilde et al., 2019</xref>), here using a strain of <italic toggle="yes">Salmonella</italic> designed to lyse after several rounds of replication and release any expressed <italic toggle="yes">C. perfringens</italic> antigens. Lesion scores were significantly reduced (average lesion score of 0.7) in birds immunized with the FBA-only-producing <italic toggle="yes">Salmonella</italic> strain compared to empty plasmid (average lesion score of 3.1, verifying once more the protective capabilities of aldolase as a vaccine against bacterial infection.</p></sec><sec id="s6-2"><title>Protozoans, Fungi, and Metazoan Parasites</title><p>Protozoans in the genus <italic toggle="yes">Plasmodium</italic> are the causative agents of malaria, one of the most burdensome parasitic diseases on the planet (<xref rid="B26" ref-type="bibr">Chu et al., 2019</xref>). A 41&#160;kDa protein (p41) was identified in as a <italic toggle="yes">Plasmodium falciparum</italic> merozoite surface antigen (<xref rid="B123" ref-type="bibr">Perrin et al., 1985</xref>). Immunofluorescence testing detected this protein at the apical end of the merozoite, thought to be located at the rhoptries. Sequence analysis revealed p41 to be aldolase (<xref rid="B20" ref-type="bibr">Certa et al., 1988</xref>). The enzyme was localized to the parasite&#8217;s cytoplasm in an active form, and to the membrane fractions in an enzymatically inactive form (<xref rid="B78" ref-type="bibr">Knapp et al., 1990</xref>). Aldolase (p41) immunization led to reduced parasitemia following <italic toggle="yes">P. falciparum</italic> challenge in monkeys. In this work (<xref rid="B123" ref-type="bibr">Perrin et al., 1985</xref>), <italic toggle="yes">Saimiri</italic> monkeys were immunized subcutaneously with purified native p41 in 40&#160;&#956;g of either sodium dodecyl sulfate (SDS) or Nonidet P-40 (NP-40) before being challenged with live parasites <italic toggle="yes">via</italic> tail vein injection. The p41/NP-40-immunized monkeys developed lower peak parasitemia (between 0.008&#8211;1.2%) than monkeys immunized with p41-SDS (&#8804;15%). These peaks were lower than those of control monkeys, which were treated with quinine when their parasitemia reached 20%. Since aldolase in NP-40 preparation is more likely to retain its native conformation, this result suggests that this is an important consideration for inducing better immunity against infection. Sera of all p41-immunized monkeys inhibited aldolase enzymatic activity measured <italic toggle="yes">in vitro</italic> by &#8764;80% (<xref rid="B145" ref-type="bibr">Srivastava et al., 1990</xref>). Human adults who have had repeated exposure to <italic toggle="yes">Plasmodium</italic> infection have anti-FBA antibodies in their sera, and this correlates with partial protection against malaria (<xref rid="B123" ref-type="bibr">Perrin et al., 1985</xref>; <xref rid="B145" ref-type="bibr">Srivastava et al., 1990</xref>).</p><p>Aldolase has also been tested as a vaccine candidate against visceral leishmaniasis&#8211;a potentially fatal sandfly-transmitted protozoan infection affecting 350 million people in 88 countries (<xref rid="B76" ref-type="bibr">Kaye and Scott 2011</xref>). <italic toggle="yes">Leishmania donovani</italic>-challenged hamsters vaccinated with rFBA along with Bacillus Calmette&#8211;Gu&#233;rin (BCG) vaccine showed a significant (&#8764;65%) reduction in parasite load in the spleen, liver, and bone marrow, and gained substantial weight during their trial period when compared to control hamsters immunized with BCG alone or non-immunized hamsters (<xref rid="B67" ref-type="bibr">Gupta et al., 2014</xref>). rFBA + BCG-immunized hamsters showed a greater delayed type hypersensitivity response to <italic toggle="yes">L. donovani</italic> challenge than control groups, and macrophages co-cultured with supernatants of lymphocytes from rFBA vaccinated hamsters showed increased production of nitric oxide (NO). Increased expression of Th1 cytokines (IFN&#947;, TNF&#945;) and iNOS was observed in rFBA-vaccinated hamsters, while Th2 cytokine (IL-4, IL-10) expression was diminished. The rFBA-vaccinated hamsters also exhibited higher IgG2 antibody titers compared to infected control groups, while IgG and IgG1 titers were decreased when compared to infected controls. rFBA-vaccinated hamsters survived longer than their non-immunized or BCG-only immunized counterparts: they remained healthy until their euthanasia 5&#8211;8 months post-infection, while the control hamsters succumbed to parasite challenge within two to 3&#160;months after &#8220;progressive increase in parasite load.&#8221; Lymphocytes of <italic toggle="yes">Leishmania</italic>-cured hamsters (30&#160;days post-treatment with miltefosine) showed a significantly increased lymphoproliferative response compared to lymphocytes from control and infected hamsters when stimulated with rFBA in a lymphocyte proliferation test (LPT). PBMCs of infected or amphotericin B-cured <italic toggle="yes">Leishmania-</italic>infected human patients showed a strong response to rFBA stimulation in LPT assays, suggesting that previous exposure to <italic toggle="yes">L. donovani</italic> aldolase can trigger an immune memory response to the enzyme. PBMCs from endemic contacts (family of infected or cured patients) and cured patients themselves released the Th1-type cytokines IL-12p40 and IFN&#947; when stimulated with rFBA (<xref rid="B67" ref-type="bibr">Gupta et al., 2014</xref>).</p><p>Fungi in the genus <italic toggle="yes">Candida</italic> (such as <italic toggle="yes">C. albicans</italic> and <italic toggle="yes">C. glabrata</italic>) are normally commensals in human microflora but become opportunistic pathogens when a human host becomes immunocompromised, leading to invasive candidiasis&#8211;one of the leading causes of mortality in both immunocompromised and hospitalized patients (<xref rid="B101" ref-type="bibr">Medrano-D&#237;az et al., 2018</xref>; <xref rid="B106" ref-type="bibr">Mix&#227;o and Gabald&#243;n 2020</xref>). Aldolase was selected as one of six candidates among <italic toggle="yes">C. albicans</italic> cell wall proteins, to be synthesized into a vaccine. A 14-amino-acid peptide derived from the N-terminus of <italic toggle="yes">C. albicans</italic> aldolase was conjugated onto a &#946;-mannitriose moiety to create the glycopeptide vaccine (&#946;-(Man)<sub>3</sub>-FBA) (<xref rid="B170" ref-type="bibr">Xin et al., 2008</xref>). Mice vaccinated with &#946;-(Man)<sub>3</sub>-FBA-pulsed dendritic cells (DCs) generated high FBA-specific antibody titers. Following a lethal challenge of <italic toggle="yes">C. albicans</italic>, immunized mice showed 80&#8211;100% survival rates compared to controls. The surviving mice had a significantly reduced fungal colony forming unit (CFU) count in kidney preparations compared to controls. Sera from immunized mice was transferred to na&#239;ve mice, which were challenged with <italic toggle="yes">C. albicans</italic>; these mice too showed significantly prolonged survival and reduced CFU counts compared to controls that received non-immunized serum or antiserum preabsorbed with fungal cells. All of the mice that received the FBA peptide-pulsed DCs survived, while &lt;25% of mice immunized with &#946;-(Man)<sub>3</sub>-pulsed DCs survived (<xref rid="B170" ref-type="bibr">Xin et al., 2008</xref>).</p><p>In later work (<xref rid="B34" ref-type="bibr">Cutler et al., 2011</xref>), immunocompromised <italic toggle="yes">Candida</italic>-colonized C57BL/6 mice were intraperitoneally administered a priming multiple antigenic peptide (MAP) aldolase vaccine and a first boost in the form of MAP-pulsed dendritic cells, followed by a MAP/Freund&#8217;s adjuvant second boost. All vaccinated mice generated high anti-MAP antibody titers. While in this work protection data were not reported, later experiments (<xref rid="B169" ref-type="bibr">Xin and Cutler, 2011</xref>) reported a protective impact of synthetic aldolase MAP injection into mice at the same time as administration of MAP-pulsed dendritic cells. All vaccinated mice exhibited signs of a protective immune response including generation of antigen-specific antibody, prolonged survival, and reduction of viable fungal CFUs in kidneys preparations versus controls (<xref rid="B169" ref-type="bibr">Xin and Cutler 2011</xref>). In addition, a MAP/glycan conjugate was used to pulse dendritic cells, and these were administered as a vaccine. This approach also provided protection against candidiasis as characterized by improved survival and reduced CFUs in kidney and brain preparations of infected mice compared to controls. Mirroring the previous study, passive transfer of immune sera from mice immunized with aldolase-pulsed DCs conferred protection on na&#239;ve mice. Furthermore, administration of a monoclonal antibody to the aldolase-MAP (called E2-9) also protected mice against candidiasis, demonstrating the importance of eliciting specific antibody responses against cell wall proteins like aldolase in controlling candidiasis. MAb E2-9 was also able to bind to the surface of <italic toggle="yes">Candida</italic> fungal cells as shown by immunofluorescence analysis (<xref rid="B169" ref-type="bibr">Xin and Cutler 2011</xref>).</p><p>In later work (<xref rid="B171" ref-type="bibr">Xin et al., 2019</xref>), the MAP was conjugated to synthetic mimotope peptides used to replace the &#946;-(Man)<sub>3</sub> glycan moiety. This was undertaken to eliminate the need for oligosaccharide synthesis, thus simplifying vaccine production. Mice that were challenged with <italic toggle="yes">C. albicans</italic> after vaccination with dendritic cells pulsed with these MAP constructs were protected against infection; these MAP-immunized mice showed comparable protection to that exhibited by mice immunized with the original MAP/glycan construct (i.e., they had significantly improved survival and reduced <italic toggle="yes">C. albicans</italic> CFUs in kidney preparations). Again, passive transfer of immune sera generated in this work protected mice from <italic toggle="yes">Candida</italic> infection. Further, IgM and IgG antibodies from vaccinated mice bound to the surface of living fungal cells (<xref rid="B171" ref-type="bibr">Xin et al., 2019</xref>).</p><p>In other vaccine work (<xref rid="B101" ref-type="bibr">Medrano-D&#237;az et al., 2018</xref>), BALB/c mice were immunized with recombinant <italic toggle="yes">C. glabrata</italic> aldolase in Freund&#8217;s adjuvant. Next, mice were inoculated with either <italic toggle="yes">C. albicans</italic> or <italic toggle="yes">C. glabrata via</italic> tail vein injection. Seven days after challenge fungal infection, spleen or liver homogenates generated from the immunized mice were found to yield significantly reduced <italic toggle="yes">C. albicans</italic> and <italic toggle="yes">C. glabrata</italic> CFUs compared to equivalent tissue homogenates from control mice. Anti-<italic toggle="yes">Candida</italic> FBA IgG antibodies from infected human patients have also been tested (<xref rid="B87" ref-type="bibr">Li et al., 2013</xref>) for candidemia diagnostic purposes in the laboratory setting with high sensitivity (87%), specificity (93%), as well as positive (77%) and negative (96%) predictive values.</p><p>Aldolase has also been used in vaccination experiments targeting multicellular parasites such as the intravascular helminth <italic toggle="yes">Schistosoma mansoni</italic>, a causative agent of human schistosomiasis, affecting 250 million individuals worldwide (<xref rid="B28" ref-type="bibr">Colley et al., 2014</xref>; <xref rid="B100" ref-type="bibr">McManus et al., 2018</xref>). An immunogenic <italic toggle="yes">S. mansoni</italic> protein (originally designated P44) was found to induce granuloma formation with PBMCs recovered from chronic schistosomiasis patients (<xref rid="B71" ref-type="bibr">Hirsch and Goes 1996</xref>; <xref rid="B97" ref-type="bibr">Marques et al., 2008</xref>). The protein was subsequently determined to be aldolase and was expressed in <italic toggle="yes">E. coli</italic> as a glutathione-<italic toggle="yes">S</italic>-transferase (GST) fusion protein. This protein (with alum and <italic toggle="yes">Propionibacterium acnes</italic> as adjuvant) was used to immunize C57BL/6J mice (<xref rid="B97" ref-type="bibr">Marques et al., 2008</xref>). Two weeks after two vaccine boosts, immunized mice were challenged with 25 <italic toggle="yes">S. mansoni</italic> cercariae (infectious larval-stage parasites); mice were euthanized 8&#160;weeks after parasite infection. Immunized mice generated significantly higher titers of anti-aldolase IgG1 compared to controls, while there was no significant production of anti-aldolase IgG2a in immunized groups. Splenocytes of aldolase-immunized mice produced significantly higher levels of Th2 cytokines IL-4 and IL-10 when compared to splenocytes from control mice when stimulated with aldolase, while levels of the Th1 cytokine IFN&#947; remained at consistent low concentrations among all groups. There was a significant &#8764;57% reduction in worm burden in immunized mice, and a significant reduction in the size of hepatic granulomas in the livers of these mice compared to controls (<xref rid="B97" ref-type="bibr">Marques et al., 2008</xref>). A 2020 vaccination study demonstrated that immunization with recombinant schistosome GAPDH resulted in increased Th2 cytokines (IL4 and IL-5) production and significant reduction in worm and egg burdens (Tang et al., 2020). This protection was further enhanced by the addition of an anti-CD24 monoclonal antibody, which increased the Th1 response (<xref rid="B181" ref-type="bibr">Tang et al., 2020</xref>). This led to the conclusion that a mixed Th1/Th2 response may show synergistic effects in protection against schistosomiasis&#8211;could similar protection be elicited by exploiting this synergy when designing other anti-parasite aldolase vaccines?</p><p>A DNA plasmid vaccine encoding <italic toggle="yes">S. mansoni</italic> aldolase was injected into CD1 Swiss mice intramuscularly, subcutaneously, or intraperitoneally four times at biweekly intervals (<xref rid="B134" ref-type="bibr">Saber et al., 2013</xref>). Mice were infected with 80 cercariae 2&#160;weeks after the last immunization. High titers of anti-aldolase IgG were detected in all groups vaccinated with a right-oriented plasmid relative to those immunized with a control (reverse orientation) plasmid. Reductions in worm burden were as high as 46% in intraperitoneally immunized mice, and these mice also showed reductions in parasite egg burden up to &#8764;40% in both the liver and intestine. Mice injected subcutaneously had worm burden reductions of 29% while intramuscular injection of the vaccine reduced worm burden by only 15%, which was not statistically significantly different from the control situation. Egg burdens in subcutaneous and intramuscular vaccination groups were not significantly reduced compared to controls. In all cases, the mean granuloma diameter and the granuloma number in aldolase-immunized mice was significantly reduced compared to vector-alone vaccinated controls, and granulomas of aldolase-immunized mice were characterized by high levels of fibrosis, increased numbers of lymphocytes, and dead miracidia (i.e., larvae within the eggs) (<xref rid="B134" ref-type="bibr">Saber et al., 2013</xref>). In comparison, DNA plasmid vaccines coding for schistosome triosephosphate isomerase (TPI), another surface-localized glycolytic enzyme, have been used in a variety of animal models. For example, one study demonstrated reduced worm and egg burdens and an increased Th1-polarized response (characterized by increased levels of IL-2, IFN&#947;, and TNF&#945;) in mice immunized <italic toggle="yes">via</italic> electroporation with a codon-optimized DNA vaccine (<xref rid="B178" ref-type="bibr">Zhu et al., 2010</xref>). It is possible codon optimization and the differing route of administration led to the distinct immune response, and further studies on aldolase vaccines using these tools may offer new insights into protective vaccine development.</p><p><italic toggle="yes">Onchocerca volvulus</italic> is a parasitic filarial nematode that causes the debilitating ocular disease onchocerciasis (also known as river blindness) that affects &#8764;18 million people globally (<xref rid="B46" ref-type="bibr">Etya&#8217;ale 2001</xref>). BALB/cByJ mice subcutaneously injected with urea-solubilized recombinant <italic toggle="yes">O. volvulus</italic> aldolase in Freund&#8217;s were surgically implanted with a subcutaneous diffusion chamber containing <italic toggle="yes">O. volvulus</italic> L3-stage larvae (<xref rid="B99" ref-type="bibr">McCarthy et al., 2002</xref>). There was a &#8764;50% reduction in larval survival 21&#160;days later in the aldolase-immunized mice compared to controls. While antibodies from sera of nonendemic control human subjects (n = 22) did not recognize recombinant aldolase by western blot analysis, the sera of 88% of <italic toggle="yes">O. volvulus</italic>-infected subjects (n = 42) and 68% of putatively immune individuals (n = 34, based on previous clinical history and exposure to infection) recognized the enzyme. Recombinant aldolase was able to induce T-cell proliferation, and production of IL-5 and IFN&#947; in PBMCs collected from putatively immune and infected individuals but not from non-endemic, control individuals. Since the protection seen in the mouse model may not predict human vaccinations outcomes, using larger animals such as non-human primates as vaccine models may replicate human immune responses <italic toggle="yes">in vivo</italic> more closely (<xref rid="B99" ref-type="bibr">McCarthy et al., 2002</xref>). Partial protection from <italic toggle="yes">O. volvulus</italic> was also demonstrated in mice immunized with a DNA vaccine coding for GAPDH, which stimulated a pre-challenge Th1 response and induced increased generation of GAPDH-specific IgG and IgM antibodies (<xref rid="B146" ref-type="bibr">Steisslinger et al., 2015</xref>).</p><p><italic toggle="yes">Trichinella spiralis</italic> is a parasitic nematode that causes trichinellosis when a human consumes uncooked, infected animal muscle tissue containing infective larvae (<xref rid="B65" ref-type="bibr">Gottstein et al., 2009</xref>). Trichinellosis occurs globally, with estimates of &#8764;10,000 cases yearly (<xref rid="B133" ref-type="bibr">Rawla and Sharma 2020</xref>). Recombinant <italic toggle="yes">T. spiralis</italic> aldolase in ISA206 adjuvant was injected subcutaneously into BALB/c mice, and the mice were orally challenged with 300 <italic toggle="yes">T. spiralis</italic> muscle larvae 2&#160;weeks after the last of two boosts (<xref rid="B174" ref-type="bibr">Yang et al., 2019</xref>). These mice showed a significant reduction in adult worm (48.7%) and muscle larval (52.5%) burden compared to controls. Total serum anti-FBA IgG titers were significantly increased in aldolase-immunized mice compared to control mice, and the IgG1 level was higher than that of IgG2a. Specific IgE titers were also increased following aldolase immunization, leading to the suggestion that expulsion of worms from the intestine may be at play, as IgE-dependent mast cell activation has been promoted as a contributing factor to the elimination of gastrointestinal nematode parasites (<xref rid="B112" ref-type="bibr">Mukai et al., 2016</xref>). A mixed Th1/Th2 response induced by vaccination was confirmed by cytokine analysis: significantly increased IL-2, IFN&#947;, IL-4, and IL-10 levels were all detected in the supernatants of aldolase-stimulated splenocytes from immunized mice, once more demonstrating the synergistic effects of the balance between Th1/Th2 immune responses in protecting against infection. Further research is required to discover the precise mechanism by which aldolase elicits a protective response against <italic toggle="yes">T. spiralis</italic> (<xref rid="B174" ref-type="bibr">Yang et al., 2019</xref>).</p><p>In summary, aldolase as an immunogen has generated protective immunity in a wide variety of vaccination trials targeting bacteria, fungi, protozoans, and metazoan parasites. <xref rid="T3" ref-type="table">Table 3</xref> provides a summary of these various immunization efforts and their outcomes. While vaccination against pathogens has generally focused on generating a protective immune response in the host, it may be of interest to researchers conducting future trials to examine the effects vaccination has against moonlighting functions. As previously mentioned, anti-aldolase antibodies have been shown to diminish moonlighting functions [e.g., reducing streptococcal binding to mammalian cells (<xref rid="B11" ref-type="bibr">Blau et al., 2007</xref>)], so it is plausible that protection observed in vaccination trials may partially stem from the curbing of vital moonlighting functions. Further research is required to fine-tune immunogen and adjuvant preparations (e.g., by introducing TLR agonists and/or enhancing vaccine design and routes of administration) in order to elicit an optimal protective immune response (e.g., perhaps a mixed Th1/Th2 responses when needed).</p><table-wrap id="T3" position="float" orientation="portrait"><label>TABLE 3</label><caption><p>A summary of experimental vaccination trials using aldolase as an immunogen against pathogenic bacteria, protozoans, fungi, and metazoan parasites. The pathogenic species, vaccine preparations, and animal models used in each study are listed. The Outcomes column summarizes the main protective and immunological consequences recorded in aldolase-vaccinated animals versus controls.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">Species</th><th align="center" rowspan="1" colspan="1">Vaccine preparation</th><th align="center" rowspan="1" colspan="1">Animal model</th><th align="center" rowspan="1" colspan="1">Outcomes</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td rowspan="3" align="center" colspan="1">Bacteria</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus pneumoniae</italic>
</td><td align="left" rowspan="1" colspan="1">Recombinant protein</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Improved survival (26&#8211;36%), robust, mixed Th1, Th2, Th17 (IFN&#947;, IL-12, IL-2, TNF&#945;, Il-4, IL-5,IL-10, IL-17A) immune response</td><td align="left" rowspan="1" colspan="1"><xref rid="B91" ref-type="bibr">Ling et al. (2004)</xref>, <xref rid="B60" ref-type="bibr">Elhaik Goldman et al. (2016)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Aquatic bacteria (<italic toggle="yes">E. tarda, V. anguillarum, V. harveyi, V. alginolyticus, A. hydrophila</italic>)</td><td align="left" rowspan="1" colspan="1">Recombinant protein</td><td align="left" rowspan="1" colspan="1">Fish</td><td align="left" rowspan="1" colspan="1">Increased survival (50&#8211;80%), upregulated immune gene (TLR2, TLR4, TLR5, MYD88) expression, increased specific antibody and cytokine (IL-8, IL-10, IL-1&#946;) production</td><td align="left" rowspan="1" colspan="1">
<xref rid="B151" ref-type="bibr">Sun et al. (2015)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Clostridium perfringens</italic>
</td><td align="left" rowspan="1" colspan="1">Recombinant protein, <italic toggle="yes">Salmonella</italic> vector</td><td align="left" rowspan="1" colspan="1">Chicken</td><td align="left" rowspan="1" colspan="1">Improved lesion scoring, increased specific IgY, IgM, IgA antibody titers, improved body weight, increased lymphocyte proliferation</td><td align="left" rowspan="1" colspan="1"><xref rid="B80" ref-type="bibr">Kulkarni et al. (2007)</xref>, <xref rid="B81" ref-type="bibr">Kulkarni et al. (2008)</xref>, <xref rid="B165" ref-type="bibr">Wilde et al. (2019)</xref></td></tr><tr><td rowspan="2" align="center" colspan="1">Protozoa</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Plasmodium falciparum</italic>
</td><td align="left" rowspan="1" colspan="1">Native protein</td><td align="left" rowspan="1" colspan="1">Monkey</td><td align="left" rowspan="1" colspan="1">Reduced parasitemia, specific antibody generation</td><td align="left" rowspan="1" colspan="1">
<xref rid="B123" ref-type="bibr">Perrin et al. (1985)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Leishmania donovani</italic>
</td><td align="left" rowspan="1" colspan="1">Recombinant protein</td><td align="left" rowspan="1" colspan="1">Hamster</td><td align="left" rowspan="1" colspan="1">Reduced parasite load, increased weight gain, prolonged survival, increased Th1 gene expression and cytokine (IFN&#947;, TNF&#945;) response, downregulated Th2 gene expression, increased specific IgG antibody generation</td><td align="left" rowspan="1" colspan="1">
<xref rid="B67" ref-type="bibr">Gupta et al. (2014)</xref>
</td></tr><tr><td rowspan="2" align="center" colspan="1">Fungi</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Candida albicans</italic>
</td><td align="left" rowspan="1" colspan="1">Multiple antigen peptide (MAP)-pulsed dendritic cells, MAP conjugated to synthetic mimotope peptides</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Specific antibody generation, prolonged survival, reduced tissue fungal load</td><td align="left" rowspan="1" colspan="1"><xref rid="B170" ref-type="bibr">Xin et al. (2008)</xref>, <xref rid="B34" ref-type="bibr">Cutler et al. (2011)</xref>, <xref rid="B169" ref-type="bibr">Xin and Cutler (2011)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Candida glabrata</italic>
</td><td align="left" rowspan="1" colspan="1">Recombinant protein</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Specific antibody generation, reduction of CFUs from tissue homogenates</td><td align="left" rowspan="1" colspan="1"><xref rid="B169" ref-type="bibr">Xin and Cutler (2011)</xref>, <xref rid="B101" ref-type="bibr">Medrano-Diaz et al. (2018)</xref>, <xref rid="B171" ref-type="bibr">Xin et al. (2019)</xref></td></tr><tr><td rowspan="3" align="center" colspan="1">Metazoa</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Schistosoma mansoni</italic>
</td><td align="left" rowspan="1" colspan="1">Glutathione-S-transferase fusion protein, DNA plasmid</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Specific IgG antibody generation, Th2 (IL-4, IL-10) cytokine production, worm (15&#8211;57%) and egg burden (0&#8211;40%) reduction, granuloma size and number reduction</td><td align="left" rowspan="1" colspan="1"><xref rid="B97" ref-type="bibr">Marques et al. (2008)</xref>, <xref rid="B134" ref-type="bibr">Saber et al. (2013)</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Onchocerca volvulus</italic>
</td><td align="left" rowspan="1" colspan="1">Recombinant protein</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Reduced larval survival (50%), specific antibody generation, T-cell proliferation, enhanced cytokine (IL-5, IFN&#947;) production</td><td align="left" rowspan="1" colspan="1">
<xref rid="B99" ref-type="bibr">McCarthy et al. (2002)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Trichinella spiralis</italic>
</td><td align="left" rowspan="1" colspan="1">Recombinant protein</td><td align="left" rowspan="1" colspan="1">Mouse</td><td align="left" rowspan="1" colspan="1">Reduction in worm burden (&#8764;49&#8211;53%), specific IgG and IgE antibody generation, mixed Th1/Th2 immune response (IL-2, IFN&#947;, IL-4, IL-10 generation)</td><td align="left" rowspan="1" colspan="1">
<xref rid="B174" ref-type="bibr">Yang et al. (2019)</xref>
</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: MAP, multiple antigen peptide; Th, T helper; IL, interleukin; Ig, immunoglobulin; TNF, tumor necrosis factor; immunoglobulin; CFU, colony forming unit</p></fn></table-wrap-foot></table-wrap></sec><sec id="s6-3"><title>Autoimmune Disease</title><p>Aldolase has been described as an autoantigen in patients with some autoimmune disorders including Alzheimer&#8217;s disease (<xref rid="B109" ref-type="bibr">Mor et al., 2005</xref>), atypical movement disorders (<xref rid="B128" ref-type="bibr">Privitera et al., 2013</xref>), and autoimmune retinopathies (<xref rid="B1" ref-type="bibr">Adamus 2017</xref>). Antibodies in serum from Alzheimer&#8217;s patients, as well as some patients with multiple sclerosis and healthy controls, bind to aldolase A (ALDOA) (<xref rid="B109" ref-type="bibr">Mor et al., 2005</xref>). These antibodies also reduce the enzymatic activity of aldolase <italic toggle="yes">in vitro</italic>. To investigate if this anti-aldolase immunity might contribute to Alzheimer&#8217;s disease pathology in an animal model, Lewis rats, C57BL mice, and NOD mice were immunized with rabbit muscle aldolase A in Freund&#8217;s adjuvant (<xref rid="B109" ref-type="bibr">Mor et al., 2005</xref>). However, this resulted in no overt pathology; no animals showed clinical signs of CNS or muscle disease, and histological analysis of organs (brains, muscle, spinal cord, heart) showed no signs of inflammation. These results have led to the conclusion that aldolase autoantibodies represent a nonspecific biomarker of Alzheimer&#8217;s disease and would be a poor immunotherapy candidate for this disease (<xref rid="B167" ref-type="bibr">Wu and Ling, 2016</xref>).</p><p>Interestingly, intraperitoneal administration (<xref rid="B173" ref-type="bibr">Yan et al., 2020</xref>) of recombinant <italic toggle="yes">Schistosoma japonicum</italic> aldolase in female non-obese diabetic (NOD) mice ameliorated induced type 1 diabetes severity and incidence (<xref rid="B173" ref-type="bibr">Yan et al., 2020</xref>). rFBA-treated animals had significantly lower diabetes incidence (40% reduction) and reduced blood glucose levels compared to control mice. These effects were ascribed to Th2 type response induction following rFBA injection, characterized by increased generation of the anti-inflammatory cytokine IL-4 and downregulation of the pro-inflammatory Th1 cytokine IFN&#947; in the spleen and pancreatic lymph nodes. Furthermore, rFBA-injected mice exhibited increased Treg cell numbers and an associated increase in IL-10 and TGF&#946; detected in the spleen and lymph nodes compared to control mice. Immunohistochemical analysis of pancreatic islets revealed that rFBA-treated mice had reduced lymphocyte infiltration and improved insulin secretion. These results led to the conclusion that rFBA injection induced anti-inflammatory Th2 immune polarization and downregulated the pro-inflammatory Th1 response, resulting in attenuated inflammation of pancreatic islets and thus ameliorating type I diabetes pathology.</p></sec></sec><sec sec-type="conclusion" id="s7"><title>Conclusion</title><p>Given its key role in the glycolytic pathway, fructose 1,6-bisphophate aldolase has long been known to play a central role in the cell&#8217;s internal glucose metabolism. More recently, this conserved protein has been discovered to possess a myriad of other, non-glycolytic functions both inside and outside the cell. In an extracellular location, aldolase has been shown to possess numerous moonlighting functions for pathogens such as binding to host cell receptors to facilitate invasion or activating plasminogen to potentially modulate host hemostasis and enhance survival.</p><p>Given its immunogenic nature in pathogen-infected human patients and its surface localization in many pathogens, aldolase has become a focus of drug discovery as well as a candidate in several animal-based vaccine studies. Drugs designed to inhibit aldolase are selected for their ability to disrupt proper function of the active site, whether that be designing a competitor that mimics the Schiff base, or a chelator that removes stabilizing metal cofactors in the cases of Class-I and Class-II aldolases, respectively. As discussed above, several Class-I and Class-II aldolase inhibitors have been identified and further work is required to refine their potency and specificity. Elucidating and targeting the various non-canonical mechanisms and pathways that pathogens use to secrete and traffic moonlighting aldolase to the extracellular environment could also be helpful in the development of new strategies and tools to combat infection (<xref rid="B74" ref-type="bibr">Jeffery 2018</xref>).</p><p>Aldolase vaccination studies involving bacteria, fungi, or parasites all invariably resulted in the development of varying degrees of protection from challenge infection, and this was associated with induced cellular and/or humoral immune responses. Novel immunoinformatics approaches to predict optimal peptide sequences with strong binding affinities to host MHC molecules while minimizing allergic reactivity may prove useful in simplifying the search for specific antigenic epitopes within the enzyme structure (<xref rid="B108" ref-type="bibr">Mohammed et al., 2018</xref>; <xref rid="B45" ref-type="bibr">Elhag et al., 2020</xref>). The development of new technologies such as immunoinformatics, the exploration of new vaccine designs and alternative routes of immunogen administration (i.e., protein versus DNA versus RNA, oral administration versus intramuscular etc.), as well as the expansion of aldolase vaccination trials and subjects in general should be undertaken to further advance efforts to generate clinically useful aldolase vaccines in order to reduce pathogenic disease and improve global health.</p></sec></body><back><ack><p>The authors would like to thank Chuck Shoemaker for insightful discussions.</p></ack><sec id="s8"><title>Author Contributions</title><p>DP wrote the first draft manuscript. DP, AD, and PS contributed to manuscript revision, read and approved the submitted version.</p></sec><sec id="s9"><title>Funding</title><p>This work was funded with support from National Institutes of Health-National Institute of Allergy and Infectious Diseases grant AI056273.</p></sec><sec sec-type="COI-statement" id="s10"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec id="s11" sec-type="disclaimer"><title>Publisher&#8217;s Note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adamus</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders</article-title>. <source>Front. Immunol.</source><volume>8</volume>, <fpage>505</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2017.00505</pub-id><pub-id pub-id-type="pmid">28503176</pub-id><pub-id pub-id-type="pmcid">PMC5408022</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alefounder</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Perham</surname><given-names>R. N.</given-names></name><name name-style="western"><surname>Short</surname><given-names>N. J.</given-names></name></person-group> (<year>1989</year>). <article-title>Cloning, Sequence Analysis and Over-expression of the Gene for the Class II Fructose 1,6-bisphosphate Aldolase of <italic toggle="yes">Escherichia coli</italic>
</article-title>. <source>Biochem. J.</source><volume>257</volume> (<issue>2</issue>), <fpage>529</fpage>&#8211;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1042/bj2570529</pub-id><pub-id pub-id-type="pmid">2649077</pub-id><pub-id pub-id-type="pmcid">PMC1135610</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allen</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>Moustafa</surname><given-names>A.</given-names></name><name name-style="western"><surname>Montsant</surname><given-names>A.</given-names></name><name name-style="western"><surname>Eckert</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kroth</surname><given-names>P. G.</given-names></name><name name-style="western"><surname>Bowler</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Evolution and Functional Diversification of Fructose Bisphosphate Aldolase Genes in Photosynthetic marine Diatoms</article-title>. <source>Mol. Biol. Evol.</source><volume>29</volume> (<issue>1</issue>), <fpage>367</fpage>&#8211;<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msr223</pub-id><pub-id pub-id-type="pmid">21903677</pub-id><pub-id pub-id-type="pmcid">PMC3245544</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arakaki</surname><given-names>T. L.</given-names></name><name name-style="western"><surname>Pezza</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Cronin</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Hopkins</surname><given-names>C. E.</given-names></name><name name-style="western"><surname>Zimmer</surname><given-names>D. B.</given-names></name><name name-style="western"><surname>Tolan</surname><given-names>D. R.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Structure of Human Brain Fructose 1,6-(bis)phosphate Aldolase: Linking Isozyme Structure with Function</article-title>. <source>Protein Sci.</source><volume>13</volume> (<issue>12</issue>), <fpage>3077</fpage>&#8211;<lpage>3084</lpage>. <pub-id pub-id-type="doi">10.1110/ps.04915904</pub-id><pub-id pub-id-type="pmid">15537755</pub-id><pub-id pub-id-type="pmcid">PMC2287316</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ay&#243;n-N&#250;&#241;ez</surname><given-names>D. A.</given-names></name><name name-style="western"><surname>Fragoso</surname><given-names>G.</given-names></name><name name-style="western"><surname>Bobes</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>Laclette</surname><given-names>J. P.</given-names></name></person-group> (<year>2018</year>). <article-title>Plasminogen-binding Proteins as an Evasion Mechanism of the Host&#8217;s Innate Immunity in Infectious Diseases</article-title>. <source>Biosci. Rep.</source><volume>38</volume> (<issue>5</issue>), <fpage>BSR20180705</fpage>. <pub-id pub-id-type="doi">10.1042/BSR20180705</pub-id><pub-id pub-id-type="pmid">30166455</pub-id><pub-id pub-id-type="pmcid">PMC6167496</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bakker</surname><given-names>B. M.</given-names></name><name name-style="western"><surname>Westerhoff</surname><given-names>H. V.</given-names></name><name name-style="western"><surname>Opperdoes</surname><given-names>F. R.</given-names></name><name name-style="western"><surname>Michels</surname><given-names>P. A. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Metabolic Control Analysis of Glycolysis in Trypanosomes as an Approach to Improve Selectivity and Effectiveness of Drugs</article-title>. <source>Mol. Biochem. Parasitol.</source><volume>106</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-6851(99)00197-8</pub-id><pub-id pub-id-type="pmid">10743606</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bassetti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vena</surname><given-names>A.</given-names></name><name name-style="western"><surname>Croxatto</surname><given-names>A.</given-names></name><name name-style="western"><surname>Righi</surname><given-names>E.</given-names></name><name name-style="western"><surname>Guery</surname><given-names>B.</given-names></name></person-group> (<year>2018</year>). <article-title>How to Manage Pseudomonas aeruginosa Infections</article-title>. <source>Drugs Context</source><volume>7</volume>, <fpage>212527</fpage>. <pub-id pub-id-type="doi">10.7573/dic.212527</pub-id><pub-id pub-id-type="pmid">29872449</pub-id><pub-id pub-id-type="pmcid">PMC5978525</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bergmann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rohde</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chhatwal</surname><given-names>G. S.</given-names></name><name name-style="western"><surname>Hammerschmidt</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>Alpha-Enolase of Streptococcus Pneumoniae Is a Plasmin(ogen)-Binding Protein Displayed on the Bacterial Cell Surface</article-title>. <source>Mol. Microbiol.</source><volume>40</volume> (<issue>6</issue>), <fpage>1273</fpage>&#8211;<lpage>1287</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2001.02448.x</pub-id><pub-id pub-id-type="pmid">11442827</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhattacharya</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ploplis</surname><given-names>V. A.</given-names></name><name name-style="western"><surname>Castellino</surname><given-names>F. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Bacterial Plasminogen Receptors Utilize Host Plasminogen System for Effective Invasion and Dissemination</article-title>. <source>J. Biomed. Biotechnol.</source><volume>2012</volume>, <fpage>482096</fpage>. <pub-id pub-id-type="doi">10.1155/2012/482096</pub-id><pub-id pub-id-type="pmid">23118509</pub-id><pub-id pub-id-type="pmcid">PMC3477821</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biller</surname><given-names>L.</given-names></name><name name-style="western"><surname>Matthiesen</surname><given-names>J.</given-names></name><name name-style="western"><surname>K&#252;hne</surname><given-names>V.</given-names></name><name name-style="western"><surname>Lotter</surname><given-names>H.</given-names></name><name name-style="western"><surname>Handal</surname><given-names>G.</given-names></name><name name-style="western"><surname>Nozaki</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>The Cell Surface Proteome of <italic toggle="yes">Entamoeba Histolytica</italic>
</article-title>. <source>Mol. Cell Proteom.</source><volume>13</volume> (<issue>1</issue>), <fpage>132</fpage>&#8211;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.m113.031393</pub-id><pub-id pub-id-type="pmcid">PMC3879609</pub-id><pub-id pub-id-type="pmid">24136294</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blau</surname><given-names>K.</given-names></name><name name-style="western"><surname>Portnoi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shagan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kaganovich</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rom</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kafka</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Flamingo Cadherin: A Putative Host Receptor forStreptococcus Pneumoniae</article-title>. <source>J. Infect. Dis.</source><volume>195</volume> (<issue>12</issue>), <fpage>1828</fpage>&#8211;<lpage>1837</lpage>. <pub-id pub-id-type="doi">10.1086/518038</pub-id><pub-id pub-id-type="pmid">17492599</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bosch</surname><given-names>J.</given-names></name><name name-style="western"><surname>Buscaglia</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Krumm</surname><given-names>B.</given-names></name><name name-style="western"><surname>Ingason</surname><given-names>B. P.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>R.</given-names></name><name name-style="western"><surname>Roach</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Aldolase Provides an Unusual Binding Site for Thrombospondin-Related Anonymous Protein in the Invasion Machinery of the Malaria Parasite</article-title>. <source>Proc. Natl. Acad. Sci.</source><volume>104</volume> (<issue>17</issue>), <fpage>7015</fpage>&#8211;<lpage>7020</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0605301104</pub-id><pub-id pub-id-type="pmid">17426153</pub-id><pub-id pub-id-type="pmcid">PMC1855406</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bottone</surname><given-names>E. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Bacillus Cereus , a Volatile Human Pathogen</article-title>. <source>Clin. Microbiol. Rev.</source><volume>23</volume> (<issue>2</issue>), <fpage>382</fpage>&#8211;<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1128/cmr.00073-09</pub-id><pub-id pub-id-type="pmid">20375358</pub-id><pub-id pub-id-type="pmcid">PMC2863360</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boucher</surname><given-names>L. E.</given-names></name><name name-style="western"><surname>Hopp</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>Muthinja</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Frischknecht</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Discovery of Plasmodium (M)TRAP-Aldolase Interaction Stabilizers Interfering with Sporozoite Motility and Invasion</article-title>. <source>ACS Infect. Dis.</source><volume>4</volume> (<issue>4</issue>), <fpage>620</fpage>&#8211;<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.7b00225</pub-id><pub-id pub-id-type="pmid">29411968</pub-id><pub-id pub-id-type="pmcid">PMC6364851</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bu</surname><given-names>P.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>K.-Y.</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>K.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>C.</given-names></name><name name-style="western"><surname>Crown</surname><given-names>S. B.</given-names></name><name name-style="western"><surname>Rakhilin</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Aldolase B-Mediated Fructose Metabolism Drives Metabolic Reprogramming of colon Cancer Liver Metastasis</article-title>. <source>Cel Metab.</source><volume>27</volume> (<issue>6</issue>), <fpage>1249</fpage>&#8211;<lpage>1262</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2018.04.003</pub-id><pub-id pub-id-type="pmcid">PMC5990465</pub-id><pub-id pub-id-type="pmid">29706565</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buscaglia</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>Coppens</surname><given-names>I.</given-names></name><name name-style="western"><surname>Hol</surname><given-names>W. G. J.</given-names></name><name name-style="western"><surname>Nussenzweig</surname><given-names>V.</given-names></name></person-group> (<year>2003</year>). <article-title>Sites of Interaction between Aldolase and Thrombospondin-Related Anonymous Protein inPlasmodium</article-title>. <source>MBoC</source><volume>14</volume> (<issue>12</issue>), <fpage>4947</fpage>&#8211;<lpage>4957</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e03-06-0355</pub-id><pub-id pub-id-type="pmid">14595113</pub-id><pub-id pub-id-type="pmcid">PMC284797</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>C&#225;ceres</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Michels</surname><given-names>P. A.</given-names></name><name name-style="western"><surname>Hannaert</surname><given-names>V.</given-names></name></person-group> (<year>2009</year>). <article-title>Genetic Validation of Aldolase and Glyceraldehyde-3-Phosphate Dehydrogenase as Drug Targets in Trypanosoma Brucei</article-title>. <source>Mol. Biochem. Parasitol.</source><volume>169</volume> (<issue>1</issue>), <fpage>50</fpage>&#8211;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbiopara.2009.09.001</pub-id><pub-id pub-id-type="pmid">19748525</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capodagli</surname><given-names>G. C.</given-names></name><name name-style="western"><surname>Sedhom</surname><given-names>W. G.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ahrendt</surname><given-names>K. A.</given-names></name><name name-style="western"><surname>Pegan</surname><given-names>S. D.</given-names></name></person-group> (<year>2014</year>). <article-title>A Noncompetitive Inhibitor for Mycobacterium tuberculosis's Class IIa Fructose 1,6-Bisphosphate Aldolase</article-title>. <source>Biochemistry</source><volume>53</volume> (<issue>1</issue>), <fpage>202</fpage>&#8211;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1021/bi401022b</pub-id><pub-id pub-id-type="pmid">24325645</pub-id><pub-id pub-id-type="pmcid">PMC4167715</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caspi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Perry</surname><given-names>G.</given-names></name><name name-style="western"><surname>Skalka</surname><given-names>N.</given-names></name><name name-style="western"><surname>Meisel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Firsow</surname><given-names>A.</given-names></name><name name-style="western"><surname>Amit</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Aldolase Positively Regulates of the Canonical Wnt Signaling Pathway</article-title>. <source>Mol. Cancer</source><volume>13</volume>, <fpage>164</fpage>. <pub-id pub-id-type="doi">10.1186/1476-4598-13-164</pub-id><pub-id pub-id-type="pmid">24993527</pub-id><pub-id pub-id-type="pmcid">PMC4094682</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Certa</surname><given-names>U.</given-names></name><name name-style="western"><surname>Ghersa</surname><given-names>P.</given-names></name><name name-style="western"><surname>Dobeli</surname><given-names>H.</given-names></name><name name-style="western"><surname>Matile</surname><given-names>H.</given-names></name><name name-style="western"><surname>Kocher</surname><given-names>H.</given-names></name><name name-style="western"><surname>Shrivastava</surname><given-names>I.</given-names></name><etal/></person-group> (<year>1988</year>). <article-title>Aldolase Activity of a <italic toggle="yes">Plasmodium Falciparum</italic> Protein with Protective Properties</article-title>. <source>Science</source><volume>240</volume> (<issue>4855</issue>), <fpage>1036</fpage>&#8211;<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1126/science.3285469</pub-id><pub-id pub-id-type="pmid">3285469</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cesarman-Maus</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hajjar</surname><given-names>K. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Molecular Mechanisms of Fibrinolysis</article-title>. <source>Br. J. Haematol.</source><volume>129</volume> (<issue>3</issue>), <fpage>307</fpage>&#8211;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2141.2005.05444.x</pub-id><pub-id pub-id-type="pmid">15842654</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaffin</surname><given-names>W. L.</given-names></name></person-group> (<year>2008</year>). <article-title><italic toggle="yes">Candida Albicans</italic> Cell wall Proteins</article-title>. <source>Microbiol. Mol. Biol. Rev.</source><volume>72</volume> (<issue>3</issue>), <fpage>495</fpage>&#8211;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1128/mmbr.00032-07</pub-id><pub-id pub-id-type="pmid">18772287</pub-id><pub-id pub-id-type="pmcid">PMC2546859</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>Y.-C.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y.-C.</given-names></name><name name-style="western"><surname>Tien</surname><given-names>C.-P.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C.-J.</given-names></name><name name-style="western"><surname>Hsiao</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Roles of Aldolase Family Genes in Human Cancers and Diseases</article-title>. <source>Trends Endocrinol. Metab.</source><volume>29</volume> (<issue>8</issue>), <fpage>549</fpage>&#8211;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1016/j.tem.2018.05.003</pub-id><pub-id pub-id-type="pmid">29907340</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>Y. C.</given-names></name><name name-style="western"><surname>Chiou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y. F.</given-names></name><name name-style="western"><surname>Su</surname><given-names>C. Y.</given-names></name><name name-style="western"><surname>Lin</surname><given-names>Y. F.</given-names></name><name name-style="western"><surname>Yang</surname><given-names>C. N.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival</article-title>. <source>Cancer Res.</source><volume>79</volume> (<issue>18</issue>), <fpage>4754</fpage>&#8211;<lpage>4766</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-18-4080</pub-id><pub-id pub-id-type="pmid">31358528</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaves</surname><given-names>E. G. A.</given-names></name><name name-style="western"><surname>Weber</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>B&#225;o</surname><given-names>S. N.</given-names></name><name name-style="western"><surname>Pereira</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>Bail&#227;o</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Borges</surname><given-names>C. L.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Analysis of <italic toggle="yes">Paracoccidioides</italic> Secreted Proteins Reveals Fructose 1,6-bisphosphate Aldolase as a Plasminogen-Binding Protein</article-title>. <source>BMC Microbiol.</source><volume>15</volume>, <fpage>53</fpage>. <pub-id pub-id-type="doi">10.1186/s12866-015-0393-9</pub-id><pub-id pub-id-type="pmid">25888027</pub-id><pub-id pub-id-type="pmcid">PMC4357084</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chu</surname><given-names>X.-M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W.-L.</given-names></name><name name-style="western"><surname>Liang</surname><given-names>L.-L.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W.</given-names></name><name name-style="western"><surname>Gong</surname><given-names>K.-K.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Triazole Derivatives and Their Antiplasmodial and Antimalarial Activities</article-title>. <source>Eur. J. Med. Chem.</source><volume>166</volume>, <fpage>206</fpage>&#8211;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2019.01.047</pub-id><pub-id pub-id-type="pmid">30711831</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cie&#347;la</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mierzejewska</surname><given-names>J.</given-names></name><name name-style="western"><surname>Adamczyk</surname><given-names>M.</given-names></name><name name-style="western"><surname>Farrants</surname><given-names>A. K.</given-names></name><name name-style="western"><surname>Boguta</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Fructose Bisphosphate Aldolase Is Involved in the Control of RNA Polymerase III-Directed Transcription</article-title>. <source>Biochim. Biophys. Acta</source><volume>1843</volume> (<issue>6</issue>), <fpage>1103</fpage>&#8211;<lpage>1110</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.02.007</pub-id><pub-id pub-id-type="pmid">24576411</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colley</surname><given-names>D. G.</given-names></name><name name-style="western"><surname>Bustinduy</surname><given-names>A. L.</given-names></name><name name-style="western"><surname>Secor</surname><given-names>W. E.</given-names></name><name name-style="western"><surname>King</surname><given-names>C. H.</given-names></name></person-group> (<year>2014</year>). <article-title>Human Schistosomiasis</article-title>. <source>Lancet</source><volume>383</volume> (<issue>9936</issue>), <fpage>2253</fpage>&#8211;<lpage>2264</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(13)61949-2</pub-id><pub-id pub-id-type="pmid">24698483</pub-id><pub-id pub-id-type="pmcid">PMC4672382</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collingridge</surname><given-names>P. W.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>R. W. B.</given-names></name><name name-style="western"><surname>Ginger</surname><given-names>M. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Moonlighting Enzymes in Parasitic Protozoa</article-title>. <source>Parasitology</source><volume>137</volume> (<issue>9</issue>), <fpage>1467</fpage>&#8211;<lpage>1475</lpage>. <pub-id pub-id-type="doi">10.1017/s0031182010000259</pub-id><pub-id pub-id-type="pmid">20233494</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>K. D.</given-names></name></person-group> (<year>1974</year>). <article-title>An Activated Intermediate Analogue</article-title>. <source>J. Biol. Chem.</source><volume>249</volume> (<issue>1</issue>), <fpage>136</fpage>&#8211;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(19)43101-3</pub-id><pub-id pub-id-type="pmid">4588689</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>McSweeney</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>A. W.</given-names></name><name name-style="western"><surname>Naismith</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Qamar</surname><given-names>S.</given-names></name><etal/></person-group> (<year>1996</year>). <article-title>The crystal Structure of a Class II Fructose-1,6-Bisphosphate Aldolase Shows a Novel Binuclear Metal-Binding Active Site Embedded in a Familiar Fold</article-title>. <source>Structure</source><volume>4</volume> (<issue>11</issue>), <fpage>1303</fpage>&#8211;<lpage>1315</lpage>. <pub-id pub-id-type="doi">10.1016/s0969-2126(96)00138-4</pub-id><pub-id pub-id-type="pmid">8939754</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Crowe</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Sievwright</surname><given-names>I. K.</given-names></name><name name-style="western"><surname>Auld</surname><given-names>G. C.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>N. R.</given-names></name><name name-style="western"><surname>Gow</surname><given-names>N. A. R.</given-names></name><name name-style="western"><surname>Booth</surname><given-names>N. A.</given-names></name></person-group> (<year>2003</year>). <article-title><italic toggle="yes">Candida Albicans</italic> Binds Human Plasminogen: Identification of Eight Plasminogen-Binding Proteins</article-title>. <source>Mol. Microbiol.</source><volume>47</volume> (<issue>6</issue>), <fpage>1637</fpage>&#8211;<lpage>1651</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.2003.03390.x</pub-id><pub-id pub-id-type="pmid">12622818</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Curcio</surname><given-names>C.</given-names></name><name name-style="western"><surname>Brugiapaglia</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bulfamante</surname><given-names>S.</given-names></name><name name-style="western"><surname>Follia</surname><given-names>L.</given-names></name><name name-style="western"><surname>Cappello</surname><given-names>P.</given-names></name><name name-style="western"><surname>Novelli</surname><given-names>F.</given-names></name></person-group> (<year>2021</year>). <article-title>The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer</article-title>. <source>Molecules</source><volume>26</volume> (<issue>6</issue>), <fpage>1642</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26061642</pub-id><pub-id pub-id-type="pmid">33804240</pub-id><pub-id pub-id-type="pmcid">PMC7998946</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cutler</surname><given-names>J. E.</given-names></name><name name-style="western"><surname>Corti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lambert</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ferris</surname><given-names>M.</given-names></name><name name-style="western"><surname>Xin</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Horizontal Transmission of <italic toggle="yes">Candida Albican</italic>s and Evidence of a Vaccine Response in Mice Colonized with the Fungus</article-title>. <source>PLOS ONE</source><volume>6</volume> (<issue>7</issue>), <fpage>e22030</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0022030</pub-id><pub-id pub-id-type="pmid">21818288</pub-id><pub-id pub-id-type="pmcid">PMC3139608</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daher</surname><given-names>R.</given-names></name><name name-style="western"><surname>Coin&#231;on</surname><given-names>M.</given-names></name><name name-style="western"><surname>Fonvielle</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gest</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Guerin</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Rational Design, Synthesis, and Evaluation of New Selective Inhibitors of Microbial Class II (Zinc Dependent) Fructose Bis-Phosphate Aldolases</article-title>. <source>J. Med. Chem.</source><volume>53</volume> (<issue>21</issue>), <fpage>7836</fpage>&#8211;<lpage>7842</lpage>. <pub-id pub-id-type="doi">10.1021/jm1009814</pub-id><pub-id pub-id-type="pmid">20929256</pub-id><pub-id pub-id-type="pmcid">PMC2974033</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dax</surname><given-names>C.</given-names></name><name name-style="western"><surname>Duffieux</surname><given-names>F.</given-names></name><name name-style="western"><surname>Chabot</surname><given-names>N.</given-names></name><name name-style="western"><surname>Coincon</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sygusch</surname><given-names>J.</given-names></name><name name-style="western"><surname>Michels</surname><given-names>P. A. M.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>Selective Irreversible Inhibition of Fructose 1,6-Bisphosphate Aldolase fromTrypanosoma Brucei</article-title>. <source>J. Med. Chem.</source><volume>49</volume> (<issue>5</issue>), <fpage>1499</fpage>&#8211;<lpage>1502</lpage>. <pub-id pub-id-type="doi">10.1021/jm050237b</pub-id><pub-id pub-id-type="pmid">16509566</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de la Paz Santangelo</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gest</surname><given-names>P. M.</given-names></name><name name-style="western"><surname>Guerin</surname><given-names>M. E.</given-names></name><name name-style="western"><surname>Coin&#231;on</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pham</surname><given-names>H.</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Glycolytic and Non-glycolytic Functions of <italic toggle="yes">Mycobacterium tuberculosis</italic> Fructose-1,6-Bisphosphate Aldolase, an Essential Enzyme Produced by Replicating and Non-replicating Bacilli</article-title>. <source>J. Biol. Chem.</source><volume>286</volume> (<issue>46</issue>), <fpage>40219</fpage>&#8211;<lpage>40231</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m111.259440</pub-id><pub-id pub-id-type="pmid">21949126</pub-id><pub-id pub-id-type="pmcid">PMC3220552</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de la Torre-Escudero</surname><given-names>E.</given-names></name><name name-style="western"><surname>P&#233;rez-S&#225;nchez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Manzano-Rom&#225;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Oleaga</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Schistosoma Bovis -host Interplay: Proteomics for Knowing and Acting</article-title>. <source>Mol. Biochem. Parasitol.</source><volume>215</volume>, <fpage>30</fpage>&#8211;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbiopara.2016.07.009</pub-id><pub-id pub-id-type="pmid">27485556</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Degen</surname><given-names>J. L.</given-names></name><name name-style="western"><surname>Bugge</surname><given-names>T. H.</given-names></name><name name-style="western"><surname>Goguen</surname><given-names>J. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Fibrin and Fibrinolysis in Infection and Host Defense</article-title>. <source>J. Thromb. Haemost.</source><volume>5</volume> (<issue>s1</issue>), <fpage>24</fpage>&#8211;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1111/j.1538-7836.2007.02519.x</pub-id><pub-id pub-id-type="pmid">17635705</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Didiasova</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schaefer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wygrecka</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>When Place Matters: Shuttling of Enolase-1 across Cellular Compartments</article-title>. <source>Front. Cel Develop. Biol.</source><volume>7</volume>, <fpage>61</fpage>. <pub-id pub-id-type="doi">10.3389/fcell.2019.00061</pub-id><pub-id pub-id-type="pmcid">PMC6498095</pub-id><pub-id pub-id-type="pmid">31106201</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>D&#246;beli</surname><given-names>H.</given-names></name><name name-style="western"><surname>Trzeciak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gillessen</surname><given-names>D.</given-names></name><name name-style="western"><surname>Matile</surname><given-names>H.</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>I. K.</given-names></name><name name-style="western"><surname>Perrin</surname><given-names>L. H.</given-names></name><etal/></person-group> (<year>1990</year>). <article-title>Expression, Purification, Biochemical Characterization and Inhibition of Recombinant <italic toggle="yes">Plasmodium Falciparum</italic> Aldolase</article-title>. <source>Mol. Biochem. Parasitol.</source><volume>41</volume> (<issue>2</issue>), <fpage>259</fpage>&#8211;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/0166-6851(90)90189-s</pub-id><pub-id pub-id-type="pmid">2204832</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Droppelmann</surname><given-names>C. A.</given-names></name><name name-style="western"><surname>S&#225;ez</surname><given-names>D. E.</given-names></name><name name-style="western"><surname>Asenjo</surname><given-names>J. L.</given-names></name><name name-style="western"><surname>Y&#225;&#241;ez</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Garc&#237;a-Rocha</surname><given-names>M.</given-names></name><name name-style="western"><surname>Concha</surname><given-names>I. I.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>A New Level of Regulation in Gluconeogenesis: Metabolic State Modulates the Intracellular Localization of Aldolase B and its Interaction with Liver Fructose-1,6-Bisphosphatase</article-title>. <source>Biochem. J.</source><volume>472</volume> (<issue>2</issue>), <fpage>225</fpage>&#8211;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1042/bj20150269</pub-id><pub-id pub-id-type="pmid">26417114</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Dabaa</surname><given-names>E.</given-names></name><name name-style="western"><surname>Mei</surname><given-names>H.</given-names></name><name name-style="western"><surname>El-Sayed</surname><given-names>A.</given-names></name><name name-style="western"><surname>Karim</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Eldesoky</surname><given-names>H. M.</given-names></name><name name-style="western"><surname>Fahim</surname><given-names>F. A.</given-names></name><etal/></person-group> (<year>1998</year>). <article-title>Cloning and Characterization of <italic toggle="yes">Schistosoma Mansoni</italic> Fructose-1,6-Bisphosphate Aldolase Isoenzyme</article-title>. <source>J. Parasitol.</source><volume>84</volume> (<issue>5</issue>), <fpage>954</fpage>&#8211;<lpage>960</lpage>. <pub-id pub-id-type="doi">10.2307/3284627</pub-id><pub-id pub-id-type="pmid">9794637</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elhag</surname><given-names>M.</given-names></name><name name-style="western"><surname>Alaagib</surname><given-names>R. M.</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>N. M.</given-names></name><name name-style="western"><surname>Abubaker</surname><given-names>M.</given-names></name><name name-style="western"><surname>Haroun</surname><given-names>E. M.</given-names></name><name name-style="western"><surname>Obi</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Design of Epitope-Based Peptide Vaccine against <italic toggle="yes">Pseudomonas aeruginosa</italic> Fructose Bisphosphate Aldolase Protein Using Immunoinformatics</article-title>. <source>J. Immunol. Res.</source><volume>2020</volume>, <fpage>947505</fpage>. <pub-id pub-id-type="doi">10.1155/2020/9475058</pub-id><pub-id pub-id-type="pmcid">PMC7666636</pub-id><pub-id pub-id-type="pmid">33204735</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Etya&#8217;ale</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>Vision 2020: Update on Onchocerciasis</article-title>. <source>Community Eye Health</source><volume>14</volume> (<issue>38</issue>), <fpage>19</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="pmid">17491908</pub-id><pub-id pub-id-type="pmcid">PMC1705929</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falcicchio</surname><given-names>P.</given-names></name><name name-style="western"><surname>Wolterink-Van Loo</surname><given-names>S.</given-names></name><name name-style="western"><surname>Franssen</surname><given-names>M. C. R.</given-names></name><name name-style="western"><surname>van der Oost</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>DHAP-dependent Aldolases from (Hyper)thermophiles: Biochemistry and Applications</article-title>. <source>Extremophiles</source><volume>18</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1007/s00792-013-0593-x</pub-id><pub-id pub-id-type="pmid">24166576</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Figueiredo</surname><given-names>B. C.</given-names></name><name name-style="western"><surname>Da&#8217;dara</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Oliviera</surname><given-names>S. C.</given-names></name><name name-style="western"><surname>Skelly</surname><given-names>P. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Schistosomes Enhance Plasminogen Activation: the Role of Tegumental Enolase</article-title>. <source>PLoS Pathog.</source><volume>11</volume> (<issue>12</issue>), <fpage>e1005335</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005335</pub-id><pub-id pub-id-type="pmid">26658895</pub-id><pub-id pub-id-type="pmcid">PMC4676649</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Figuera</surname><given-names>L.</given-names></name><name name-style="western"><surname>G&#243;mez-Arreaza</surname><given-names>A.</given-names></name><name name-style="western"><surname>Avil&#225;n</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Parasitism in Optima Forma: Exploiting the Host Fibrinolytic System for Invasion</article-title>. <source>Acta Tropica</source><volume>128</volume> (<issue>1</issue>), <fpage>116</fpage>&#8211;<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2013.06.023</pub-id><pub-id pub-id-type="pmid">23850506</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flora</surname><given-names>S. J. S.</given-names></name><name name-style="western"><surname>Pachauri</surname><given-names>V.</given-names></name></person-group> (<year>2010</year>). <article-title>Chelation in Metal Intoxication</article-title>. <source>Int. J. Environ. Res. Public Health</source><volume>7</volume> (<issue>7</issue>), <fpage>2745</fpage>&#8211;<lpage>2788</lpage>. <pub-id pub-id-type="doi">10.3390/ijerph7072745</pub-id><pub-id pub-id-type="pmid">20717537</pub-id><pub-id pub-id-type="pmcid">PMC2922724</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Flores-Ramirez</surname><given-names>G.</given-names></name><name name-style="western"><surname>Jankovicova</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bilkova</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Miernyk</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Skultety</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Identification of <italic toggle="yes">Coxiella Burnetii</italic> Surface-Exposed and Cell Envelope Associated Proteins Using a Combined Bioinformatics Plus Proteomics Strategy</article-title>. <source>Proteomics</source><volume>14</volume> (<issue>16</issue>), <fpage>1868</fpage>&#8211;<lpage>1881</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201300338</pub-id><pub-id pub-id-type="pmid">24909302</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fluegge</surname><given-names>K.</given-names></name><name name-style="western"><surname>Schweier</surname><given-names>O.</given-names></name><name name-style="western"><surname>Schiltz</surname><given-names>E.</given-names></name><name name-style="western"><surname>Batsford</surname><given-names>S.</given-names></name><name name-style="western"><surname>Berner</surname><given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Identification and Immunoreactivity of Proteins Released from <italic toggle="yes">Streptococcus Agalactiae</italic>
</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source><volume>23</volume> (<issue>11</issue>), <fpage>818</fpage>&#8211;<lpage>824</lpage>. <pub-id pub-id-type="doi">10.1007/s10096-004-1229-y</pub-id><pub-id pub-id-type="pmid">15490293</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fulton</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Petit</surname><given-names>M. D.</given-names></name><name name-style="western"><surname>Kilmury</surname><given-names>S. L. N.</given-names></name><name name-style="western"><surname>Wolfraim</surname><given-names>L. A.</given-names></name><name name-style="western"><surname>House</surname><given-names>R. V.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Immunoproteomic Analysis of the Human Antibody Response to Natural Tularemia Infection with Type A or Type B Strains or LVS Vaccination</article-title>. <source>Int. J. Med. Microbiol.</source><volume>301</volume> (<issue>7</issue>), <fpage>591</fpage>&#8211;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2011.07.002</pub-id><pub-id pub-id-type="pmid">21873113</pub-id><pub-id pub-id-type="pmcid">PMC3184521</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galkin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kulakova</surname><given-names>L.</given-names></name><name name-style="western"><surname>Melamud</surname><given-names>E.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>C.</given-names></name><name name-style="western"><surname>Mariano</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Characterization, Kinetics, and crystal Structures of Fructose-1,6-Bisphosphate Aldolase from the Human Parasite, <italic toggle="yes">Giardia Lamblia</italic>
</article-title>. <source>J. Biol. Chem.</source><volume>282</volume> (<issue>7</issue>), <fpage>4859</fpage>&#8211;<lpage>4867</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m609534200</pub-id><pub-id pub-id-type="pmid">17166851</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galkin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><name name-style="western"><surname>Kulakova</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pal</surname><given-names>L. R.</given-names></name><name name-style="western"><surname>Dunaway-Mariano</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Structural Insights into the Substrate Binding and Stereoselectivity of Giardia Fructose-1,6-Bisphosphate Aldolase,</article-title>. <source>Biochemistry</source><volume>48</volume> (<issue>14</issue>), <fpage>3186</fpage>&#8211;<lpage>3196</lpage>. <pub-id pub-id-type="doi">10.1021/bi9001166</pub-id><pub-id pub-id-type="pmid">19236002</pub-id><pub-id pub-id-type="pmcid">PMC2666783</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galperin</surname><given-names>M. Y.</given-names></name><name name-style="western"><surname>Walker</surname><given-names>D. R.</given-names></name><name name-style="western"><surname>Koonin</surname><given-names>E. V.</given-names></name></person-group> (<year>1998</year>). <article-title>Analogous Enzymes: Independent Inventions in Enzyme Evolution</article-title>. <source>Genome Res.</source><volume>8</volume> (<issue>8</issue>), <fpage>779</fpage>&#8211;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1101/gr.8.8.779</pub-id><pub-id pub-id-type="pmid">9724324</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gamblin</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>B.</given-names></name><name name-style="western"><surname>Millar</surname><given-names>J. R.</given-names></name><name name-style="western"><surname>Davies</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Littlechild</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Watson</surname><given-names>H. C.</given-names></name></person-group> (<year>1990</year>). <article-title>The crystal Structure of Human Muscle Aldolase at 3.0 &#197; Resolution</article-title>. <source>FEBS Lett.</source><volume>262</volume> (<issue>2</issue>), <fpage>282</fpage>&#8211;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(90)80211-z</pub-id><pub-id pub-id-type="pmid">2335208</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>X.</given-names></name><name name-style="western"><surname>Bao</surname><given-names>S.</given-names></name><name name-style="western"><surname>Xing</surname><given-names>X.</given-names></name><name name-style="western"><surname>Fu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Xue</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Fructose-1,6-bisphosphate Aldolase of <italic toggle="yes">Mycoplasma Bovis</italic> Is a Plasminogen-Binding Adhesin</article-title>. <source>Microb. Pathog.</source><volume>124</volume>, <fpage>230</fpage>&#8211;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2018.08.032</pub-id><pub-id pub-id-type="pmid">30142464</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gizak</surname><given-names>A.</given-names></name><name name-style="western"><surname>Wi&#347;niewski</surname><given-names>J.</given-names></name><name name-style="western"><surname>Heron</surname><given-names>P.</given-names></name><name name-style="western"><surname>Mamczur</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sygusch</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rakus</surname><given-names>D.</given-names></name></person-group> (<year>2019</year>). <article-title>Targeting a Moonlighting Function of Aldolase Induces Apoptosis in Cancer Cells</article-title>. <source>Cell Death Dis</source><volume>10</volume>, <fpage>712</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-019-1968-4</pub-id><pub-id pub-id-type="pmid">31558701</pub-id><pub-id pub-id-type="pmcid">PMC6763475</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goldman</surname><given-names>S. E.</given-names></name><name name-style="western"><surname>Dotan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Talias</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lilo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Azriel</surname><given-names>S.</given-names></name><name name-style="western"><surname>Malka</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Streptococcus Pneumoniae Fructose-1, 6-bisphosphate Aldolase, a Protein Vaccine Candidate, Elicits Th1/Th2/Th17-type Cytokine Responses in Mice</article-title>. <source>Int. J. Mol. Med.</source><volume>37</volume> (<issue>4</issue>), <fpage>1127</fpage>&#8211;<lpage>1138</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.2016.2512</pub-id><pub-id pub-id-type="pmid">26935978</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>G&#243;mez-Arreaza</surname><given-names>A.</given-names></name><name name-style="western"><surname>Acosta</surname><given-names>H.</given-names></name><name name-style="western"><surname>Qui&#241;ones</surname><given-names>W.</given-names></name><name name-style="western"><surname>Concepci&#243;n</surname><given-names>J. L.</given-names></name><name name-style="western"><surname>Michels</surname><given-names>P. A. M.</given-names></name><name name-style="western"><surname>Avil&#225;n</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Extracellular Functions of Glycolytic Enzymes of Parasites: Unpredicted Use of Ancient Proteins</article-title>. <source>Mol. Biochem. Parasitol.</source><volume>193</volume> (<issue>2</issue>), <fpage>75</fpage>&#8211;<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbiopara.2014.02.005</pub-id><pub-id pub-id-type="pmid">24602601</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez-Miguel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Morch&#243;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Siles-Lucas</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sim&#243;n</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Fibrinolysis and Proliferative Endarteritis: Two Related Processes in Chronic Infections? The Model of the Blood-Borne Pathogen <italic toggle="yes">Dirofilaria Immitis</italic>
</article-title>. <source>PLoS One</source><volume>10</volume>, <fpage>e0124445</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0124445</pub-id><pub-id pub-id-type="pmid">25875022</pub-id><pub-id pub-id-type="pmcid">PMC4395379</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gonz&#225;lez-Miguel</surname><given-names>J.</given-names></name><name name-style="western"><surname>Morch&#243;n</surname><given-names>R.</given-names></name><name name-style="western"><surname>Carret&#243;n</surname><given-names>E.</given-names></name><name name-style="western"><surname>Montoya-Alonso</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Sim&#243;n</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Surface Associated Antigens of <italic toggle="yes">Dirofilaria Immitis</italic> Adult Worms Activate the Host Fibrinolytic System</article-title>. <source>Vet. Parasitol.</source><volume>196</volume> (<issue>1</issue>), <fpage>235</fpage>&#8211;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetpar.2013.01.028</pub-id><pub-id pub-id-type="pmid">23433649</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goo</surname><given-names>Y.-K.</given-names></name><name name-style="western"><surname>Ueno</surname><given-names>A.</given-names></name><name name-style="western"><surname>Terkawi</surname><given-names>M. A.</given-names></name><name name-style="western"><surname>Oluga Aboge</surname><given-names>G.</given-names></name><name name-style="western"><surname>Junya</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Igarashi</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Actin Polymerization Mediated by <italic toggle="yes">Babesia Gibsoni</italic> Aldolase Is Required for Parasite Invasion</article-title>. <source>Exp. Parasitol.</source><volume>135</volume> (<issue>1</issue>), <fpage>42</fpage>&#8211;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2013.06.002</pub-id><pub-id pub-id-type="pmid">23792005</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gottstein</surname><given-names>B.</given-names></name><name name-style="western"><surname>Pozio</surname><given-names>E.</given-names></name><name name-style="western"><surname>N&#246;ckler</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Epidemiology, Diagnosis, Treatment, and Control of Trichinellosis</article-title>. <source>Clin. Microbiol. Rev.</source><volume>22</volume> (<issue>1</issue>), <fpage>127</fpage>&#8211;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1128/cmr.00026-08</pub-id><pub-id pub-id-type="pmid">19136437</pub-id><pub-id pub-id-type="pmcid">PMC2620635</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grandjean</surname><given-names>G.</given-names></name><name name-style="western"><surname>de Jong</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>James</surname><given-names>B. P.</given-names></name><name name-style="western"><surname>Koh</surname><given-names>M. Y.</given-names></name><name name-style="western"><surname>Lemos</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kingston</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Definition of a Novel Feed-Forward Mechanism for Glycolysis-HIF1&#945; Signaling in Hypoxic Tumors Highlights Aldolase A as a Therapeutic Target</article-title>. <source>Cancer Res.</source><volume>76</volume> (<issue>14</issue>), <fpage>4259</fpage>&#8211;<lpage>4269</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.can-16-0401</pub-id><pub-id pub-id-type="pmid">27261507</pub-id><pub-id pub-id-type="pmcid">PMC5082982</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kushawaha</surname><given-names>P. K.</given-names></name><name name-style="western"><surname>Tripathi</surname><given-names>C. P.</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sahasrabuddhe</surname><given-names>A. A.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Characterization of Glycolytic Enzymes - rAldolase and rEnolase of <italic toggle="yes">Leishmania Donovani</italic>, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis</article-title>. <source>PLOS ONE</source><volume>9</volume> (<issue>1</issue>), <fpage>e86073</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0086073</pub-id><pub-id pub-id-type="pmid">24475071</pub-id><pub-id pub-id-type="pmcid">PMC3901665</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>D. R.</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Reed</surname><given-names>C. D.</given-names></name><name name-style="western"><surname>Watt</surname><given-names>C. I.</given-names></name><name name-style="western"><surname>Berry</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hunter</surname><given-names>W. N.</given-names></name></person-group> (<year>1999</year>). <article-title>The crystal Structure of Escherichia coli Class II Fructose-1,6-Bisphosphate Aldolase in Complex with Phosphoglycolohydroxamate Reveals Details of Mechanism and Specificity 1 1Edited by R. Huber</article-title>. <source>J. Mol. Biol.</source><volume>287</volume> (<issue>2</issue>), <fpage>383</fpage>&#8211;<lpage>394</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1999.2609</pub-id><pub-id pub-id-type="pmid">10080900</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harrop</surname><given-names>R.</given-names></name><name name-style="western"><surname>Coulson</surname><given-names>P. S.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>R. A.</given-names></name></person-group> (<year>1999</year>). <article-title>Characterization, Cloning and Immunogenicity of Antigens Released by Lung-Stage Larvae of <italic toggle="yes">Schistosoma Mansoni</italic>
</article-title>. <source>Parasitology</source><volume>118</volume> (<issue>6</issue>), <fpage>583</fpage>&#8211;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.1017/s003118209900431x</pub-id><pub-id pub-id-type="pmid">10406037</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heron</surname><given-names>P. W.</given-names></name><name name-style="western"><surname>Abell&#225;n-Flos</surname><given-names>M.</given-names></name><name name-style="western"><surname>Salmon</surname><given-names>L.</given-names></name><name name-style="western"><surname>Sygusch</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Bisphosphonate Inhibitors of Mammalian Glycolytic Aldolase</article-title>. <source>J. Med. Chem.</source><volume>61</volume> (<issue>23</issue>), <fpage>10558</fpage>&#8211;<lpage>10572</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.8b01000</pub-id><pub-id pub-id-type="pmid">30418024</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirsch</surname><given-names>C.</given-names></name><name name-style="western"><surname>Goes</surname><given-names>A. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Characterization of fractionatedSchistosoma Mansonisoluble Adult Worm Antigens that Elicit Human Cell Proliferation and Granuloma Formationin Vitro</article-title>. <source>Parasitology</source><volume>112</volume> (<issue>6</issue>), <fpage>529</fpage>&#8211;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1017/s0031182000066105</pub-id><pub-id pub-id-type="pmid">8684827</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhi</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Fructose-1,6-bisphosphate Aldolase Is Involved in <italic toggle="yes">Mycoplasma Bovis</italic> Colonization as a Fibronectin-Binding Adhesin</article-title>. <source>Res. Vet. Sci.</source><volume>124</volume>, <fpage>70</fpage>&#8211;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.rvsc.2019.02.010</pub-id><pub-id pub-id-type="pmid">30852357</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeffery</surname><given-names>C. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Moonlighting Proteins</article-title>. <source>Trends Biochem. Sci.</source><volume>24</volume> (<issue>1</issue>), <fpage>8</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1016/s0968-0004(98)01335-8</pub-id><pub-id pub-id-type="pmid">10087914</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jeffery</surname><given-names>C. J.</given-names></name></person-group> (<year>2018</year>). <article-title>Protein Moonlighting: what Is it, and Why Is it Important?</article-title><source>Phil. Trans. R. Soc. B</source><volume>373</volume> (<issue>1738</issue>), <fpage>20160523</fpage>. <pub-id pub-id-type="doi">10.1098/rstb.2016.0523</pub-id><pub-id pub-id-type="pmid">29203708</pub-id><pub-id pub-id-type="pmcid">PMC5717523</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karkowska-Kuleta</surname><given-names>J.</given-names></name><name name-style="western"><surname>Satala</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bochenska</surname><given-names>O.</given-names></name><name name-style="western"><surname>Rapala-Kozik</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kozik</surname><given-names>A.</given-names></name></person-group> (<year>2019</year>). <article-title>Moonlighting Proteins Are Variably Exposed at the Cell Surfaces of Candida Glabrata, Candida Parapsilosis and Candida tropicalis under Certain Growth Conditions</article-title>. <source>BMC Microbiol.</source><volume>19</volume>, <fpage>149</fpage>. <pub-id pub-id-type="doi">10.1186/s12866-019-1524-5</pub-id><pub-id pub-id-type="pmid">31269895</pub-id><pub-id pub-id-type="pmcid">PMC6609379</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaye</surname><given-names>P.</given-names></name><name name-style="western"><surname>Scott</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Leishmaniasis: Complexity at the Host-Pathogen Interface</article-title>. <source>Nat. Rev. Microbiol.</source><volume>9</volume> (<issue>8</issue>), <fpage>604</fpage>&#8211;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2608</pub-id><pub-id pub-id-type="pmid">21747391</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kim</surname><given-names>J. H.</given-names></name><name name-style="western"><surname>Lee</surname><given-names>T. G.</given-names></name><name name-style="western"><surname>Hirata</surname><given-names>M.</given-names></name><name name-style="western"><surname>Suh</surname><given-names>P. G.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title>Phospholipase D2 Directly Interacts with Aldolase <italic toggle="yes">via</italic> its PH Domain</article-title>. <source>Biochemistry</source><volume>41</volume> (<issue>10</issue>), <fpage>3414</fpage>&#8211;<lpage>3421</lpage>. <pub-id pub-id-type="doi">10.1021/bi015700a</pub-id><pub-id pub-id-type="pmid">11876650</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knapp</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hundt</surname><given-names>E.</given-names></name><name name-style="western"><surname>K&#252;pper</surname><given-names>H. A.</given-names></name></person-group> (<year>1990</year>). <article-title><italic toggle="yes">Plasmodium Falciparum</italic> Aldolase: Gene Structure and Localization</article-title>. <source>Mol. Biochem. Parasitol.</source><volume>40</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1016/0166-6851(90)90074-v</pub-id><pub-id pub-id-type="pmid">2190085</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kovach</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kaakoush</surname><given-names>N. O.</given-names></name><name name-style="western"><surname>Lamb</surname><given-names>S.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Raftery</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Immunoreactive Proteins ofCampylobacter Concisus, an Emergent Intestinal Pathogen</article-title>. <source>FEMS Immunol. Med. Microbiol.</source><volume>63</volume> (<issue>3</issue>), <fpage>387</fpage>&#8211;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-695x.2011.00864.x</pub-id><pub-id pub-id-type="pmid">22092566</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulkarni</surname><given-names>R. R.</given-names></name><name name-style="western"><surname>Parreira</surname><given-names>V. R.</given-names></name><name name-style="western"><surname>Sharif</surname><given-names>S.</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>J. F.</given-names></name></person-group> (<year>2007</year>). <article-title>Immunization of Broiler Chickens against Clostridium perfringens -Induced Necrotic Enteritis</article-title>. <source>Clin. Vaccin. Immunol</source><volume>14</volume> (<issue>9</issue>), <fpage>1070</fpage>&#8211;<lpage>1077</lpage>. <pub-id pub-id-type="doi">10.1128/cvi.00162-07</pub-id><pub-id pub-id-type="pmcid">PMC2043299</pub-id><pub-id pub-id-type="pmid">17634510</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulkarni</surname><given-names>R. R.</given-names></name><name name-style="western"><surname>Parreira</surname><given-names>V. R.</given-names></name><name name-style="western"><surname>Sharif</surname><given-names>S.</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>J. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Oral Immunization of Broiler Chickens against Necrotic Enteritis with an Attenuated <italic toggle="yes">Salmonella</italic> Vaccine Vector Expressing <italic toggle="yes">Clostridium perfringens</italic> Antigens</article-title>. <source>Vaccine</source><volume>26</volume> (<issue>33</issue>), <fpage>4194</fpage>&#8211;<lpage>4203</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2008.05.079</pub-id><pub-id pub-id-type="pmid">18597901</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labb&#233;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Krismanich</surname><given-names>A. P.</given-names></name><name name-style="western"><surname>de Groot</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rasmusson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>M. D. R.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Development of Metal-Chelating Inhibitors for the Class II Fructose 1,6-bisphosphate (FBP) Aldolase</article-title>. <source>J. Inorg. Biochem.</source><volume>112</volume>, <fpage>49</fpage>&#8211;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinorgbio.2012.02.032</pub-id><pub-id pub-id-type="pmid">22546686</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>L&#228;hteenm&#228;ki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Edelman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Korhonen</surname><given-names>T. K.</given-names></name></person-group> (<year>2005</year>). <article-title>Bacterial Metastasis: the Host Plasminogen System in Bacterial Invasion</article-title>. <source>Trends Microbiol.</source><volume>13</volume> (<issue>2</issue>), <fpage>79</fpage>&#8211;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2004.12.003</pub-id><pub-id pub-id-type="pmid">15680767</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lebherz</surname><given-names>H. G.</given-names></name><name name-style="western"><surname>Rutter</surname><given-names>W. J.</given-names></name></person-group> (<year>1969</year>). <article-title>Distribution of Fructose Diphosphate Aldolase Variants in Biological Systems</article-title>. <source>Biochemistry</source><volume>8</volume> (<issue>1</issue>), <fpage>109</fpage>&#8211;<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1021/bi00829a016</pub-id><pub-id pub-id-type="pmid">5777313</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>C-H.</given-names></name><name name-style="western"><surname>Chuah</surname><given-names>S-K.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>C-C.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F-J.</given-names></name></person-group> (<year>2020</year>). <article-title>The Surface Protein Fructose-1, 6 Bisphosphate Aldolase of Klebsiella pneumoniae Serotype K1: Role of Interaction with Neutrophils</article-title>. <source>Pathogens</source><volume>9</volume> (<issue>12</issue>), <fpage>1009</fpage>. <pub-id pub-id-type="doi">10.3390/pathogens9121009</pub-id><pub-id pub-id-type="pmcid">PMC7759916</pub-id><pub-id pub-id-type="pmid">33266305</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lei</surname><given-names>B.</given-names></name><name name-style="western"><surname>Mackie</surname><given-names>S.</given-names></name><name name-style="western"><surname>Lukomski</surname><given-names>S.</given-names></name><name name-style="western"><surname>Musser</surname><given-names>J. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Identification and Immunogenicity of Group A <italic toggle="yes">Streptococcus</italic> Culture Supernatant Proteins</article-title>. <source>Infect. Immun.</source><volume>68</volume> (<issue>12</issue>), <fpage>6807</fpage>&#8211;<lpage>6818</lpage>. <pub-id pub-id-type="doi">10.1128/iai.68.12.6807-6818.2000</pub-id><pub-id pub-id-type="pmid">11083799</pub-id><pub-id pub-id-type="pmcid">PMC97784</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lew</surname><given-names>C. R.</given-names></name><name name-style="western"><surname>Tolan</surname><given-names>D. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Aldolase Sequesters WASP and Affects WASP/Arp2/3-stimulated Actin Dynamics</article-title>. <source>J. Cel. Biochem.</source><volume>114</volume> (<issue>8</issue>), <fpage>1928</fpage>&#8211;<lpage>1939</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.24538</pub-id><pub-id pub-id-type="pmid">23495010</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>C.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Diagnostic Value of Immunoglobulin G Antibodies against <italic toggle="yes">Candida</italic> Enolase and Fructose-Bisphosphate Aldolase for Candidemia</article-title>. <source>BMC Infect. Dis.</source><volume>13</volume>, <fpage>253</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2334-13-253</pub-id><pub-id pub-id-type="pmid">23725337</pub-id><pub-id pub-id-type="pmcid">PMC3673856</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>F.</given-names></name><name name-style="western"><surname>Gao</surname><given-names>H.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>F.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>J.</given-names></name></person-group> (<year>2019a</year>). <article-title>ALDOLASE A Regulates Invasion of Bladder Cancer Cells <italic toggle="yes">via</italic> E&#8208;cadherin&#8208;EGFR Signaling</article-title>. <source>J. Cel Biochem</source><volume>120</volume> (<issue>8</issue>), <fpage>13694</fpage>&#8211;<lpage>13705</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.28642</pub-id><pub-id pub-id-type="pmid">31081974</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C.-S.</given-names></name><name name-style="western"><surname>Zong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Feng</surname><given-names>J.-W.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019b</year>). <article-title>Transient Receptor Potential V Channels Are Essential for Glucose Sensing by Aldolase and AMPK</article-title>. <source>Cel Metab.</source><volume>30</volume> (<issue>3</issue>), <fpage>508</fpage>&#8211;<lpage>524</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2019.05.018</pub-id><pub-id pub-id-type="pmcid">PMC6720459</pub-id><pub-id pub-id-type="pmid">31204282</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Molecular and Biochemical Characterizations of Three Fructose-1,6-Bisphosphate Aldolases from <italic toggle="yes">Clonorchis Sinensis</italic>
</article-title>. <source>Mol. Biochem. Parasitol.</source><volume>194</volume> (<issue>1</issue>), <fpage>36</fpage>&#8211;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbiopara.2014.04.005</pub-id><pub-id pub-id-type="pmid">24768689</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ling</surname><given-names>E.</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>G.</given-names></name><name name-style="western"><surname>Portnoi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dagan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Overweg</surname><given-names>K.</given-names></name><name name-style="western"><surname>Mulholland</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2004</year>). <article-title>Glycolytic Enzymes Associated with the Cell Surface of <italic toggle="yes">Streptococcus Pneumoniae</italic> Are Antigenic in Humans and Elicit Protective Immune Responses in the Mouse</article-title>. <source>Clin. Exp. Immunol.</source><volume>138</volume> (<issue>2</issue>), <fpage>290</fpage>&#8211;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2004.02628.x</pub-id><pub-id pub-id-type="pmid">15498039</pub-id><pub-id pub-id-type="pmcid">PMC1809218</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lorentzen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pohl</surname><given-names>E.</given-names></name><name name-style="western"><surname>Zwart</surname><given-names>P.</given-names></name><name name-style="western"><surname>Stark</surname><given-names>A.</given-names></name><name name-style="western"><surname>Russell</surname><given-names>R. B.</given-names></name><name name-style="western"><surname>Knura</surname><given-names>T.</given-names></name><etal/></person-group> (<year>2003</year>). <article-title>Crystal Structure of an Archaeal Class I Aldolase and the Evolution of (&#946;&#945;)8 Barrel Proteins</article-title>. <source>J. Biol. Chem.</source><volume>278</volume> (<issue>47</issue>), <fpage>47253</fpage>&#8211;<lpage>47260</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m305922200</pub-id><pub-id pub-id-type="pmid">12941964</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lorentzen</surname><given-names>E.</given-names></name><name name-style="western"><surname>Siebers</surname><given-names>B.</given-names></name><name name-style="western"><surname>Hensel</surname><given-names>R.</given-names></name><name name-style="western"><surname>Pohl</surname><given-names>E.</given-names></name></person-group> (<year>2004</year>). <article-title>Structure, Function and Evolution of the Archaeal Class I Fructose-1,6-Bisphosphate Aldolase</article-title>. <source>Biochem. Soc. Trans.</source><volume>32</volume> (<issue>2</issue>), <fpage>259</fpage>&#8211;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1042/bst0320259</pub-id><pub-id pub-id-type="pmid">15046584</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lorenzatto</surname><given-names>K. R.</given-names></name><name name-style="western"><surname>Monteiro</surname><given-names>K. M.</given-names></name><name name-style="western"><surname>Paredes</surname><given-names>R.</given-names></name><name name-style="western"><surname>Paludo</surname><given-names>G. P.</given-names></name><name name-style="western"><surname>da Fons&#234;ca</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Galanti</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Fructose-bisphosphate Aldolase and Enolase from <italic toggle="yes">Echinococcus Granulosus</italic>: Genes, Expression Patterns and Protein Interactions of Two Potential Moonlighting Proteins</article-title>. <source>Gene</source><volume>506</volume> (<issue>1</issue>), <fpage>76</fpage>&#8211;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2012.06.046</pub-id><pub-id pub-id-type="pmid">22750316</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.-Y.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>L.-J.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Upregulation of the ALDOA/DNA-PK/p53 Pathway by Dietary Restriction Suppresses Tumor Growth</article-title>. <source>Oncogene</source><volume>37</volume> (<issue>8</issue>), <fpage>1041</fpage>&#8211;<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1038/onc.2017.398</pub-id><pub-id pub-id-type="pmid">29084207</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maines</surname><given-names>T. R.</given-names></name><name name-style="western"><surname>Young</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dinh</surname><given-names>N. N.-N.</given-names></name><name name-style="western"><surname>Brinton</surname><given-names>M. A.</given-names></name></person-group> (<year>2005</year>). <article-title>Two Cellular Proteins that Interact with a Stem Loop in the Simian Hemorrhagic Fever Virus 3&#8242;(+)NCR RNA</article-title>. <source>Virus. Res.</source><volume>109</volume> (<issue>2</issue>), <fpage>109</fpage>&#8211;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1016/j.virusres.2004.11.014</pub-id><pub-id pub-id-type="pmid">15763141</pub-id><pub-id pub-id-type="pmcid">PMC7126611</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marques</surname><given-names>H. H.</given-names></name><name name-style="western"><surname>Zouain</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>Torres</surname><given-names>C. B. B.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Alves</surname><given-names>J. B.</given-names></name><name name-style="western"><surname>Goes</surname><given-names>A. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Protective Effect and Granuloma Down-Modulation Promoted by RP44 Antigen a Fructose 1,6 Bisphosphate Aldolase of <italic toggle="yes">Schistosoma Mansoni</italic>
</article-title>. <source>Immunobiology</source><volume>213</volume> (<issue>5</issue>), <fpage>437</fpage>&#8211;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1016/j.imbio.2007.10.002</pub-id><pub-id pub-id-type="pmid">18472052</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marsh</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Lebherz</surname><given-names>H. G.</given-names></name></person-group> (<year>1992</year>). <article-title>Fructose-bisphosphate Aldolases: an Evolutionary History</article-title>. <source>Trends Biochem. Sci.</source><volume>17</volume> (<issue>3</issue>), <fpage>110</fpage>&#8211;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/0968-0004(92)90247-7</pub-id><pub-id pub-id-type="pmid">1412694</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McCarthy</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Wieseman</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tropea</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kaslow</surname><given-names>D.</given-names></name><name name-style="western"><surname>Abraham</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lustigman</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2002</year>). <article-title><italic toggle="yes">Onchocerca Volvulus</italic> Glycolytic Enzyme Fructose-1,6-Bisphosphate Aldolase as a Target for a Protective Immune Response in Humans</article-title>. <source>Infect. Immun.</source><volume>70</volume> (<issue>2</issue>), <fpage>851</fpage>&#8211;<lpage>858</lpage>. <pub-id pub-id-type="doi">10.1128/iai.70.2.851-858.2002</pub-id><pub-id pub-id-type="pmid">11796620</pub-id><pub-id pub-id-type="pmcid">PMC127653</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McManus</surname><given-names>D. P.</given-names></name><name name-style="western"><surname>Dunne</surname><given-names>D. W.</given-names></name><name name-style="western"><surname>Sacko</surname><given-names>M.</given-names></name><name name-style="western"><surname>Utzinger</surname><given-names>J.</given-names></name><name name-style="western"><surname>Vennervald</surname><given-names>B. J.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X-N.</given-names></name></person-group> (<year>2018</year>). <article-title>Schistosomiasis</article-title>. <source>Nat. Rev. Dis. Primers</source><volume>4</volume> (<issue>1</issue>), <fpage>13</fpage>. <pub-id pub-id-type="doi">10.1038/s41572-018-0013-8</pub-id><pub-id pub-id-type="pmid">30093684</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medrano-D&#237;az</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Vega-Gonz&#225;lez</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ruiz-Baca</surname><given-names>E.</given-names></name><name name-style="western"><surname>Moreno</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cu&#233;llar-Cruz</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Moonlighting Proteins Induce protection in a Mouse Model against <italic toggle="yes">Candida</italic> Species</article-title>. <source>Microb. Pathog.</source><volume>124</volume>, <fpage>21</fpage>&#8211;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2018.08.024</pub-id><pub-id pub-id-type="pmid">30118801</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Melkonian</surname><given-names>E. A.</given-names></name><name name-style="western"><surname>Asuka</surname><given-names>E.</given-names></name><name name-style="western"><surname>Schury</surname><given-names>M. P.</given-names></name></person-group> (<year>2020</year>). &#8220;<article-title>Physiology, Gluconeogenesis</article-title>,&#8221; in <source>StatPearls</source> (<publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>). <pub-id pub-id-type="pmid">31082163</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendon&#231;a</surname><given-names>M.</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>G. M. S. G.</given-names></name><name name-style="western"><surname>Concei&#231;&#227;o</surname><given-names>F. R.</given-names></name><name name-style="western"><surname>Hust</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mendon&#231;a</surname><given-names>K. S.</given-names></name><name name-style="western"><surname>Moreira</surname><given-names>&#194;. N.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Fructose 1,6-bisphosphate Aldolase, a Novel Immunogenic Surface Protein on Listeria Species</article-title>. <source>PLoS One</source><volume>11</volume> (<issue>8</issue>), <fpage>e0160544</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0160544</pub-id><pub-id pub-id-type="pmid">27489951</pub-id><pub-id pub-id-type="pmcid">PMC4973958</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merkulova</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hurtado-Lorenzo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hosokawa</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Brown</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ausiello</surname><given-names>D. A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Aldolase Directly Interacts with ARNO and Modulates Cell Morphology and Acidic Vesicle Distribution</article-title>. <source>Am. J. Physiol. Cel Physiol.</source><volume>300</volume> (<issue>6</issue>), <fpage>C1442</fpage>&#8211;<lpage>C1455</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00076.2010</pub-id><pub-id pub-id-type="pmcid">PMC3118619</pub-id><pub-id pub-id-type="pmid">21307348</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Michels</surname><given-names>P. A.</given-names></name><name name-style="western"><surname>Fothergill-Gilmore</surname><given-names>L. A.</given-names></name></person-group> (<year>2017</year>). &#8220;<source>Glycolytic Enzymes</source>,&#8221; in <source>eLS</source>. <publisher-loc>Chichester</publisher-loc>: <publisher-name>American Cancer Society</publisher-name>, <fpage>1</fpage>&#8211;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1002/9780470015902.a0000621.pub3</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mix&#227;o</surname><given-names>V.</given-names></name><name name-style="western"><surname>Gabald&#243;n</surname><given-names>T.</given-names></name></person-group> (<year>2020</year>). <article-title>Genomic Evidence for a Hybrid Origin of the Yeast Opportunistic Pathogen <italic toggle="yes">Candida Albicans</italic>
</article-title>. <source>BMC Biol.</source><volume>18</volume>, <fpage>48</fpage>. <pub-id pub-id-type="doi">10.1186/s12915-020-00776-6</pub-id><pub-id pub-id-type="pmid">32375762</pub-id><pub-id pub-id-type="pmcid">PMC7204223</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyake</surname><given-names>K.</given-names></name><name name-style="western"><surname>Nishioka</surname><given-names>M.</given-names></name><name name-style="western"><surname>Imura</surname><given-names>S.</given-names></name><name name-style="western"><surname>Batmunkh</surname><given-names>E.</given-names></name><name name-style="western"><surname>Uto</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Nagasawa</surname><given-names>H.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>The Novel Hypoxic Cytotoxin, TX-2098 Has Antitumor Effect in Pancreatic Cancer; Possible Mechanism through Inhibiting VEGF and Hypoxia Inducible Factor-1&#945; Targeted Gene Expression</article-title>. <source>Exp. Cel Res.</source><volume>318</volume> (<issue>13</issue>), <fpage>1554</fpage>&#8211;<lpage>1563</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexcr.2012.03.013</pub-id><pub-id pub-id-type="pmid">22472348</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohammed</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>ALnaby</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Sabeel</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>AbdElmarouf</surname><given-names>F. M.</given-names></name><name name-style="western"><surname>Dirar</surname><given-names>A. I.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>M. M.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Epitope-based Peptide Vaccine against Fructose-Bisphosphate Aldolase of Madurella Mycetomatis Using Immunoinformatics Approaches</article-title>. <source>Bioinform. Biol. Insights</source><volume>12</volume>, <fpage>1177932218809703</fpage>. <pub-id pub-id-type="doi">10.1177/1177932218809703</pub-id><pub-id pub-id-type="pmid">30542244</pub-id><pub-id pub-id-type="pmcid">PMC6236636</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mor</surname><given-names>F.</given-names></name><name name-style="western"><surname>Izak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>I. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Identification of Aldolase as a Target Antigen in Alzheimer's Disease</article-title>. <source>J. Immunol.</source><volume>175</volume> (<issue>5</issue>), <fpage>3439</fpage>&#8211;<lpage>3445</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.175.5.3439</pub-id><pub-id pub-id-type="pmid">16116239</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morales</surname><given-names>A.</given-names></name><name name-style="western"><surname>Espino</surname><given-names>A. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Evaluation and Characterization of <italic toggle="yes">Fasciola Hepatica</italic> Tegument Protein Extract for Serodiagnosis of Human Fascioliasis</article-title>. <source>Clin. Vaccin. Immunol.</source><volume>19</volume> (<issue>11</issue>), <fpage>1870</fpage>&#8211;<lpage>1878</lpage>. <pub-id pub-id-type="doi">10.1128/cvi.00487-12</pub-id><pub-id pub-id-type="pmcid">PMC3491547</pub-id><pub-id pub-id-type="pmid">23015645</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moser</surname><given-names>T. L.</given-names></name><name name-style="western"><surname>Enghild</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Pizzo</surname><given-names>S. V.</given-names></name><name name-style="western"><surname>Stack</surname><given-names>M. S.</given-names></name></person-group> (<year>1993</year>). <article-title>The Extracellular Matrix Proteins Laminin and Fibronectin Contain Binding Domains for Human Plasminogen and Tissue Plasminogen Activator</article-title>. <source>J. Biol. Chem.</source><volume>268</volume> (<issue>25</issue>), <fpage>18917</fpage>&#8211;<lpage>18923</lpage>. <pub-id pub-id-type="doi">10.1016/s0021-9258(17)46714-7</pub-id><pub-id pub-id-type="pmid">8360181</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mukai</surname><given-names>K.</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>M.</given-names></name><name name-style="western"><surname>Starkl</surname><given-names>P.</given-names></name><name name-style="western"><surname>Marichal</surname><given-names>T.</given-names></name><name name-style="western"><surname>Galli</surname><given-names>S. J.</given-names></name></person-group> (<year>2016</year>). <article-title>IgE and Mast Cells in Host Defense against Parasites and Venoms</article-title>. <source>Semin. Immunopathol.</source><volume>38</volume> (<issue>5</issue>), <fpage>581</fpage>&#8211;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1007/s00281-016-0565-1</pub-id><pub-id pub-id-type="pmid">27225312</pub-id><pub-id pub-id-type="pmcid">PMC5010491</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mutapi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Bourke</surname><given-names>C.</given-names></name><name name-style="western"><surname>Harcus</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Midzi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Mduluza</surname><given-names>T.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>C. M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Differential Recognition Patterns of <italic toggle="yes">Schistosoma Haematobium</italic> Adult Worm Antigens by the Human Antibodies IgA, IgE, IgG1 and IgG4</article-title>. <source>Parasite Immunol.</source><volume>33</volume> (<issue>3</issue>), <fpage>181</fpage>&#8211;<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3024.2010.01270.x</pub-id><pub-id pub-id-type="pmid">21204849</pub-id><pub-id pub-id-type="pmcid">PMC3084999</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mutoh</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hayashi</surname><given-names>Y.</given-names></name></person-group> (<year>1994</year>). <article-title>Molecular Cloning and Nucleotide Sequencing of <italic toggle="yes">Schizosaccharomyces pombe</italic> Homologue of the Class II Fructose-L,6-Bisphosphate Aldolase Gene</article-title>. <source>Biochim. Biophys. Acta</source><volume>1183</volume> (<issue>3</issue>), <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1016/0005-2728(94)90084-1</pub-id><pub-id pub-id-type="pmid">8286404</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakahara</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>H.</given-names></name><name name-style="western"><surname>Miyake</surname><given-names>C.</given-names></name><name name-style="western"><surname>Yokota</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Purification and Characterization of Class-I and Class-II Fructose-1,6-Bisphosphate Aldolases from the Cyanobacterium <italic toggle="yes">Synechocystis</italic> Sp. PCC 6803</article-title>. <source>Plant Cel Physiol.</source><volume>44</volume> (<issue>3</issue>), <fpage>326</fpage>&#8211;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1093/pcp/pcg044</pub-id><pub-id pub-id-type="pmid">12668779</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nandan</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tran</surname><given-names>T.</given-names></name><name name-style="western"><surname>Trinh</surname><given-names>E.</given-names></name><name name-style="western"><surname>Silverman</surname><given-names>J. M.</given-names></name><name name-style="western"><surname>Lopez</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Identification of Leishmania Fructose-1,6-Bisphosphate Aldolase as a Novel Activator of Host Macrophage Src Homology 2 Domain Containing Protein Tyrosine Phosphatase SHP-1</article-title>. <source>Biochem. Biophys. Res. Commun.</source><volume>364</volume> (<issue>3</issue>), <fpage>601</fpage>&#8211;<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.10.065</pub-id><pub-id pub-id-type="pmid">18028878</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nemetski</surname><given-names>S. M.</given-names></name><name name-style="western"><surname>Cardozo</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Bosch</surname><given-names>G.</given-names></name><name name-style="western"><surname>Weltzer</surname><given-names>R.</given-names></name><name name-style="western"><surname>O&#8217;Malley</surname><given-names>K.</given-names></name><name name-style="western"><surname>Ejigiri</surname><given-names>I.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Inhibition by Stabilization: Targeting the <italic toggle="yes">Plasmodium Falciparum</italic> Aldolase&#8211;TRAP Complex</article-title>. <source>Malar. J.</source><volume>14</volume> (<issue>1</issue>), <fpage>324</fpage>. <pub-id pub-id-type="doi">10.1186/s12936-015-0834-9</pub-id><pub-id pub-id-type="pmid">26289816</pub-id><pub-id pub-id-type="pmcid">PMC4545932</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Oldfield</surname><given-names>N. J.</given-names></name><name name-style="western"><surname>Shams</surname><given-names>F.</given-names></name><name name-style="western"><surname>Wooldridge</surname><given-names>K. G.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>D. P. J.</given-names></name></person-group> (<year>2017</year>). &#8220;<article-title>Moonlighting Functions of Bacterial Fructose 1,6-bisphosphate Aldolase</article-title>,&#8221; in <source>Moonlighting Proteins: Novel Virulence Factors in Bacterial Infections</source>. Editor <person-group person-group-type="editor"><name name-style="western"><surname>Henderson</surname><given-names>B.</given-names></name></person-group>. <edition>1st Edition</edition> (<publisher-name>Wiley-Blackwell</publisher-name>), <fpage>321</fpage>&#8211;<lpage>327</lpage>. </mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pagani</surname><given-names>T. D.</given-names></name><name name-style="western"><surname>Guimar&#227;es</surname><given-names>A. C. R.</given-names></name><name name-style="western"><surname>Waghabi</surname><given-names>M. C.</given-names></name><name name-style="western"><surname>Corr&#234;a</surname><given-names>P. R.</given-names></name><name name-style="western"><surname>Kalume</surname><given-names>D. E.</given-names></name><name name-style="western"><surname>Berr&#234;do-Pinho</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Exploring the Potential Role of Moonlighting Function of the Surface-Associated Proteins from Mycobacterium Bovis BCG Moreau and Pasteur by Comparative Proteomic</article-title>. <source>Front. Immunol.</source><volume>10</volume>, <fpage>716</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00716</pub-id><pub-id pub-id-type="pmid">31080447</pub-id><pub-id pub-id-type="pmcid">PMC6497762</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palm</surname><given-names>J. E. D.</given-names></name><name name-style="western"><surname>Weiland</surname><given-names>M. E. L.</given-names></name><name name-style="western"><surname>Griffiths</surname><given-names>W. J.</given-names></name><name name-style="western"><surname>Ljungstr&#246;m</surname><given-names>I.</given-names></name><name name-style="western"><surname>Sv&#228;rd</surname><given-names>S. G.</given-names></name></person-group> (<year>2003</year>). <article-title>Identification of Immunoreactive Proteins during Acute Human Giardiasis</article-title>. <source>J. Infect. Dis.</source><volume>187</volume> (<issue>12</issue>), <fpage>1849</fpage>&#8211;<lpage>1859</lpage>. <pub-id pub-id-type="doi">10.1086/375356</pub-id><pub-id pub-id-type="pmid">12792861</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pegan</surname><given-names>S. D.</given-names></name><name name-style="western"><surname>Rukseree</surname><given-names>K.</given-names></name><name name-style="western"><surname>Capodagli</surname><given-names>G. C.</given-names></name><name name-style="western"><surname>Baker</surname><given-names>E. A.</given-names></name><name name-style="western"><surname>Krasnykh</surname><given-names>O.</given-names></name><name name-style="western"><surname>Franzblau</surname><given-names>S. G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Active Site Loop Dynamics of a Class IIa Fructose 1,6-Bisphosphate Aldolase from Mycobacterium tuberculosis</article-title>. <source>Biochemistry</source><volume>52</volume> (<issue>5</issue>), <fpage>912</fpage>&#8211;<lpage>925</lpage>. <pub-id pub-id-type="doi">10.1021/bi300928u</pub-id><pub-id pub-id-type="pmid">23298222</pub-id><pub-id pub-id-type="pmcid">PMC4170518</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pegan</surname><given-names>S. D.</given-names></name><name name-style="western"><surname>Rukseree</surname><given-names>K.</given-names></name><name name-style="western"><surname>Franzblau</surname><given-names>S. G.</given-names></name><name name-style="western"><surname>Mesecar</surname><given-names>A. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Structural Basis for Catalysis of a Tetrameric Class IIa Fructose 1,6-Bisphosphate Aldolase from Mycobacterium tuberculosis</article-title>. <source>J. Mol. Biol.</source><volume>386</volume> (<issue>4</issue>), <fpage>1038</fpage>&#8211;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2009.01.003</pub-id><pub-id pub-id-type="pmid">19167403</pub-id><pub-id pub-id-type="pmcid">PMC2654403</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perrin</surname><given-names>L. H.</given-names></name><name name-style="western"><surname>Merkli</surname><given-names>B.</given-names></name><name name-style="western"><surname>Gabra</surname><given-names>M. S.</given-names></name><name name-style="western"><surname>Stocker</surname><given-names>J. W.</given-names></name><name name-style="western"><surname>Chizzolini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Richle</surname><given-names>R.</given-names></name></person-group> (<year>1985</year>). <article-title>Immunization with a <italic toggle="yes">Plasmodium Falciparum</italic> Merozoite Surface Antigen Induces a Partial Immunity in Monkeys</article-title>. <source>J. Clin. Invest.</source><volume>75</volume> (<issue>5</issue>), <fpage>1718</fpage>&#8211;<lpage>1721</lpage>. <pub-id pub-id-type="doi">10.1172/jci111881</pub-id><pub-id pub-id-type="pmid">3889058</pub-id><pub-id pub-id-type="pmcid">PMC425516</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pirovich</surname><given-names>D. B.</given-names></name><name name-style="western"><surname>Da'dara</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Skelly</surname><given-names>P. J.</given-names></name></person-group> (<year>2020</year>). <article-title><italic toggle="yes">Schistosoma Mansoni</italic> Glyceraldehyde-3-Phosphate Dehydrogenase Enhances Formation of the Blood-Clot Lysis Protein Plasmin</article-title>. <source>Biol. Open</source><volume>9</volume> (<issue>3</issue>), <fpage>bio050385</fpage>. <pub-id pub-id-type="doi">10.1242/bio.050385</pub-id><pub-id pub-id-type="pmid">32098782</pub-id><pub-id pub-id-type="pmcid">PMC7104858</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pirovich</surname><given-names>D.</given-names></name><name name-style="western"><surname>Da'dara</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Skelly</surname><given-names>P. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Why Do Intravascular Schistosomes Coat Themselves in Glycolytic Enzymes?</article-title><source>BioEssays</source><volume>41</volume> (<issue>12</issue>), <fpage>1900103</fpage>. <pub-id pub-id-type="doi">10.1002/bies.201900103</pub-id><pub-id pub-id-type="pmid">31661165</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Portnoi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ling</surname><given-names>E.</given-names></name><name name-style="western"><surname>Feldman</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dagan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Mizrachi-Nebenzahl</surname><given-names>Y.</given-names></name></person-group> (<year>2006</year>). <article-title>The Vaccine Potential of <italic toggle="yes">Streptococcus Pneumoniae</italic> Surface Lectin- and Non-lectin Proteins</article-title>. <source>Vaccine</source><volume>24</volume> (<issue>11</issue>), <fpage>1868</fpage>&#8211;<lpage>1873</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2005.10.053</pub-id><pub-id pub-id-type="pmid">16316712</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prasad</surname><given-names>C. S.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tiwari</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Evolutionary and Functional Analysis of Fructose Bisphosphate Aldolase of Plant Parasitic Nematodes</article-title>. <source>Bioinformation</source><volume>9</volume> (<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.6026/97320630009001</pub-id><pub-id pub-id-type="pmid">23390337</pub-id><pub-id pub-id-type="pmcid">PMC3563409</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Privitera</surname><given-names>D.</given-names></name><name name-style="western"><surname>Corti</surname><given-names>V.</given-names></name><name name-style="western"><surname>Alessio</surname><given-names>M.</given-names></name><name name-style="western"><surname>Volont&#232;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lampasona</surname><given-names>V.</given-names></name><name name-style="western"><surname>Comi</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Proteomic Identification of Aldolase A as an Autoantibody Target in Patients with Atypical Movement Disorders</article-title>. <source>Neurol. Sci.</source><volume>34</volume> (<issue>3</issue>), <fpage>313</fpage>&#8211;<lpage>320</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-012-0996-y</pub-id><pub-id pub-id-type="pmid">22391679</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramajo-Hern&#225;ndez</surname><given-names>A.</given-names></name><name name-style="western"><surname>P&#233;rez-S&#225;nchez</surname><given-names>R.</given-names></name><name name-style="western"><surname>Ramajo-Mart&#237;n</surname><given-names>V.</given-names></name><name name-style="western"><surname>Oleaga</surname><given-names>A.</given-names></name></person-group> (<year>2007</year>). <article-title><italic toggle="yes">Schistosoma Bovis</italic>: Plasminogen Binding in Adults and the Identification of Plasminogen-Binding Proteins from the Worm Tegument</article-title>. <source>Exp. Parasitol.</source><volume>115</volume> (<issue>1</issue>), <fpage>83</fpage>&#8211;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2006.07.003</pub-id><pub-id pub-id-type="pmid">16962583</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ramsaywak</surname><given-names>P. C.</given-names></name><name name-style="western"><surname>Labb&#233;</surname><given-names>G.</given-names></name><name name-style="western"><surname>Siemann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dmitrienko</surname><given-names>G. I.</given-names></name><name name-style="western"><surname>Guillemette</surname><given-names>J. G.</given-names></name></person-group> (<year>2004</year>). <article-title>Molecular Cloning, Expression, Purification, and Characterization of Fructose 1,6-bisphosphate Aldolase from Mycobacterium Tuberculosis-A Novel Class II A Tetramer</article-title>. <source>Protein Expr. Purif.</source><volume>37</volume> (<issue>1</issue>), <fpage>220</fpage>&#8211;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/j.pep.2004.05.011</pub-id><pub-id pub-id-type="pmid">15294302</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rangarajan</surname><given-names>E. S.</given-names></name><name name-style="western"><surname>Park</surname><given-names>H.</given-names></name><name name-style="western"><surname>Fortin</surname><given-names>E.</given-names></name><name name-style="western"><surname>Sygusch</surname><given-names>J.</given-names></name><name name-style="western"><surname>Izard</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Mechanism of Aldolase Control of Sorting Nexin 9 Function in Endocytosis</article-title>. <source>J. Biol. Chem.</source><volume>285</volume> (<issue>16</issue>), <fpage>11983</fpage>&#8211;<lpage>11990</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m109.092049</pub-id><pub-id pub-id-type="pmid">20129922</pub-id><pub-id pub-id-type="pmcid">PMC2852936</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ravid&#224;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Cwiklinski</surname><given-names>K.</given-names></name><name name-style="western"><surname>Aldridge</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>P.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>R.</given-names></name><name name-style="western"><surname>Gerlach</surname><given-names>J. Q.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title><italic toggle="yes">Fasciola Hepatica</italic> Surface Tegument: Glycoproteins at the Interface of Parasite and Host</article-title>. <source>Mol. Cell Proteom.</source><volume>15</volume> (<issue>10</issue>), <fpage>3139</fpage>&#8211;<lpage>3153</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.m116.059774</pub-id><pub-id pub-id-type="pmcid">PMC5054340</pub-id><pub-id pub-id-type="pmid">27466253</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Rawla</surname><given-names>P.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). &#8220;<article-title>Trichinella Spiralis (Trichnellosis)</article-title>,&#8221; in <source>StatPearls</source> (<publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>). </mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saber</surname><given-names>M.</given-names></name><name name-style="western"><surname>Diab</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hammam</surname><given-names>O.</given-names></name><name name-style="western"><surname>Karim</surname><given-names>A.</given-names></name><name name-style="western"><surname>Medhat</surname><given-names>A.</given-names></name><name name-style="western"><surname>Khela</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Protective and Anti-pathology Effects of Sm Fructose-1,6-Bisphosphate Aldolase-Based DNA Vaccine against <italic toggle="yes">Schistosoma Mansoni</italic> by Changing Route of Injection</article-title>. <source>Korean J. Parasitol.</source><volume>51</volume> (<issue>2</issue>), <fpage>155</fpage>&#8211;<lpage>163</lpage>. <pub-id pub-id-type="doi">10.3347/kjp.2013.51.2.155</pub-id><pub-id pub-id-type="pmid">23710082</pub-id><pub-id pub-id-type="pmcid">PMC3662058</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>L. N.</given-names></name><name name-style="western"><surname>Gallo</surname><given-names>M. B. C.</given-names></name><name name-style="western"><surname>Silva</surname><given-names>E. S.</given-names></name><name name-style="western"><surname>Figueiredo</surname><given-names>C. A. V.</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>P. J.</given-names></name><name name-style="western"><surname>Barreto</surname><given-names>M. L.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>A Proteomic Approach to Identify Proteins fromTrichuris Trichiuraextract with Immunomodulatory Effects</article-title>. <source>Parasite Immunol.</source><volume>35</volume> (<issue>5</issue>), <fpage>188</fpage>&#8211;<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1111/pim.12025</pub-id><pub-id pub-id-type="pmid">23398517</pub-id><pub-id pub-id-type="pmcid">PMC7612816</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Say</surname><given-names>R. F.</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>G.</given-names></name></person-group> (<year>2010</year>). <article-title>Fructose 1,6-bisphosphate Aldolase/phosphatase May Be an Ancestral Gluconeogenic Enzyme</article-title>. <source>Nature</source><volume>464</volume> (<issue>7291</issue>), <fpage>1077</fpage>&#8211;<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1038/nature08884</pub-id><pub-id pub-id-type="pmid">20348906</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Semenyuta</surname><given-names>I. V.</given-names></name><name name-style="western"><surname>Kobzar</surname><given-names>O. L.</given-names></name><name name-style="western"><surname>Hodyna</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Brovarets</surname><given-names>V. S.</given-names></name><name name-style="western"><surname>Metelytsia</surname><given-names>L. O.</given-names></name></person-group> (<year>2019</year>). <article-title>In Silico study of 4-phosphorylated Derivatives of 1,3-oxazole as Inhibitors of Candida Albicans Fructose-1,6-Bisphosphate Aldolase II</article-title>. <source>Heliyon</source><volume>5</volume> (<issue>4</issue>), <fpage>e01462</fpage>. <pub-id pub-id-type="doi">10.1016/j.heliyon.2019.e01462</pub-id><pub-id pub-id-type="pmid">31011642</pub-id><pub-id pub-id-type="pmcid">PMC6460381</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Severin</surname><given-names>A.</given-names></name><name name-style="western"><surname>Nickbarg</surname><given-names>E.</given-names></name><name name-style="western"><surname>Wooters</surname><given-names>J.</given-names></name><name name-style="western"><surname>Quazi</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Matsuka</surname><given-names>Y. V.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Proteomic Analysis and Identification of <italic toggle="yes">Streptococcus Pyogenes</italic> Surface-Associated Proteins</article-title>. <source>J. Bacteriol.</source><volume>189</volume> (<issue>5</issue>), <fpage>1514</fpage>&#8211;<lpage>1522</lpage>. <pub-id pub-id-type="doi">10.1128/jb.01132-06</pub-id><pub-id pub-id-type="pmid">17142387</pub-id><pub-id pub-id-type="pmcid">PMC1855729</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shakerley</surname><given-names>N. L.</given-names></name><name name-style="western"><surname>Chandrasekaran</surname><given-names>A.</given-names></name><name name-style="western"><surname>Trebak</surname><given-names>M.</given-names></name><name name-style="western"><surname>Miller</surname><given-names>B. A.</given-names></name><name name-style="western"><surname>Melendez</surname><given-names>J. A.</given-names></name></person-group> (<year>2016</year>). <article-title><italic toggle="yes">Francisella Tularensis</italic> Catalase Restricts Immune Function by Impairing TRPM2 Channel Activity</article-title>. <source>J. Biol. Chem.</source><volume>291</volume> (<issue>8</issue>), <fpage>3871</fpage>&#8211;<lpage>3881</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m115.706879</pub-id><pub-id pub-id-type="pmid">26679996</pub-id><pub-id pub-id-type="pmcid">PMC4759167</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shams</surname><given-names>F.</given-names></name><name name-style="western"><surname>Oldfield</surname><given-names>N. J.</given-names></name><name name-style="western"><surname>Lai</surname><given-names>S. K.</given-names></name><name name-style="western"><surname>Tunio</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Wooldridge</surname><given-names>K. G.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>D. P. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Fructose&#8208;1,6&#8208;bisphosphate Aldolase of Neisseria Meningitidis Binds Human Plasminogen <italic toggle="yes">via</italic> its C&#8208;terminal Lysine Residue</article-title>. <source>Microbiologyopen</source><volume>5</volume> (<issue>2</issue>), <fpage>340</fpage>&#8211;<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1002/mbo3.331</pub-id><pub-id pub-id-type="pmid">26732512</pub-id><pub-id pub-id-type="pmcid">PMC4831477</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shams</surname><given-names>F.</given-names></name><name name-style="western"><surname>Oldfield</surname><given-names>N. J.</given-names></name><name name-style="western"><surname>Wooldridge</surname><given-names>K. G.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>D. P. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Fructose-1,6-bisphosphate Aldolase (FBA)-a Conserved Glycolytic Enzyme with Virulence Functions in Bacteria: 'ill Met by Moonlight'</article-title>. <source>Biochem. Soc. Trans.</source><volume>42</volume> (<issue>6</issue>), <fpage>1792</fpage>&#8211;<lpage>1795</lpage>. <pub-id pub-id-type="doi">10.1042/bst20140203</pub-id><pub-id pub-id-type="pmid">25399608</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Sibley</surname><given-names>L. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Toxoplasmaaldolase Is Required for Metabolism but Dispensable for Host-Cell Invasion</article-title>. <source>Proc. Natl. Acad. Sci. USA</source><volume>111</volume> (<issue>9</issue>), <fpage>3567</fpage>&#8211;<lpage>3572</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1315156111</pub-id><pub-id pub-id-type="pmid">24550496</pub-id><pub-id pub-id-type="pmcid">PMC3948255</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siebers</surname><given-names>B.</given-names></name><name name-style="western"><surname>Brinkmann</surname><given-names>H.</given-names></name><name name-style="western"><surname>D&#246;rr</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tjaden</surname><given-names>B.</given-names></name><name name-style="western"><surname>Lilie</surname><given-names>H.</given-names></name><name name-style="western"><surname>van der Oost</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Archaeal Fructose-1,6-Bisphosphate Aldolases Constitute a New Family of Archaeal Type Class I Aldolase</article-title>. <source>J. Biol. Chem.</source><volume>276</volume> (<issue>31</issue>), <fpage>28710</fpage>&#8211;<lpage>28718</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m103447200</pub-id><pub-id pub-id-type="pmid">11387336</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siemann</surname><given-names>S.</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Viswanatha</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dmitrienko</surname><given-names>G. I.</given-names></name></person-group> (<year>2003</year>). <article-title>Thiols as Classical and Slow-Binding Inhibitors of IMP-1 and Other Binuclear Metallo-&#946;-Lactamases&#8224;</article-title>. <source>Biochemistry</source><volume>42</volume> (<issue>6</issue>), <fpage>1673</fpage>&#8211;<lpage>1683</lpage>. <pub-id pub-id-type="doi">10.1021/bi027072i</pub-id><pub-id pub-id-type="pmid">12578382</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Srivastava</surname><given-names>I. K.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>M.</given-names></name><name name-style="western"><surname>Certa</surname><given-names>U.</given-names></name><name name-style="western"><surname>D&#246;beli</surname><given-names>H.</given-names></name><name name-style="western"><surname>Perrin</surname><given-names>L. H.</given-names></name></person-group> (<year>1990</year>). <article-title>Specificity and Inhibitory Activity of Antibodies to <italic toggle="yes">Plasmodium Falciparum</italic> Aldolase</article-title>. <source>J. Immunol.</source><volume>144</volume> (<issue>4</issue>), <fpage>1497</fpage>&#8211;<lpage>1503</lpage>. <pub-id pub-id-type="pmid">2406342</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steisslinger</surname><given-names>V.</given-names></name><name name-style="western"><surname>Korten</surname><given-names>S.</given-names></name><name name-style="western"><surname>Brattif</surname><given-names>N. W.</given-names></name><name name-style="western"><surname>Erttmann</surname><given-names>K. D.</given-names></name></person-group> (<year>2015</year>). <article-title>DNA Vaccine Encoding the Moonlighting Protein <italic toggle="yes">Onchocerca Volvulus</italic> Glyceraldehyde-3-Phosphate Dehydrogenase (Ov-GAPDH) Leads to Partial protection in a Mouse Model of Human Filariasis</article-title>. <source>Vaccine</source><volume>33</volume>, <fpage>5861</fpage>&#8211;<lpage>5867</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2015.07.110</pub-id><pub-id pub-id-type="pmid">26320419</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stie</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bruni</surname><given-names>G.</given-names></name><name name-style="western"><surname>Fox</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Surface-associated Plasminogen Binding of <italic toggle="yes">Cryptococcus Neoforman</italic>s Promotes Extracellular Matrix Invasion</article-title>. <source>PLoS One</source><volume>4</volume>, <fpage>e5780</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0005780</pub-id><pub-id pub-id-type="pmid">19492051</pub-id><pub-id pub-id-type="pmcid">PMC2685986</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strapazon</surname><given-names>E.</given-names></name><name name-style="western"><surname>Steck</surname><given-names>T. L.</given-names></name></person-group> (<year>1976</year>). <article-title>Binding of Rabbit Muscle Aldolase to Band 3, the Predominant Polypeptide of the Human Erythrocyte Membrane</article-title>. <source>Biochemistry</source><volume>15</volume> (<issue>7</issue>), <fpage>1421</fpage>&#8211;<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1021/bi00652a011</pub-id><pub-id pub-id-type="pmid">1259946</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stribling</surname><given-names>D.</given-names></name><name name-style="western"><surname>Perham</surname><given-names>R. N.</given-names></name></person-group> (<year>1973</year>). <article-title>Purification and Characterization of Two Fructose Diphosphate Aldolases from Escherichia coli (Crookes' Strain)</article-title>. <source>Biochem. J.</source><volume>131</volume> (<issue>4</issue>), <fpage>833</fpage>&#8211;<lpage>841</lpage>. <pub-id pub-id-type="doi">10.1042/bj1310833</pub-id><pub-id pub-id-type="pmid">4198624</pub-id><pub-id pub-id-type="pmcid">PMC1177543</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>S. Z.</given-names></name><name name-style="western"><surname>Empie</surname><given-names>M. W.</given-names></name></person-group> (<year>2012</year>). <article-title>Fructose Metabolism in Humans - what Isotopic Tracer Studies Tell Us</article-title>. <source>Nutr. Metab.</source><volume>9</volume>, <fpage>89</fpage>. <pub-id pub-id-type="doi">10.1186/1743-7075-9-89</pub-id><pub-id pub-id-type="pmcid">PMC3533803</pub-id><pub-id pub-id-type="pmid">23031075</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>B.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>The Secreted Fructose 1,6-bisphosphate Aldolase as a Broad Spectrum Vaccine Candidate against Pathogenic Bacteria in Aquaculture</article-title>. <source>Fish Shellfish Immunol.</source><volume>46</volume> (<issue>2</issue>), <fpage>638</fpage>&#8211;<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1016/j.fsi.2015.08.001</pub-id><pub-id pub-id-type="pmid">26256425</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ta</surname><given-names>T.-V.</given-names></name><name name-style="western"><surname>Takano</surname><given-names>R.</given-names></name><name name-style="western"><surname>Kamei</surname><given-names>K.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X.-Y.</given-names></name><name name-style="western"><surname>Kariya</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>K.</given-names></name><etal/></person-group> (<year>1999</year>). <article-title>Fructose 1,6-bisphosphate Aldolase Is a Heparin-Binding Protein</article-title>. <source>J. Biochem.</source><volume>125</volume> (<issue>3</issue>), <fpage>554</fpage>&#8211;<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a022320</pub-id><pub-id pub-id-type="pmid">10050044</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>C. L.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Y. P.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>W. H.</given-names></name><name name-style="western"><surname>Jin</surname><given-names>L.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z. L.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z. R.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Effects of Regulatory T Cells on Glyceraldehyde-3-Phosphate Dehydrogenase Vaccine Efficacy Against <italic toggle="yes">Schistosoma japonicum</italic>
</article-title>. <source>Acta. Trop.</source><volume>202</volume>, <fpage>105239</fpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2019.105239</pub-id><pub-id pub-id-type="pmid">31669534</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teixeira</surname><given-names>M. M.</given-names></name><name name-style="western"><surname>Theodoro</surname><given-names>R. C.</given-names></name><name name-style="western"><surname>Oliveira</surname><given-names>F. F.</given-names></name><name name-style="western"><surname>Machado</surname><given-names>G. C.</given-names></name><name name-style="western"><surname>Hahn</surname><given-names>R. C.</given-names></name><name name-style="western"><surname>Bagagli</surname><given-names>E.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title><italic toggle="yes">Paracoccidioides Lutzii</italic> Sp. nov.: Biological and Clinical Implications</article-title>. <source>Med. Mycol.</source><volume>52</volume> (<issue>1</issue>), <fpage>19</fpage>&#8211;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.3109/13693786.2013.794311</pub-id><pub-id pub-id-type="pmid">23768243</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thiangtrongjit</surname><given-names>T.</given-names></name><name name-style="western"><surname>Adisakwattana</surname><given-names>P.</given-names></name><name name-style="western"><surname>Limpanont</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Dekumyoy</surname><given-names>P.</given-names></name><name name-style="western"><surname>Nuamtanong</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chusongsang</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Proteomic and Immunomic Analysis of <italic toggle="yes">Schistosoma Mekongi</italic> Egg Proteins</article-title>. <source>Exp. Parasitol.</source><volume>191</volume>, <fpage>88</fpage>&#8211;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2018.07.002</pub-id><pub-id pub-id-type="pmid">30009810</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomson</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Howlett</surname><given-names>G. J.</given-names></name><name name-style="western"><surname>Ashcroft</surname><given-names>A. E.</given-names></name><name name-style="western"><surname>Berry</surname><given-names>A.</given-names></name></person-group> (<year>1998</year>). <article-title>The dhnA Gene of <italic toggle="yes">Escherichia coli</italic> Encodes a Class I Fructose Bisphosphate Aldolase</article-title>. <source>Biochem. J.</source><volume>331</volume> (<issue>Pt 2</issue>), <fpage>437</fpage>&#8211;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1042/bj3310437</pub-id><pub-id pub-id-type="pmid">9531482</pub-id><pub-id pub-id-type="pmcid">PMC1219373</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tien</surname><given-names>C.-F.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>S.-C.</given-names></name><name name-style="western"><surname>Ho</surname><given-names>Y.-P.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y.-S.</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>J.-H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>R.-Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Inhibition of Aldolase A Blocks Biogenesis of ATP and Attenuates Japanese Encephalitis Virus Production</article-title>. <source>Biochem. Biophys. Res. Commun.</source><volume>443</volume> (<issue>2</issue>), <fpage>464</fpage>&#8211;<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2013.11.128</pub-id><pub-id pub-id-type="pmid">24321549</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tolan</surname><given-names>D. R.</given-names></name><name name-style="western"><surname>Niclas</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bruce</surname><given-names>B. D.</given-names></name><name name-style="western"><surname>Lebo</surname><given-names>R. V.</given-names></name></person-group> (<year>1987</year>). <article-title>Evolutionary Implications of the Human Aldolase-A, -B, -C, and -pseudogene Chromosome Locations</article-title>. <source>Am. J. Hum. Genet.</source><volume>41</volume> (<issue>5</issue>), <fpage>907</fpage>&#8211;<lpage>924</lpage>. <pub-id pub-id-type="pmid">3674018</pub-id><pub-id pub-id-type="pmcid">PMC1684339</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tunio</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Oldfield</surname><given-names>N. J.</given-names></name><name name-style="western"><surname>Berry</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ala'Aldeen</surname><given-names>D. A. A.</given-names></name><name name-style="western"><surname>Wooldridge</surname><given-names>K. G.</given-names></name><name name-style="western"><surname>Turner</surname><given-names>D. P. J.</given-names></name></person-group> (<year>2010</year>). <article-title>The Moonlighting Protein Fructose-1, 6-bisphosphate Aldolase of <italic toggle="yes">Neisseria Meningitidis</italic>: Surface Localization and Role in Host Cell Adhesion</article-title>. <source>Mol. Microbiol.</source><volume>76</volume> (<issue>3</issue>), <fpage>605</fpage>&#8211;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2010.07098.x</pub-id><pub-id pub-id-type="pmid">20199602</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Duin</surname><given-names>D.</given-names></name><name name-style="western"><surname>Medzhitov</surname><given-names>R.</given-names></name><name name-style="western"><surname>Shaw</surname><given-names>A. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Triggering TLR Signaling in Vaccination</article-title>. <source>Trends. Immunol.</source><volume>27</volume> (<issue>1</issue>), <fpage>49</fpage>&#8211;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.it.2005.11.005</pub-id><pub-id pub-id-type="pmid">16310411</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vander Heiden</surname><given-names>M. G.</given-names></name><name name-style="western"><surname>Cantley</surname><given-names>L. C.</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>C. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Understanding the Warburg Effect: the Metabolic Requirements of Cell Proliferation</article-title>. <source>Science</source><volume>324</volume> (<issue>5930</issue>), <fpage>1029</fpage>&#8211;<lpage>1033</lpage>. <pub-id pub-id-type="doi">10.1126/science.1160809</pub-id><pub-id pub-id-type="pmid">19460998</pub-id><pub-id pub-id-type="pmcid">PMC2849637</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verlinde</surname><given-names>C. L. M. J.</given-names></name><name name-style="western"><surname>Hannaert</surname><given-names>V.</given-names></name><name name-style="western"><surname>Blonski</surname><given-names>C.</given-names></name><name name-style="western"><surname>Willson</surname><given-names>M.</given-names></name><name name-style="western"><surname>P&#233;ri&#233;</surname><given-names>J. J.</given-names></name><name name-style="western"><surname>Fothergill-Gilmore</surname><given-names>L. A.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Glycolysis as a Target for the Design of New Anti-trypanosome Drugs</article-title>. <source>Drug Resist. Updates</source><volume>4</volume> (<issue>1</issue>), <fpage>50</fpage>&#8211;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1054/drup.2000.0177</pub-id><pub-id pub-id-type="pmid">11512153</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Volker</surname><given-names>K. W.</given-names></name><name name-style="western"><surname>Knull</surname><given-names>H. R.</given-names></name></person-group> (<year>1997</year>). <article-title>A Glycolytic Enzyme Binding Domain on Tubulin</article-title>. <source>Arch. Biochem. Biophys.</source><volume>338</volume> (<issue>2</issue>), <fpage>237</fpage>&#8211;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1006/abbi.1996.9819</pub-id><pub-id pub-id-type="pmid">9028878</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tolan</surname><given-names>D. R.</given-names></name><name name-style="western"><surname>Pagliaro</surname><given-names>L.</given-names></name></person-group> (<year>1997</year>). <article-title>Metabolic Compartmentation in Living Cells: Structural Association of Aldolase</article-title>. <source>Exp. Cel Res.</source><volume>237</volume> (<issue>2</issue>), <fpage>445</fpage>&#8211;<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1006/excr.1997.3811</pub-id><pub-id pub-id-type="pmid">9434640</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Jeffery</surname><given-names>C. J.</given-names></name></person-group> (<year>2016</year>). <article-title>An Analysis of Surface Proteomics Results Reveals Novel Candidates for Intracellular/surface Moonlighting Proteins in Bacteria</article-title>. <source>Mol. Biosyst.</source><volume>12</volume> (<issue>2</issue>), <fpage>1420</fpage>&#8211;<lpage>1431</lpage>. <pub-id pub-id-type="doi">10.1039/c5mb00550g</pub-id><pub-id pub-id-type="pmid">26938107</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilde</surname><given-names>S.</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Tafoya</surname><given-names>A. M.</given-names></name><name name-style="western"><surname>Horsman</surname><given-names>J.</given-names></name><name name-style="western"><surname>Yousif</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vazquez</surname><given-names>L. A.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Salmonella-vectored Vaccine Delivering Three Clostridium perfringens Antigens Protects Poultry against Necrotic Enteritis</article-title>. <source>PLoS One</source><volume>14</volume>, <fpage>e0197721</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0197721</pub-id><pub-id pub-id-type="pmid">30753181</pub-id><pub-id pub-id-type="pmcid">PMC6372158</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Witke</surname><given-names>C.</given-names></name><name name-style="western"><surname>G&#246;tz</surname><given-names>F.</given-names></name></person-group> (<year>1993</year>). <article-title>Cloning, Sequencing, and Characterization of the Gene Encoding the Class I Fructose-1,6-Bisphosphate Aldolase of <italic toggle="yes">Staphylococcus Carnosus</italic>
</article-title>. <source>J. Bacteriol.</source><volume>175</volume> (<issue>22</issue>), <fpage>7495</fpage>&#8211;<lpage>7499</lpage>. <pub-id pub-id-type="doi">10.1128/jb.175.22.7495-7499.1993</pub-id><pub-id pub-id-type="pmid">8226699</pub-id><pub-id pub-id-type="pmcid">PMC206899</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Autoantibodies in Alzheimer's Disease: Potential Biomarkers, Pathogenic Roles, and Therapeutic Implications</article-title>. <source>J. Biomed. Res.</source><volume>30</volume> (<issue>5</issue>), <fpage>361</fpage>&#8211;<lpage>372</lpage>. <pub-id pub-id-type="doi">10.7555/JBR.30.20150131</pub-id><pub-id pub-id-type="pmid">27476881</pub-id><pub-id pub-id-type="pmcid">PMC5044708</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Immunoproteomic Assay of Surface Proteins ofStreptococcus Suisserotype 9</article-title>. <source>FEMS Immunol. Med. Microbiol.</source><volume>53</volume> (<issue>1</issue>), <fpage>52</fpage>&#8211;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1111/j.1574-695x.2008.00401.x</pub-id><pub-id pub-id-type="pmid">18371070</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Cutler</surname><given-names>J. E.</given-names></name></person-group> (<year>2011</year>). <article-title>Vaccine and Monoclonal Antibody that Enhance Mouse Resistance to Candidiasis</article-title>. <source>Clin. Vaccin. Immunol.</source><volume>18</volume> (<issue>10</issue>), <fpage>1656</fpage>&#8211;<lpage>1667</lpage>. <pub-id pub-id-type="doi">10.1128/cvi.05215-11</pub-id><pub-id pub-id-type="pmcid">PMC3187024</pub-id><pub-id pub-id-type="pmid">21832099</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Dziadek</surname><given-names>S.</given-names></name><name name-style="western"><surname>Bundle</surname><given-names>D. R.</given-names></name><name name-style="western"><surname>Cutler</surname><given-names>J. E.</given-names></name></person-group> (<year>2008</year>). <article-title>Synthetic Glycopeptide Vaccines Combining -mannan and Peptide Epitopes Induce protection against Candidiasis</article-title>. <source>Proc. Natl. Acad. Sci.</source><volume>105</volume> (<issue>36</issue>), <fpage>13526</fpage>&#8211;<lpage>13531</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0803195105</pub-id><pub-id pub-id-type="pmid">18725625</pub-id><pub-id pub-id-type="pmcid">PMC2533223</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xin</surname><given-names>H.</given-names></name><name name-style="western"><surname>Glee</surname><given-names>P.</given-names></name><name name-style="western"><surname>Adams</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mohiuddin</surname><given-names>F.</given-names></name><name name-style="western"><surname>Eberle</surname><given-names>K.</given-names></name></person-group> (<year>2019</year>). <article-title>Design of a Mimotope-Peptide Based Double Epitope Vaccine against Disseminated Candidiasis</article-title>. <source>Vaccine</source><volume>37</volume> (<issue>18</issue>), <fpage>2430</fpage>&#8211;<lpage>2438</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2019.03.061</pub-id><pub-id pub-id-type="pmid">30930005</pub-id><pub-id pub-id-type="pmcid">PMC6497404</pub-id></mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xolalpa</surname><given-names>W.</given-names></name><name name-style="western"><surname>Vallecillo</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Lara</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mendoza-Hernandez</surname><given-names>G.</given-names></name><name name-style="western"><surname>Comini</surname><given-names>M.</given-names></name><name name-style="western"><surname>Spallek</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Identification of Novel Bacterial Plasminogen-Binding Proteins in the Human Pathogen <italic toggle="yes">Mycobacterium tuberculosis</italic>
</article-title>. <source>Proteomics</source><volume>7</volume> (<issue>18</issue>), <fpage>3332</fpage>&#8211;<lpage>3341</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200600876</pub-id><pub-id pub-id-type="pmid">17849409</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>K.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name><name name-style="western"><surname>Luo</surname><given-names>Q.</given-names></name><name name-style="western"><surname>Shen</surname><given-names>J.</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Amelioration of Type 1 Diabetes by Recombinant Fructose-1,6-Bisphosphate Aldolase and Cystatin Derived from <italic toggle="yes">Schistosoma Japonicum</italic> in a Murine Model</article-title>. <source>Parasitol. Res.</source><volume>119</volume> (<issue>1</issue>), <fpage>203</fpage>&#8211;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-019-06511-7</pub-id><pub-id pub-id-type="pmid">31845020</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Bai</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>C.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>W.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Molecular Characterization of Fructose-1,6-Bisphosphate Aldolase from <italic toggle="yes">Trichinella spiralis</italic> and its Potential in Inducing Immune protection</article-title>. <source>Front. Cel Infect. Microbiol.</source><volume>9</volume>, <fpage>122</fpage>. <pub-id pub-id-type="doi">10.3389/fcimb.2019.00122</pub-id><pub-id pub-id-type="pmcid">PMC6491450</pub-id><pub-id pub-id-type="pmid">31069178</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yeltman</surname><given-names>D. R.</given-names></name><name name-style="western"><surname>Harris</surname><given-names>B. G.</given-names></name></person-group> (<year>1977</year>). <article-title>Purification and Characterization of Aldolase from Human Erythrocytes</article-title>. <source>Biochim. Biophys. Acta Enzymol.</source><volume>484</volume> (<issue>1</issue>), <fpage>188</fpage>&#8211;<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2744(77)90124-3</pub-id><pub-id pub-id-type="pmid">889843</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hua</surname><given-names>L.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Fructose-1,6-bisphosphate Aldolase Encoded by a Core Gene of Mycoplasma Hyopneumoniae Contributes to Host Cell Adhesion</article-title>. <source>Vet. Res.</source><volume>49</volume>, <fpage>114</fpage>. <pub-id pub-id-type="doi">10.1186/s13567-018-0610-2</pub-id><pub-id pub-id-type="pmid">30454073</pub-id><pub-id pub-id-type="pmcid">PMC6245935</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>C.-S.</given-names></name><name name-style="western"><surname>Hawley</surname><given-names>S. A.</given-names></name><name name-style="western"><surname>Zong</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Gray</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Fructose-1,6-bisphosphate and Aldolase Mediate Glucose Sensing by AMPK</article-title>. <source>Nature</source><volume>548</volume> (<issue>7665</issue>), <fpage>112</fpage>&#8211;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1038/nature23275</pub-id><pub-id pub-id-type="pmid">28723898</pub-id><pub-id pub-id-type="pmcid">PMC5544942</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>F.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Synergistic Enhancement of Immunogenicity and protection in Mice against Schistosoma Japonicum with Codon Optimization and Electroporation Delivery of SjTPI DNA Vaccines</article-title>. <source>Vaccine</source><volume>28</volume> (<issue>32</issue>), <fpage>5347</fpage>&#8211;<lpage>5355</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2010.05.017</pub-id><pub-id pub-id-type="pmid">20483191</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ziveri</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tros</surname><given-names>F.</given-names></name><name name-style="western"><surname>Guerrera</surname><given-names>I. C.</given-names></name><name name-style="western"><surname>Chhuon</surname><given-names>C.</given-names></name><name name-style="western"><surname>Audry</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dupuis</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>The Metabolic Enzyme Fructose-1,6-Bisphosphate Aldolase Acts as a Transcriptional Regulator in Pathogenic Francisella</article-title>. <source>Nat. Commun.</source><volume>8</volume>, <fpage>853</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-00889-7</pub-id><pub-id pub-id-type="pmid">29021545</pub-id><pub-id pub-id-type="pmcid">PMC5636795</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>